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ABSTRACT 
Transient change of cytosolic calcium level leads to physiological actions, which are 
modulated by the intracellular calcium stores, and gated by membrane calcium channels/pumps.  
To closely monitor calcium dynamics there is a pressing need to develop calcium sensors that are 
targeted to high calcium environment such as the ER/SR with relatively low binding affinity and 
fast kinetic properties to complement the current calcium indicator toolkits. In this dissertation, 
the development of fast red florescent calcium binding protein using the protein design is report-
ed. The results show the calcium dependent fluorescence increase of mCherry mutant MCD1 
(RapidER) and MCD15 (RapidER’) is able to monitor the ER calcium release in several cell 
lines responding to perturbations of extracellular calcium signaling. The specific targeting to the 
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ER membrane was achieved by fusing the ryanodine receptor 1 transmembrane domains for the 
spatio-temporal calcium imaging.  
To understand the underlying mechanism of calcium binding induced fluorescence in-
crease in the designed calcium sensor CatchER, the fluorescence lifetime of CatchER was de-
termined in calcium free and bound forms using time resolved florescence spectroscopy. The re-
sults suggest that calcium binding inhibits the geminate quenching, resulting in a longer lifetime 
when the anionic form is indirectly excited at 395 nm. It is believed that such unique calcium-
induced lifetime change can be applied to monitor calcium signaling in cell imaging.  
NMR spectroscopy was used to investigate the protein-protein/ligand interaction in this 
dissertation. The residual dipolar coupling and T1, T2, NOE dynamic study were carried out to 
understand the binding mode of CaM and the N-terminal intracellular loop of connexin 43. The 
results show that both N and C terminal domains of Ca
2+
-CaM contact with the peptide, leading 
to a partially unwound and bending central helix of CaM. The ligand binding induced conforma-
tional change was demonstrated by selectively labeled proteins including (1) extracellular do-
main of calcium sensing receptor and (2) the bacterial membrane protein SecA fragments C34 
and N68.  
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1 INTRODUCTION 
1.1 Calcium signaling and its role in physiological functions 
Ca
2+
 plays an indispensable role in physiology and biochemistry of organisms. With a 
tight systemic regulation by hormones, calcium levels in the blood and soft tissues must be main-
tained in a very narrow concentration range for normal physiological functioning. Calcium sig-
naling is originated from the steep concentration gradients across membranes, including plasma 
membrane, the membranes of the endoplastic reticulum (ER), mitochondria (1), lysosome (2), 
and other organelles. The extracellular calcium concentration is maintained at 1-2 mM, while 
hundreds of nanomollar in the cytoplasm.  
Calcium-sensing receptor (CaR), first cloned and characterized by Brown and colleagues 
(3), senses the change in extracellular fluid Ca
2+
 concentration, and regulates the releasing of 
hormones like PTH and calcitonin to control calcium homeostasis. Ca
2+
 concentration in cyto-
plasm is approximately at the level of 10
-7
 M, while in the organelles it is higher up to 10
-4
-10
-3
 
M. The intracellular calcium concentration is regulated by ion channels in those membranes. For 
example, when cells are activated, calcium influx into cells through plasma calcium channels 
like voltage-gated calcium channel in the excitable cells, and the plasma membrane Ca
2+
 ATPase 
(PMCA) can transport calcium out of cells; smooth endoplasmic reticular Ca
2+
 ATPase trans-
porters (SERCA) transports calcium into the ER lumen and the ryanodine receptor (RyR) and 
inositol 1,4,5-trisphosphate receptor (IP3R) can release calcium from ER, resulting in a calcium 
transient in cytosol (4).  
Calcium signals come from transient rises of the cytoplasmic Ca
2+ 
concentration, which 
mediates the constriction and relaxation of blood vessels, nerve impulse transmission, muscle 
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contraction, cell-cycle progression, lymphocyte activation, and the secretion of hormones(5-7). 
Several calcium binding proteins are involved in signaling pathways, called calcium signaling 
proteins, such as calmodulin, S100 proteins, protein kinase C, and C2 domains(4). ER, as the 
primary intracellular Ca
2+
 store, can produce intrinsic Ca
2+
 release and propagation of Ca
2+
 oscil-
lations(8-10), where the concentration is only known to be in the micromolar level so far. In ex-
citatory Ca
2+
 signaling, the voltage change, extra- or intracellular ligand binding will trigger the 
plasma membrane ion channels to open. The initial increase in Ca
2+
 concentration will lead to 
more release from the ER, primarily through RyR, which is called calcium induced calcium re-
lease (CICR) in the cardiac myocytes. ATP, ionomycin, histamine, caffeine and glutamine, etc. 
will activate the Ca
2+
 receptors and pumps located in ER, such as IP3R and RyR, to release Ca
2+
 
from ER into cytoplasm(11-13). In the non-excitable cells, the first depletion of Ca
2+
 in the ER 
will activates the Stim/Orai complex formation and cause store operated calcium influx (SOC). 
Also, SOC refills Ca
2+
 into the  ER from extracellular environment via both the plasma and the 
ER membrane channels(14). The alternation of cellular Ca
2+
 concentration activates intracellular 
Ca
2+
 sensing proteins, transmitter-gated and voltage-gated ion channels, gap junction channels, 
further regulating numerous cellular events and cell-to-cell signaling.   
1.1.1 Calcium signaling network  
Calcium signaling is a network involving organelles inside a cell. The endoplasmic retic-
ulum (ER) is the major calcium storage and the source of intracellular calcium transients. Mito-
chondria, Golgi, lysosome are also recognized as the intracellular calcium stores and conduct 
corresponding calcium signaling via the activity of membrane calcium channels. Those calcium 
storages and the channels function together to regulate a physiological dynamic event. On the 
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other hand, increasing evidences support that calcium signaling is temporal and spatial to prevent 
excess responses.  
In addition to be a calcium storage, the ER is the factory to synthesize proteins and re-
sponsible for post-translational modification, and protein trafficking.  A misfolded protein is first 
recognized by the ER and induces ER stress, which in turn initiates the unfolded protein response 
(UPR) to relieve the stress. It is important to maintain the normal resting calcium level in ER to 
ensure correct function of those ER proteins like ER chaperones(15). Many proteins in the ER 
share the feature of calcium binding with low affinity and high capacity such as calreticulin and 
calsequestrin. The former one serves as one of the ER chaperones and plays a very important 
role in the folding and loading of MHC class I molecules. Calsequestrin is a calcium buffer pro-
tein in the ER lumen with > 40 calcium binding sites and regulates the activity of ryanodine re-
ceptor (RyR) with association of junctin and triadin. Briefly, when calcium sites are occupied, 
calsequestrin has a conformational change from ransom coil to helices, dissociates with junctin 
and triadin and activate RyR.  
Calcium influx across mitochondria is closely related to the membrane potential, and 
controls the mitochondria energy production. Intramitochondrial calcium can activate enzymes 
coupled to the Krebs cycle. Moreover, calcium uptake can modulate the intracellular calcium 
signaling, regulate mitochondrial motility and morphology, and induce cell death. The calcium 
channel in the mitochondrial outer membrane is called voltage-dependent anion channels 
(VDAC), which is permeable to free calcium and may have a role in the crosstalk between the 
ER and the mitochondria(16). In the inner membrane of mitochondria, the inward calcium chan-
nel includes mitochondrial calcium uniporter (MCU), mitochondrial RyR, the rapid mode of mi-
tochondrial Ca
2+
 uptake (RAM). Mitochondrial Na
+
-Ca
2+
 exchanger (mNCX) is one of the major 
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outward calcium channels(17). ER-mitochondrial coupling provides the local calcium signaling 
and plays an important role in the early phases of ER stress
(18)
 and apoptosis
(19)
. Several calcium 
channels are thought to play roles in the ER-mitochondrial interface, and the hot spots of high 
calcium level were found to enable the efficient calcium transfer
(20)
; however, the details still 
remain unclear. 
1.1.2 Kinetics of the ER related calcium channels 
The ER controls the intracellular calcium signaling by regulating the activities of its 
membrane calcium channels. As shown in Figure 1.1, the kinetics of those channels plays a cen-
tral role to modulate the calcium-dependent physiological events such as excitation-contraction 
coupling (ECC).  Dihydropyridine receptor (DHPR) and ryanodine receptor (RyR) are two pri-
mary proteins involved in the early stage of ECC, which are different in cardiac and skeletal my-
ocytes. In skeletal muscle, four DHPR resemble together and physically contacts with RyR1. 
Membrane depolarization induced conformational change of DHPR triggers opening of RyR1 
and hence the calcium influx via DHPR is not required for the skeletal muscle cells.  While, in 
cardiac muscle, calcium influx due to the activation of DHPR is essential for the later opening of 
RyR2, called calcium induced calcium release (CICR). The mean open time of DHPR is around 
0.5 ms and the time constant of activation of RyR is about 0.6 ms (21). The activity of RyR is 
biphasically modulated by Ca
2+
 concentration. The onset has a time constant of ~1 ms and the 
deactivation time constant is about 2-5 ms. The duration of a single action potential is 2-5 ms for 
the skeletal muscle, 100-400 ms for cardiac muscle and <1 ms for nerve(21).   
IP3R is another calcium release channel in ER membrane. Like RyR, IP3R’s activity is al-
so dependent on calcium concentration and exhibits a bell shape. Moreover, the activation of this 
channel requires binding of IP3, which is one of the cleavage products of phosphatidylinositol 4,5 
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bisphosphate (PIP2) by phospholipase C (PLC). The activity of IP3R is more complex than RyR. 
At least two opening states are engaged in the channel’s activity. The fast one has a time constant 
<10 ms and the slow component has a time constant more than 200 ms (22).  
 
Figure 1.1. The time scale of the calcium channels in the intracellular membranes. 
 
1.2 Calcium signaling and diseases  
Ca
2+
 signaling is important for homeostatic handling of cardiovascular functions. The ac-
tivation of cardiac myocytes requires the addition of ~100 µM Ca
2+
 in cytosol, for which the 
Ca
2+
 source is the sarcoplasmic reticulum (SR)(23). The cardiac ryanodine receptor (RyR2), 
IP3R and SERCA2a are three pivotal channels for the Ca
2+
 mobilization from SR to cytosol dur-
ing this agonist-induced process. Dysfunction of these proteins has been proved to be the leading 
cause of heart failure with increasing evidence collected both from animals and humans (24, 25). 
The prolonged increase of the cytosolic Ca
2+
 level in cardiac myocytes will result in downregula-
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tion of Ca
2+
  signaling proteins in cardiac hypertrophy, leading to defects of muscle contraction 
and relaxation and ultimately heart failure (26). Alzheimer’s disease (AD) is the worldwide aged 
disease that is characterized as extensive synaptic and neuronal loss. Although the cause of AD 
still remains unclear, abnormal expression level of calcium signaling proteins has been found 
from animal models and postmortem brain samples. The increased Ca
2+
 level in neuron cells due 
to the extensive release of calcium ion from the ER triggers a series of signaling process and af-
fects the synaptic stability and neuronal health(27). 
1.2.1 Calcium signaling and apoptosis 
One of the calcium signaling pathways is related to apoptosis. Calcium overload in the 
ER will lead to the crosstalk between the ER and mitochondria. Mitochondria can uptake calci-
um directly from the ER and the increased accumulation of calcium is a trigger for the release of 
cytochrome C to cytosol where it can activate initiator caspase-9 and executioner caspase-3 and 
lead to apoptosis (28, 29).  Also, ER stress can lead to the sustained calcium accumulation in mi-
trochondrial matrix, triggering permeability transition, dissipation of the electrochemical poten-
tial, matrix swelling, relocalization of Bax to mitochondria, and release of cytrochrome C (30). 
There is a cytochrome C independent pathway to induce apoptosis, which is the calpain-induced 
apoptosis in ER. Calpain is a calcium-dependent cysteine protease, which activates caspase-12 
localized in the ER, leading to the subsequent activation of caspase-9. Tharpsigargin induced 
apoptosis was independent of cytochome C and thus probably was induced by calpain(29). 
It has been reported that Bcl-2 can form complex with IP3R and disrupt its normal func-
tion by dephospharylation of IP3R, which in turn blocks the apoptosis signal (31). Rong and the 
coworkers also showed evidence that the BH4 domain of Bcl-2 interacted with IP3R to inhibit 
the channel open so as to block the calcium induced apoptosis (32). There is a big debate in the 
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relationship between Bcl-2 and the ER calcium content (33, 34). In the previous study, people 
found that Bcl-2 decreases the ER free calcium content (35, 36). Sano and co-workers recently 
found that the passive Ca
2+
 leaking from the ER caused by BI-1, which can be rescued by over-
expression of SERCA or treatment of SERCA activators (37). This result also built the linkage 
between the mitochondrial bioenergetics and autophagy. However, using some ER calcium indi-
cators with lower calcium binding affinity than the calcium dyes, some groups found that Bcl-2 
can increase the ER calcium content (38).  
1.2.2 Calcium signaling and Alzheimer’s Disease (AD) 
The hallmark of AD is the excessive production of β-amyloid (Aβ) and its massive ac-
cumulation in amyloid plaque. Aβ monomer can not activate calcium influx and even may play a 
role in protecting mature neurons against excitotoxic death (39, 40).  Misfolding of Aβ results in 
oligomerization and it’s the major cause of the final product amyloid plaque. However, more and 
more evidence showed that the plaque may not be primarily responsible for the neurological def-
icits. It has been further proposed that the plaque may contribute to the removal of small toxic 
soluble species(41, 42). The Aβ oligomer of 2-50 peptides is soluble and has been characterized 
as the most toxic forms and the small intermediate potently disrupts cellular calcium homeo-
statsis (40, 43). The Aβ oligomer can impair the normal function of endogeneous plasmaluminal 
ion channels, disrupt the membrane integrity and form the cation pore(44). The consequences of 
those effects are the unregulated calcium flux, which is the major factor underlying Aβ toxicity. 
In normal neuron cells, protective and pathogenic calcium cascades exist together and can be 
triggered sequentially. For example, excess calcium first activates NFκB-like anti-apoptotic fac-
tors and then the increased intracellular calcium through Aβ mediated mechanisms leads to mito-
chondrial calcium overload and causes apoptosis. Calcium dysfunction can cause the apoptosis, 
 8 
 
synaptic degeneration, and excitotoxicity. On the other hand, due to the correlation between the 
calcium homeostasis and AD, some drugs are expected to rescue abnormal calcium signaling (45, 
46). 
1.3 Development of calcium indicators 
1.3.1 Organic calcium dyes 
Calcium sensor has been emerged to study cardiac and neuronal processes. There are two 
major classes of current calcium sensors. The first one is the small organic molecules, which has 
been developed by Roger Tsien and others (Figure 1.2). They are evolved from single-
wavelength intensity change to ratiometric signal change (47-49). These sensors exhibit the great 
signal dynamic range (30-50 fold) upon binding Ca
2+
 and a broad range of binding affinity. 
However, the major limitation of their application in living cells is that they cannot be targeted to 
specific subcellular organelles due to the non-specific membrane permeability (50). Therefore, 
the precise cytological localization cannot be guaranteed. It is also difficult to load these sensors 
into denser or thicker tissues, hindering further research with animals and humans. 
 
Figure 1.2. The representative organic calcium dyes. 
(A) Fura-2 AM, (B) Calcium Green 1-5N, (C) Mag-fura-2. 
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1.3.2 Genetically encoded calcium indicators (GECIs) 
The second class is the protein-based Ca
2+ 
sensors. Aequorin, a bioluminescent calcium 
sensor, was originally isolated from luminescent jellyfish and other marine organisms. It gener-
ates luminescence as a result of Ca
2+
-induced conformational change in the presence of its pros-
thetic group, coelenterazine. The major advantage of aequorin over other indicators is that lumi-
nescence does not rely on  any optical excitation, eliminating the interference from auto-
fluorescence(51). The primary limitation of aequorin is that luminescence results from oxidation 
of the prosthetic group coelenterazine after binding three Ca
2+
 so that continuous addition of coe-
lenterazine into the media is required (52), which obstacles its application in real-time detection.  
Genetically encoded calcium sensors has been rapidly developed in the last decade, in-
cluding the calmodulin-based sensor(53-55) and the troponin-based sensor (e.g. TN0-L15, TN-
XXL(56)) (Figure 1.3 and Table 1.1). The fluorescent resonance energy transfer (FRET)-based 
Ca
2+
 sensors are designed based on the significant spectral overlap of the donor emission spec-
trum and the acceptor excitation spectrum. Calcium concentration change triggers a radiometric 
change of the spectra and the background noise can be reduced. The FRET pair is linked by the 
native CaM or some active Ca
2+
 binding domain, which will get close to each other upon the 
Ca
2+
 binding-induced conformational change of CaM. The representative FRET-based genetical-
ly calcium sensors are GCamp series, Yellow
 
Cameleon (YC series)(57-60) and pericam(61). 
The early generation of these sensors suffered the photobleaching, pH instability, low expression 
level in cells, and low reproducibility, etc.(62). Some of these problems have being gradually 
solved through various modifications of these sensors and even the dynamic range has been in-
creased up to 100 fold (55). However, there are several drawbacks of this kind of sensors re-
mained to be removed. Specifically they are the bulky size (more than 60 kDa), high requirement 
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of microscopy facility (dual excitation and emission wavelengths), narrow Ca
2+
 binding affinity 
range (almost the same as native CaM), and the risk of perturbing cellular Ca
2+
 signaling and 
non-specific binding to other small peptides by the functional group CaM or its variants. In con-
trast, Nakai, Miyawaki and colleagues developed a single fluorescent protein-based Ca
2+
 probe, 
who fused M13 fragment and CaM in N- and C-terminals of the circular permutated EGFP and 
EYFP (cpEGFP and cpEYFP), respectively(61, 63-65). However, its cooperative Ca
2+
 binding 
feature due to the four EF-hand motifs of CaM limits the application in quantitative measurement.  
 
Figure 1.3. The cartoon structure of GECIs.  
(A) the calcium loaded form of GCaMP-2 (PDB ID: 3EK8). (B) The calcium induced conformational 
change of FRET-based Cameleons. (C) The calcium binding geometry (a) and calcium induced fluores-
cence enhancement (PDB ID: 4L12) (b). 
 
CatchER (Calcium sensor for detecting high concentration in the ER) is an EGFP-based 
calcium sensor with fluorescence change at a single wavelength that developed in Yang lab (66). 
The feature of CatchER is the fast kinetics and the low affinity to calcium (Kd = ~180 µM). It 
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was successfully used to monitor the SR calcium release in mouse flexor digitorum brevis (FDB). 
Compared to D1ER, another calcium sensor derived from cameleon with a low calcium binding 
affinity (Kd = ~60 µM) (38), CatchER exhibits a better fidelity and faster off-rate.  D4cpv-
calsequestrin was reported by Sztretye in 2011 to be a new ratiometric calcium indicator targeted 
to the skeletal muscle SR (18) (19).  The dissociation constant was 222 µM and its dynamic 
change of 2.5 had a big improvement over comparable sensors.  
Table 1.1 The color distribution and binding affinity of GECIs. 
Subcellular com-
partment 
CYAN GREEN Yellow RED 
Intracellular 
(0.1-1 μM) 
B-GECO 
(Kd=0.2-0.5 μM) 
GCaMP  
(Kd=0.5 μM) 
G-GECO  
(Kd=0.6-1.2 μM) 
Flash pericam  
(Kd=0.7 μM) 
R-
GECO  
(Kd=0.5 
μM) YC3.6 (Kd=0.3 μM) 
TN-XXL (Kd=0.8 
μM) 
Golgi YC3.3 (Kd=4.4 μM)    
Lysosome     
Mitochondria/ 
Nuclear envelope 
(1-10 μM) 
Cameleon-2 
(Kd=0.07; 11 μM); 
YC4.6  
(Kd=0.06, 14.4 μM); 
 Ratiometric 
pericam  
(Kd=1.7 μM);  
Camgaroo -2 
(Kd=5.3 μM); 
 
ER/SR 
(0.2-1 mM) 
D1ER  
(Kd=0.8, 60 μM); 
Cameleon-4 
(Kd=0.083, 700 μM) 
CatchER  
(Kd= 190 μM) 
  
1.3.3 Calcium binding kinetics of current calcium indicators 
Understanding calcium signaling was advanced by the development of calcium dyes and 
genetically encoded calcium indicators (GECIs) (50, 67-72). Organic calcium dyes are often 
used to monitor calcium transients in the cytosol because the Kd is in the magnitude of hundreds 
of nanomollar. However, the detection of Δ[Ca2+] induced by a train of high frequency, especial-
ly the rapid release from the ER store, is largely limited by the availability of calcium indicators. 
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It has been reported that it is not suitable for the calcium dye Oregon Green BAPTA 1 to detect 
the calcium transients upon action potential stimulation of more than 50 Hz because the slow de-
cay (koff=2.6 s
-1
) results in the accumulation of signals (67, 73-75).  
The low affinity calcium dyes, with their low affinity and rapid off rate, such as Fluo-5N 
(76-78), Mag-Fluo-4 (79), Calcium-green-5N (80, 81) were used to monitor calcium change in 
internal calcium stores including the mitochondria and the endoplasmic reticulum (82-84). How-
ever, the reported kinetics and the amount of calcium concentration change during EC coupling 
in skeletal and cardiac muscle cells as well as neurons were largely varied. For example, it was 
reported a broad range from 3.3 to 8.0 ms of the calcium release presented by the full duration at 
half-maximum (FDHM) at room temperature from the mouse fast-twitch fibers upon the action 
potential (85-88). Such variations are likely a result of limitations associated with calcium dyes, 
including the spatial localization of dyes, binding affinity, and kinetics (kon and koff )(71, 89).  
The development of genetically encoded indicators (GECI), such as GCaMP, GECO, TN 
and Cameleon series, enables to probe spatial-temporal cellular events and cell signaling in real 
time (19, 54, 60, 90-97). GECI are composed with a fluorescent protein moiety and native cyto-
solic calcium trigger proteins (CBPs) such as calmodulin (CaM) or troponin C (TnC) that are 
used to sense calcium concentration change and calcium-induced global conformational rear-
rangement. Each CaM or TnC binds four calcium ions cooperatively with a strong calcium bind-
ing affinity (Kd=10
-7
 M) and calcium binding on rates in the magnitude of 10
7
 M
-1
s
-1 
that enable 
them to sense the
 
immediate [Ca
2+
] rise in the cytosol (98-101). Meanwhile, these GECIs have 
slow dissociation rate around 0.1-10 s
-1
 likely due to the cooperativity associated with multiple 
calcium binding sites and multiple layers of conformational change (102, 103). Their slow kinet-
ics of signal decay hampers their applications in probing physiological fast calcium transient es-
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pecially in the neuron and skeletal muscle cells (56, 91, 104). Further efforts to reduce the calci-
um binding affinities in Cameleon D1ER results in a multiple Kds around 0.8 and 60 μM and the 
off rate around 256 s
-1
 (38). Such sensor, however, was not able to capture the calcium release 
from SR upon the stimulation in the mouse FDB fibers (105, 106). In addition, the risks of inter-
ference to the normal physiological pathways would be considered due to the interaction be-
tween the native calcium binding proteins with their target proteins. 
To fulfill the unmet need of a fast calcium indicator required for monitoring calcium re-
leases in high concentrations such as the ER/SR and not incorporating native calcium binding 
proteins, we developed a calcium sensor called CatchER without using the native calcium bind-
ing domain (66). CatchER was created by designing a calcium binding site into a single en-
hanced green fluorescent protein (EGFP). The binding stoichiometry is 1:1 and the Kd is 0.18 
mM in vitro and 0.8 mM calibrated in situ allowing measurement of basal calcium in different 
cell lines and their changes in response to different drugs. Compared to Cameleon D1ER, Catch-
ER exhibits faster kinetics, allowing it to catch the SR calcium change in the skeletal muscle 
cells (107). To date, however, there is no sensors available for measuring calcium responses at 
the red wavelength region with an advantage of better tissue penetration to complement the green 
sensors developed by us and others (66). In the Chapter 3, we reported the achievement of de-
signing calcium binding protein MCD1 (RapidER) using a red florescent protein mCherry by 
integrating key factors for calcium binding kinetics and metal induced optical property change.  
We show that the designed red calcium binding sensor MCD1 (RapidER), on the surface of 
mCherry, is able to report calcium concentration by fluorescence in the range of 10
-4
-10
-3
 M with 
an unprecedented dissociation rate in the magnitude of 10
3
 s
-1
. Our finding reveals essential fac-
tors needed for future design of fast calcium binding proteins, fulfilling a pressing need for moni-
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toring calcium dynamics in fast biological processes. Table 1.2 summarizes the kinetic data of 
recent applied calcium indicators, and includes two calcium sensors developed by Yang’s lab.  
 
Table 1.2 Kinetic parameters of recent major calcium indicators. 
GECI/Dye Rise time constant Decay time constant kon (M
-1 s-1) koff  (s
-1) 
GCaMP2a 14 ms 75 ms 
 
13 
GCaMP2c 0.63s 0.38s 
 
2.6 
TN-XLa 240 ms 430 ms 
 
2.3 
TN-XXLf 1.04 s 0.88 s 
 
1.1 
D1ERb 
  
3.6x106 256 
YC3.3c 1.41s 1.05s 
 
12 
YC3.6c 0.82s 0.73s 
 
1.4 
YC2.6c 
 
5.24s 
 
0.2 
D3cpvc 0.68s 1.96s 
 
0.5 
TN-L15c 0.81s 1.49s 
 
0.7 
TN-XLc 0.59s 0.20s 
 
5 
GCaMP1.6c 1.38s 0.45s 
 
2.2 
CatchER 
 
1.44 ms ~3.89x106 ~700 
RapidER 
 
0.33 ms >2.5x107 >2100 
OGB-1c 0.24s 0.38s 
 
2.6 
Fluo-4e   6.0x108 210 
Calcium Green-
5Nd   4.0x108 9259 
Mag-Fura-2d   7.5x108 26760 
Fluo-5Fe   3.0x108 300 
a McCombs, Methods, 2008, data collected in vitro. 
b Palmer, PNAS, 2004, data collected in vitro. 
c Hendel, J Neurosic, 2008, data collected in vivo. 
d T-jump 1997 
e Scott,R. J. Neurosci. 2006 
f Mank M. Nat. Meth. 2008, 40 Hz AP (0.2-0.4 nA for 10 ms) in 2s 
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1.4 Fluorescent proteins 
1.4.1 mCherry, a red fluorescent protein originated from coral 
mCherry is a bright monomeric red fluorescent protein derived from DsRed, which was 
isolated from Discosoma sp.(108-110). mCherry has a cylindrical beta-can structure folded by 
eleven β-strands connected with main chain hydrogen bonds (Figure 1.4 A and C), belonging to 
the GFP super-family. The fluorophore is formed by autocatalytic cyclization of residues M66, 
Y67 and G68 and is buried inside the beta-can. The complex hydrogen-bond network between 
Met-Tyr-Gly triad and its neighboring residues produces the distinguished fluorescence, which 
exhibits an emission wavelength at 587 nm that can be excited at 610 nm. Unlike GFP (Figure 
1.4 B and D), the chromophore conjugated system in mCherry is extended to the backbone of the 
residue Phe in the N-terminal of the chromophore Met so as to generate a bigger π-system than 
GFP. The lower energy results in the red shifted spectrum. Compared to GFP that have been 
widely expressed in established cell lines, primary cells and transgenic animals for the targeting 
imaging or detection of specific molecule, mCherry takes the advantages of its longer wave-
length, pH tolerance and shorter maturation time. Long wavelength is preferred in molecular im-
aging studies of living subjects since it causes less photo damage to cells, less auto-fluorescence 
background and better tissue penetration (111). 
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Figure 1.4. Crystal structure comparison of mCherry and GFP.  
(A) The cartoon structure of mCherry (PDB ID: 2H5Q) and (B) The cartoon structure of GFP (PDB ID: 
2WUR) with the chromophore presented in dots. The conjugated system are highlighted in the chromo-
phores of mCherry (C) and GFP (D).  
 
EGFP is derived from wild type GFP in 1995 with F64L and S65T, where S65T was first 
mutated by Tsien(112) to improve the spectral properties such as increasing fluorescence, photo-
stability and shift the major exciation peak to 488 nm while maintaining the emission maxima. 
F64L was mutated by Thastrup based on S65T mutant to increase its folding efficiency at 37°C.  
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1.4.2 cp-mKate, a far red fluorescent protein 
 The mKate was first reported by Chudakov group in 2007, which is far-red fluo-
rescent protein originated from sea anemone Entacmaea quadricolor, named eqFP578 (113). 
Chudakov and colleagues developed the protein TurboRFP featured with fast maturation, pH-
stability and high brightness based on eqFP578, and further developed Katushka and its mono-
mer mKate. The Stoke’s shift of mKate is enlarged with the excitation and emission at 588 and 
635 nm compared to mCherry (excited at 578 and emitted at 610 nm), as well as the quantum 
yield (φ=0.33). The extinction coefficient was 45 mM-1 cm-1, and the brightness is around 45% 
of EGFP. The pKa of mKate (6.0) is greater than mCherry (3.5), suggesting that the chromo-
phore is more protonated than mCherry at normal physiological condition (pH 7.2).  There is no 
sign of aggregation formed when expressing mKate in mammalian cells so far. The crystal struc-
ture of mKate at different pH revealed the different isoforms of the chromophore. The trans form 
favors acidic environment and is dimmer than the cis form which is dominant at higher pH (71, 
114). There is a light-induced cis-trans isomerization observed when irradiated by the green light.  
 The second generation of mKate is named mKate2, which was also reported by 
Chudakov’s group (115). By mutions of V49A, M152T and K239R, its biophysical properties 
were enhanced. The quantum yield and the extinction coefficient were increased by 30% and 
100%, respectively, resulting in the increase of the brightness of 300%. In addition, the pKa was 
decreased to as low as 5.4. 
1.5 Structure, dynamics and function of Calmodulin (CaM) 
Calmodulin (CaM) is a ubiquitous, calcium binding protein which can be found in eukar-
yotic cells, to regulate a variety of physiological events. The genetic evolution of calmodulin 
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shows it is a highly conserved protein, and calcium binding proteins found in high G+C Gram-
positive bacteria appear high similarity with eukaryotic calmodulin, suggesting the evolutionary 
prototyping of EF-hand containing calcium binding proteins (116).  The mammalian CaM has 
four EF-hand calcium binding motifs evenly distributed in two terminal domains. The calcium 
binding affinity of C-domain is 10-fold higher than that of N-domain (117, 118), in the range of 
1-10 μM.  The association and dissociation rate of calcium binding to the isolated CaM terminal 
domains were reported by several groups (119) including Baylay and the co-workers using 
43
Ca 
NMR spectroscopy (100), Martin (120), Black (121) and Johnson (122) using stopped-flow. The 
dissociation rate (500-1000 s
-1
) of N-domain is approximately 100-fold higher than that of C-
domain (2-10 s
-1
).  
  The cooperative binding of calcium ions at each domain induces global conformational 
rearrangement of CaM, which in turn binds the target protein to regulate a variety of physiologi-
cal events.  CaM adopts different conformations when interacts with the targets including en-
zymes and Ca
2+
-activated channels (123). In addition, the domain motion can be independent for 
both two and function separately. For example, the activation and inhibition bifunctional regula-
tion of CaM was found in the voltage-gated Ca
2+
-channel Cav2.1, where Ca
2+
-loaded CaM C-
domain activate the channel while the N-domain occupied by Ca
2+
 due to increased intracellular 
[Ca
2+
] inhibits the channel activity (124).  
The structure of Ca
2+
-free CaM was first solved by NMR due to lack of the well-folded 
rigid structure (125). The interaction between CaM and its target peptide, their dynamic proper-
ties and the binding mode is widely investigated by NMR spectroscopy, including the paramag-
netic relaxation enhancement, residual dipolar coupling and T1/T2/NOE. The binding mode of 
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CaM plays essential role in modulating the conformational change and activity of the target pro-
tein, which will be discussed in Chapter 7.  
1.6 Motivation of this dissertation and questions to be addressed 
In the past decades, the Yang lab has been taking effort to understand the features of cal-
cium binding and design the calcium binding site in the non-calcium binding proteins.  The pre-
vious member revised the calcium binding sites in the protein database  and pulled out the fea-
tures. The tools of calcium binding site prediction were developed.  Starting with CD2, we suc-
cessfully added  the calcium binding site and modulate the binding affinity. As accumulated ex-
perience and knowledge, the first GFP-based calcium indicator targeted in high calcium envi-
ronment called EGFP-G1 was generated. To increase the dynamic range and the protein folding, 
continuous attempt was taken and one of the second generation of sensor s called CatchER, with 
dramatically increased dynamic range and kinetic property, was developed and applied in inves-
tigating the SR calcium change in collaboration with Dr. Osvaldo Delbono. Motivated by the 
need to expand the spectral window of calcium sensors for high calcium environment, and re-
duce the fluorescence dependence on physiological pH change, I desired to generate a class of 
red fluorescent protein-based calcium indicators. 
Our challenges in this study are (1) to maintain the fluorescence while introducing the 
calcium binding ability; (2) to enlarge the dynamic range upon binding calcium; (3) to emerge 
the ratiometric change instead of the single wavelength change to avoid the background noise; (4) 
to modify the Kd to make it suitable for different cells.  
The long term goal of the project is to design fluorescent calcium sensors and apply it to 
discover the calcium-dependent physiological functions and also to detect the relevant diseases. 
Quantitative real-time monitor of Ca
2+
 concentration in particular physiological microenviron-
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ment such as the endoplasmic reticulum (ER)/sarcoplasmic reticulum (SR) and interspace be-
tween adjacent cells is essential for exploring the mechanism of Ca
2+
-dependent signaling pro-
cesses. The idea of current reported genetically encoded Ca
2+
 sensors is based on natural Ca
2+
 
binding proteins, calmodulin, which is limited due to the perturbation and interference of func-
tional Ca
2+
 signaling (54, 126-128) and the bulky size of the fusion protein causes potential prob-
lems like maturation time, expression level and aggregation. Also, the natural high binding affin-
ity (Kd ranged from nanomolar to micromollar) of calmodulin restricts their application for de-
tecting the fluctuation of Ca
2+
 concentration in most calcium-related biological activities where 
the calcium level is approximately hundreds of nanomollar. To overcome these limitations, my 
purpose is to design Ca
2+
 biosensors by engineering a single Ca
2+
 binding site into monomeric 
fluorescent protein and target it to a specific subcellular location for spatial-temporal detection of 
calcium dyanmics.  
To achieve the goal, several questions need to be answered in this dissertation: 1) what is 
the criteria to select fluorescent proteins to mount the calcium binding site? 2) How to control the 
calcium binding affinity? 3) How to improve the metal selectivity? 4) How to investigate and 
control the calcium binding induced conformational change? 5) How to correlate the calcium 
binding induced conformational change with fluorescence change? 8) What can be learned from 
the existing calcium indicators like CatchER? 7) How to select the tag for a specific targeting? 8) 
How to combine the structure, dynamics and function study of proteins? 
1.7 Overview of this dissertation 
To address the pressing needs for a red-shifted calcium indicator in high calcium subcel-
lular environment and questions discussed above, in this Ph.D. dissertation, I have developed a 
class of red fluorescent calcium binding proteins, MCD1 series, by protein engineering.   
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Chapter 2 includes the experimental methods and protocols that we used for the disserta-
tion.  
Chapter 3 describes the rationales for design a class of calcium binding sites in the red 
fluorescent protein mCherry. The effort in cloning, expression, purification, optical, biophysical 
and conformational characterization, metal binding and in situ evaluation of MCD1 variants will 
be reported.  
Chapter 4 reveals the structure and dynamics of CatchER in absence and presence of cal-
cium by NMR and molecular dynamics simulation.  
Chapter 5 reports the calcium effect on the ground and excited-state prototropic proper-
ties of CatchER. 
Chapter 6 reports the screening of the ER membrane anchoring sequence, and the cellular 
localization, as well as the performance of  calcium sensing in situ of the tagged CatchER.  
Chapter 7 reports the dynamic interaction of calmodulin and its target peptides through 
the residual dipolar coupling and T1, T2, NOE by using NMR spectroscopy.  
Chapter 8 introduces two case studies of investigating the conformational change of large 
proteins involved protein-ligand interactions by NMR incorporating selective labeling method.  
In Appendix A and B, I organized the established protocols and scripts to analyze the 
NMR data, including calculation and fitting of the dynamics parameter by T1, T2 and NOE, 
analysis of RDC, and measurement of the hydrodynamic radius. Appendix C records the detailed 
hydrogen bond analysis by AMBER-PTRAJ (Chapter 4). Appendix D showed the method vali-
dation for the lysine methylation and the methyl signal detection by 
1
H-
13
C HMQC. Appendix E 
documented the protocol to produce lentivirus. 
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2 MATERIALS AND METHODS 
2.1 Clone construction and PCR 
2.1.1 Materials and supplies 
Pfu DNA polymerase and the E. coli. strain XL-10 Gold were purchased from Stratagene. 
KOD hot start PCR kit (Novagen) was purchased from EMD Millipore. The E. coli. strain DH5α, 
the plasmid vector pCDNA3.1(+), was purchased from Invitrogen. All the restriction enzymes, 
T4 DNA ligase, and T4 polynucleotide kinase (PNK) were purchased from New England Bi-
olabs. The rapid DNA ligase kit was purchased from Roche. The plasmid pRSETb encoding 
mCherry was obtained from Dr. Roger Tsien from University of California at San Diego. The 
plasmid pRSETa encoding cp-mKate was obtained from Dr. Michael Kotlikoff at Cornell Uni-
versity. Primers were ordered from Integrated DNA Technologies. DNA sequencing for all 
clones was carried out by GENEWIZ Inc.. The restriction enzyme cleavage was checked using 
the web server Web Cutter (http://rna.lundberg.gu.se/cutter2/). The plasmid extraction was car-
ried out using the QIAGEN mini-prep and maxi-prep kits. 
2.1.2 Approaches 
mCherry or cp-mKate variants with designed binding sites were created by site-specific 
mutagenesis using Pfu DNA polymerase. The grafting method was used to insert a Ca
2+
 binding 
motif or replace a segment of DNA, for example, to substitute an original loop with a Ca
2+
 bind-
ing motif. The primers were designed by limiting the melting temperature Tm  of the annealed 
fragments in the range of 55-65 C, not longer than 45 base pairs (bps) and the GC content less 
than 70%. Tm was calculated using the salt-adjusted equation (Equation 2.1). 
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NGCKNaTm /675)(%41.0])[]([(log6.165.81 10 

               Equation 2.1 
  
mCherry subcloned to pRSETb was consisted of a His-tag, a T7 phage gene 10 leader 
enhancing the expression of foreign DNA in E. coli., the enterokinase (EK) cleavage site and the 
mCherry gene in order from 5' to 3' end. The BamHI restriction site was inserted right after the 
EK cleavage site and EcoRI site was located after the stop codon. For mammalian expression, 
the DNA encoding the designed proteins was subcloned to pCDNA3.1(+) vector by inserting the 
BamHI/EcoRI double digested DNA from the pRSETb vector. The mCherry DNA was sub-
cloned to pET28α for bacterial expression as well using the same double digestion method. To 
target the proteins in endoplasmic reticulum (ER) lumen, ER retention sequence KDEL was 
fused to the C-terminal before the stop codon and ER targeting sequence of calreticulin 
MLLSVPLLLGLLGLAAAD was inserted to the N-terminal after SacI recognition site of 
pCDNA3.1(+) and before the BamHI site.  
2.2 Protein expression and purification  
2.2.1 Materials and supplies 
The granulated LB broth miller media, yeast extract, tryptone, agar were purchased from 
EMD Millipore. The E. coli. strains BL21(DE3), BL21 (DE3) PlysS and Rosetta gami DE3 
PlysS were obtained from Novagen for protein expression. The polyclonal anti-DsRed antibody 
was purchased from Clontech. The isotopic labeled 
15
NH4Cl was purchased from Cambridge Iso-
tope Laboratories Inc.. The FPLC system (AKTA prime and AKTA FPLC), the Ni-chelating Hi-
Trap column, the ion exchange Q and SP column, the gel filtration Superdex-75 column and the 
hydrophobic interaction HIC column, were purchased from GE Healthcare. 
 24 
 
2.2.2 Approaches 
For 1 liter media, 25 g LB broth medium was used and pH was adjusted to 7.0, followed 
by autoclave at 121°C, 15 MPa for 15 min.  E.coli. strain BL21(DE3) was screened to express 
wild type EGFP and its variants, wild type mCherry, MCD1 and its derivatives, while 
BL21(DE3) PlysS was selected to express MCD2 and its derivatives. mCherry and its variants 
were fused into pRSETb with resistance of ampicillin; EGFP and its variants were fused to 
pET28b with resistance of kanamycin. Bacteria with the desired plasmid were precultured in 10 
ml LB media containing the particular antibiotics (100µg/ml ampicilin for pRSETb and 30µg/ml 
kanamycin for pET28b) overnight at 225 rpm, 37°C. The preculture was mixed with 1 L fresh 
LB media containing antibiotics and the culture was continued to be incubated at 37°C, 225 rpm 
until OD600 reached 0.5-0.6. At this point, 200 µl IPTG (1 M stock) was added to induce ex-
pression and the temperature was lowered to 25°C. The protein was expressed for overnight. To 
express proteins in Rosetta gami (DE3) PlysS, the temperature was adjusted to be 30 ºC after 
mixing the 10 ml preculture to the 1 L media pre-warmed at 37°C, allowing the bacteria to adopt 
the temperature change before IPTG induction.  
The cell pellets were harvested by centrifugation at 5,000 g at 4°C for 10 min. Extraction 
buffer (20 mM Tris, 100 mM NaCl, 0.1% Triton X-100, pH 8.0) was added to resuspend the pel-
lets. Both French Press (1240 CELL DIS) and sonication (Brenson Sonifier 450) were used to 
break the cells. For French Press, 20 mL extraction buffer was used for 1 L culture and 1000 psi 
was applied to break cells according to the manufactory manual.  For sonication, 10 ml extrac-
tion buffer was used for 1 L culture and the instrument was set as output control at 6, duty cycle 
at 80% and 30 pulses for one cycle. 6 cycles were applied and the interval between two cycles 
was 5 min. Centrifugation at 17,000 rpm at 4°C for 30 min was applied to separate the cell debris 
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and the soluble parts. The protein solution was filtered using 0.45 µm membrane (Millipore) and 
loaded to 5 ml Hi-Trap column charged with Ni
2+
. FPLC was chosen to purify the protein of in-
terest using AKTA prime. Before loading the protein, the column was charged with 0.1 M NiSO4 
and equilibrated with Buffer A (50 mM phosphate, 250 mM NaCl, pH 7.4). The pump B was 
washed by Buffer B (50 mM phosphate, 250 mM NaCl, 0.5 M imidazol, pH 7.4). Protein with 
His-Tag was bound to column while other nonbound fragments were washed away by 300 ml 
Buffer A. An additional wash step was done with 10 ml 10% Buffer B. A gradient of 10-100% 
Buffer B was applied to elute the bound protein. The purity of fractions was determined by SDS-
PAGE. The additional purification steps were required if the SDS-PAGE gels showing the exist-
ence of other proteins. The Mono-Q column and gel filtration Superdex-75 column were used to 
remove impurities. The purified fractions were collected and dialyzed in 2 L buffer of 10 mM 
Tris (pH 7.4) three times. The dialyzed protein was then concentrated and stored at -20 ºC or 
used for experiments. 
2.3 Determination of biophysical properties 
2.3.1 pKa measurement 
To measure the chromophore pKa of mCherry variants, separate samples were made at 
each pH to be measured and the absorbance and fluorescence of the samples were examined. 
Various buffers were utilized to maintain the pH at each desired value, which are listed in table 2. 
The protein concentration was ~10 µM for each mutant. The samples were allowed to equilibrate 
overnight at 4
o
C. For UV-vis spectra, a baseline was run for each pH with the appropriate buffer 
before the sample at that pH was measured. The absorbance was measured from 700 nm to 220 
nm so all protein peaks would be included. The fluorescence was measured with the excitation at 
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587 nm, and the emission spectra were collected from 595 to 700 nm while the excitation scan 
was done by fixing emission maxima at 610 nm and spectra was from 450 to 600 nm. The sam-
ple at pH 9 was measured first so the slit widths could be set for optimal intensity, and the sam-
ples were measured with decreasing pH. The pH was calculated after the spectra were acquired 
using Equation 2.2. 
)
1010
1010 maxmin
pkapH
pKapH YY
Y




    Equation 2.2 
 
Table 2.1 A list of the buffers utilized for the pH dependence measurements. 
Buffer pH 
0.5 M Sodium Acetate (CH3COONa) 2.0 
10 mM Sodium Acetate (CH3COONa) 3.0, 4.0, 4.5 
10 mM MES (2-Morpholinoethanesulfonic acid) 5.0, 5.5, 6.0 
10 mM PIPES (1,4-Piperazinediethanesulfonic acid) 6.5, 7.0 
10 mM Tris [Tris (hydroxymethyl) aminomethane] 7.4, 8.0, 9.0 
 
2.3.2 Extinction coefficient of mCherry and its variants 
The molar extinction coefficient (є) of a protein at 280 nm depends almost exclusively on 
the number of aromatic residues, particularly tryptophan, and can be estimated from the se-
quence of amino acids. If the extinction coefficient is known, it can be used to determine the 
concentration of a protein in solution based on the Beer’s law. All proteins contribute to absorb-
ance at 280 nm. Here we concern about dimerization and cleavage of mCherry according to the 
SDS-PAGE results. In order to calculate the extinction coefficient of the chromophore, the ex-
tinction coefficient of alkali denatured chromophore was used as a reference(58, 109). The 
chromophore at pH 13 has the same extinction coefficient and the absorbance maxima shifts to 
around 455 nm as long as the chromophore is the same.  Aliquot of 10 M NaOH was added to 
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the sample to reach pH 13 and the spectrum was taken immediately. Equation 2.3 was used to 
calculate the extinction coefficient. 
)(
455
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455587
nm
nm
nmnm
A
A
     Equation 2.3 
In the equation 3, ε is the extinction coefficient; A is the absorbance. ε587 nm and A587 nm 
were obtained from the mCherry and its variants at pH 7.4, while ε455 nm and A455 nm were from 
the proteins at pH 13.0, which in principle is the same for all variants.  
2.3.3 Quantum yield and brightness of mCherry and its variants 
The quantum yield (Φ) of a protein is defined as the number of photons emitted as fluo-
rescence, divided by the number of excited states that were produced in the excitation (129) 
(130). In other words, it is the fluorescent light emitted by the protein divided by the absorbance 
of light of the protein. A quantum yield ratio of zero value means no fluorescence, while a quan-
tum yield ratio of 1 means 100% fluorescence. As described by equation 2.4, we can determine 
the quantum yield for mCherry proteins by measuring the emitted fluorescent intensities at 
610nm and the absorbance of the chromophore at 586 nm at different protein concentrations. In 
this work, we will used mCherry WT as a control to calculate quantum yield of other variants. 
By calculating both the molar extinction coefficient and quantum yield of a specific variant, we 
can obtain the brightness of that protein by using Equation 2.5, which is the product of the two 
values. Brightness is defined as a visual perception in which a source appears to emit or reflect a 
given amount of light. In other words, brightness is the perception elicited by the luminance of a 
visual target (58, 129) (130). 
Ultraviolet and visible (UV-vis) absorption spectra of mCherry and its variants were de-
termined with a Shimadzu UV-1601 spectrophotometer (Shimadzu). A fluorescence spectropho-
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tometer (Photon Technology International, Inc.) was used to monitor the fluorescence property 
with a 10 mm path length quartz cell at room temperature. The fluorescence emission spectra 
were collected in the region of 595-750 nm when excited at 587 nm; likewise, the excitation 
spectra were measured in the region of 400 -600 nm when emitted at 610 nm. The quantum yield 
and brightness of all mCherry variants were calculated using Equations 2.4 and 2.5. 
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 B     Equation 2.5 
In Equation 2.4, φ is the quantum yield of the protein of interest; F/A is the slope of the 
fluorescence intensity as a function of the absorbance; the subscript P indicates the protein of 
interest and r indicates the reference protein, which is the wild type mCherry in this work.   
2.4 Metal binding assays for designed calcium binding proteins 
2.4.1 Dissociation constant (Kd) determination 
Calcium was titrated to the protein sample to trigger the increase of fluorescence until the 
fluorescence intensity reach maximum. The commercial standard calcium chloride solution of 
100 mM was used for titration. For each sensor, triplication of calcium titration was carried out. 
For CatchER, protein samples of concentration of 2 µM, 10 µM and 20 µM were tested to verify 
that Kd is protein concentration independent. For mCherry, 5μM and 10 µM protein was used. 
The Kd was calculated using Equations 2.6 and 2.7(131). 
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Here, F is the fluorescence intensity read from the fluorimeter; Fmax and Fmin  are the 
highest and lowest fluorescence intensity reading in an individual experiment; [P]T and [Ca
2+
]T 
are the total concentration of protein and calcium; a is the dynamic range of fluorescence change.  
2.4.2 Calcium binding using Tb3+ as a probe  
To further prove the calcium binding to mCherry-based calcium sensors, Tb
3+
-FRET was 
applied. Titration was monitored by fluorescence spectrophotometer (Photon Technology Inter-
national, Inc.) with excitation at 282 nm and emission in the range of 500-570 nm. To avoid pre-
cipitation due to the formation of Tb(OH)3, pH was maintained at 6.5 using 20 mM PIPES. KCl 
with a final concentration of 10 mM was supplemented to minimize non-specific metal binding. 
Tb
3+
 stock was prepared in the same buffer with a final concentration of 10 mM and 100 mM. 
Protein concentration was approximately 6 µM to ensure the amount of the donor for FRET, and 
minimize the precipitation as well. 
2.4.3 Metal selectivity 
Selectivity of a calcium sensor against other physiological metals and small molecules is 
an important criterion. The physiological metals such as Mg
2+
, Zn
2+
, Cu
2+
, Na
+
 and K
+
, and small 
molecules such as ATP, GTP, ADP and GDP were added to the sensor pre-loaded with 1 mM 
Ca
2+
. The optical properties was monitored by both UV-vis and fluorescence spectrophotometer. 
The concentrations of each competitor were as least 5 times as much as those of the free form in 
the physiological conditions.  
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2.4.4 Equilibrium dialysis assay 
2.4.4.1 Simulation of equilibrium-dialysis assay 
The purpose of the dialysis equilibration is to verify the direct binding of calcium to the 
protein. The protein filled into the dialysis bag was dialyzed against 10 mM Tris-HCl buffer con-
taining calcium at certain concentration. When reaching the equilibrium state, since protein binds 
to calcium, the total calcium inside the dialysis bag is more than that of the same volume of the 
buffer outside the bag. The difference can be detected by ICP-OES. This method can verify the 
ligand binding even the binding is weak, for example, in the magnitude of 10
-3
 M. The scheme 1 
shows the typical 1:1 binding reaction.  
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To achieve the optimal result, the simulation was run by MatLab based on Equation 2.8. 
Assuming the Kd value is 0.5 µM and the unit for both protein and calcium is µM, the Matlab m 
file as below: 
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clear all 
close all 
clc 
 
[x,y] = meshgrid(0:5:1000); 
z=(x+y-x*500./(500+y))./y; 
 
meshz(x,y,z); 
xlabel('P_t'); 
ylabel('Ca_(71)'); 
zlabel('Ca_(132)/Ca_(58)'); 
2.4.4.2 Total metal measurement using ICP-OES 
The equilibrium-dialysis assay was conducted to illustrate the binding constant of mCher-
ry variants. The positive (α-lactalbumin) and negative (w.t.-mCherry and buffer) control was 
used to validate this method. According to a simulation of this experiment, to obtain the large 
ratio of [Ca
2+
]bag to [Ca
2+
]out, the concentrated protein and small calcium will be used. For this 
experiment, 5 ml 30 µM protein in 10 mM Tris, pH 7.4 was dialyzed against 1.6 L buffer con-
taining 15 µM Ca
2+
 10 mM Tris, pH 7.4 for 48 h at 4 °C. The sample inside and outside the dial-
ysis bag were collected and analyzed using ICP-OES. To obtain  Well-folded mCherry variants 
concentration was determined by UV at 587 nm and total protein concentration was determined 
using extinction coefficient at 280 nm.  
The standard calcium solution was prepared by commercial calcium standard (0.1 M 
VWR) and the ultra-pure water supplemented with 2 % HNO3 as Table 2.2 below. The internal 
standard is 1 g/ml YCl3, prepared in 2% HNO3. The calcium concentration was monitored by the 
following wavelength in nm: 396.847, 317.933, 219.779, 370.602, 643.907, 220.861 and 
373.690. The [Y
3+
] is monitored by 360.074 and 371.029 nm. 
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Table 2.2 Preparation of calcium standard for ICP-OES calibration 
Ca
2+
 
(
a
ppm) 
Ca
2+
 
(µM) 
Total vol-
ume (ml) 
Add 
d
blank 
(ml) 
Take out 
blank (µl) 
b
Ca
2+
 stock 
1 (µl) 
Final HNO3 
10 250 15 15.00 37.50 37.5 2.00 
4 100 15 15.00 15.00 15 2.00 
3 75 15 15.00 11.25 11.25 2.00 
2 50 15 15.00 7.50 7.5 2.00 
1 25 15 15.00 3.75 3.75 2.00 
Ca
2+
 
(ppm) 
Ca
2+
 
(µM) 
Total vol-
ume (ml) 
Add blank 
(ml) 
Take out 
blank (µl) 
c
Ca
2+
 stock 
2 (µl) 
Final HNO3 
0.5 12.5 15 15.00 37.50 37.5 2.00 
0.3 7.5 15 15.00 22.50 22.5 2.00 
0.1 2.5 15 15.00 7.50 7.5 2.00 
0.05 1.25 15 15.00 3.75 3.75 2.00 
0 0 15 15.00 0.00 0 2.00 
a1 ppm = 1 µg/ml; bCa2+ stock 1=100 mM (Std. from VWR); cCa2+ stock 2=5 mM prepared by 2% HNO3 
in ultra-pure water; dHNO3 final=2%, prepared using 70% HNO3 diluted by ultra-pure water. 
2.5 Kinetics study of calcium binding 
Stopped-flow kinetic measurement were performed on a Hi-Tech SF-61 stopped-flow 
spectrofluorimeter equipped with the mercury-Xe lamp (10 mm path length, dead time of 2 ms) 
with a 1:1 (v/v) ratio of the protein sensor and calcium at 20 °C. Fluorescence emission changes 
associated with binding of calcium to the protein were determined by mixing calcium in the 
range of 1/5 Kd - 5Kd  and 10 mM Tris buffer, pH 7.4 with excitation at 587 nm and a long-pass 
600 nm filter. Florescence changes associated with dissociation of calcium from the protein were 
measured upon mixing the protein pre-loaded with calcium of the concentration equal to Kd and 
EGTA of 10-fold equivalent protein concentration in the same buffer. Generally, six duplicate 
measurements were carried out for each point, and the last three were fitted to obtain the ob-
served rate, kobs, by fitting of the stopped-flow traces according to the single-exponential func-
tion shown in Equation 2.9.  
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For MCD15, which has Kd at 0.5 mM,  the final [Ca
2+
] are: 100, 200, 300, 500, 900, 1300, 
2500 µM. Calcium solutions will be prepared as: 200, 400, 600, 1000, 1800, 2600, 5000 µM. To 
obtain a high S/N ratio, the fluorescence intensity is required to be high. Also, the lowest calcium 
concentration should be at least 5 times higher than the protein concentration to fulfill the as-
sumption that [Ca
2+
] >> [Protein]. As a result, the final protein concentrations were 10 and 20 
µM. MCD15 purified from pET28α in E. coli. BL21 (DE3) was used for the kinetics study.  The 
lowest (buffer) and highest signal (protein mixed with calcium of the highest concentration) will 
be taken first to figure out the dynamic range, and the instrument setting will be adjusted to en-
hance the dynamic range. 
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Here, F is the fluorescence intensity reading from the fluorimeter; F0 is the initial fluores-
cence intensity, which is the lowest one as well; F∞ is the fluorescence maximum; amp is the 
amplitude of the fluorescence; kobs is the observed rate constant, which is obtained by exponen-
tial fitting the fluorescence time course; kon and koff are the on and off rate of calcium binding; τ 
is the observed lifetime of calcium dissociation.  
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2.6 Fluorescence lifetime measurement 
2.6.1 Sample preparation 
Proteins used for the lifetime measurement were expressed by E.coli. BL21 (DE3) Gold 
and purified using the Ni
2+
 charged prepacked Hi-Trap column and the size exclusion column 
packed with Superdex-75 (GE Healthcare). The concentrated pure protein in 10 mM Tris, pH 7.4, 
were lyophilized and dissolved by in H2O and D2O (95% D). The final pH and pD were checked 
and adjusted to 7.4 and 7.8, respectively. To obtain the optimal signal in lifetime measurements, 
the absorbance spectra were collected and the protein concentration was adjusted to get the peak 
height maximum at 395 nm in the range of 0.2-0.3. The final concentration of 10 mM Ca
2+
 was 
supplemented to obtain the calcium-loaded CatchER. 
2.6.2 Lifetime measurements 
The fluorimeter was equipped with two lasers, 372 nm and 467 nm. Both wavelengths 
were applied to excite the neutral and anionic forms of CatchER. The monitored emission wave-
lengths are 440 nm for the neutral form, 510 nm for the anionic form. The 1024 data points were 
collected for the set of excitation at 372 nm and emission at 440 nm in 5 ns and 20 ns separately, 
with steps of 0.004883 ns and 0.019531 ns, respectively. For the sets of emission at 510 nm, 
1024 data points were collected in 20 ns and 50 ns, with steps of 0.019531 ns and 0.04883 ns, 
respectively. All measurements were carried out at 25 ºC. 
2.6.3 Data analysis 
The instrument response function was taken into account and deconvoluted using the 
program FFIT developed by Tkachenko (Equation 2.10). The time course of fluorescence decay 
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was fitted using exponential equation (Equation 2.11). The artificial components were ignored, 
which was recognized as the negative amplitude reflecting the initial fluorescence rise prior to 
decay, the component with lifetime smaller than 10 ps and greater than 15 ns. The valid fitting 
fulfilled the conditions of chi-square in the range of 0.9-1.3 and the residuals in the range of ±4. 
The average lifetime was calculated as Equation 2.12 for each fitting.  
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Here, Fi(t) is the fluorescence intensity at any given time t; I is the instrumental response 
function; fi(x) is the real fluorescence of the chromophore/protein at the time x; A is the ampli-
tude of the background fluorescence; τi is the lifetime of the component i.  
2.7 Nuclear magnetic resonance spectroscopy 
The molecule dynamics can be roughly classified by the time scale. The molecule tum-
bling  is ranged in pico-sec to nano-sec. The molecule internal motion is from pico-sec to micro-
sec. The molecule diffusion is relatively slow, in the range of milli-sec to sec. The chemical reac-
tion or exchange has a larger range, from sub-micro-sec to sec.  
2.7.1 Protein dynamics study by T1, T2, and Nuclear Overhauser Effect (NOE) 
The molecule tumbling ranged in pico-sec to nano-sec motion can be studied by collect-
ing T1, T2 relaxation and internal ratio of NOE values. From R1, R2 and NOE, the dynamic pa-
rameters like J(0), J(ωN), J(0.87ωH), the order parameter S
2
, correlation time τc and exchange rate 
Rex can be obtained by reduced spectral density function mapping. The greater internal motion 
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can be reflected by decrease of J(0) and J(ωN) and increase of J(0.87ωH). The chemical exchange 
is reflected by significantly increased J(0). S
2
 is the square of the generalized order parameter 
characterizing the amplitude of the internal motion, which can be used to justify the degree of the 
internal motion, ranged in 0-1. If S
2
=1, you will stay in the same orientation at any time, mean-
ing that this residue is completely rigid. The correlation time is the measure of how fast a mole-
cule tumbling in the liquid, or the rate of molecule motion, which is different from the isotropic 
rotational correlation time τm. The exchange rate Rex is a function of exchange rates, populations 
and chemical shifts of different conformations. See the protocol of the data processing in Appen-
dix A.1. 
2.7.2 Residual dipolar coupling (RDC) 
RDC originates from the anisotropic component of the dipolar interaction, which is de-
pendent on the angle between an internuclear vector and the magnetic field. When a molecule 
orients uniformly as it does in normal solution, RDCs average to zero and are not observable. If 
it is dissolved in a dilute liquid crystalline medium or other orienting medium, it becomes partial-
ly aligned and the dipolar couplings are not completely averaged to zero. This leads to a small 
contribution to the splitting of NMR signals. The angular dependence of these contributions pro-
vides the structural information. RDCs can be used to validate protein structures, to refine struc-
tures to improve quality, and to provide constraints as a part of an initial structure determina-
tion.  RDCs can also be used to determine the rotational symmetry axis of oligomers and this in-
formation can be used to properly orient the positions of subunits within an oligomeric complex.   
 HSQC-TROSY pairs provide one way of measuring RDCs.  The procedure is applicable 
to proteins of small and moderate size (10-30 kDa). The measurements are easily visualized as 
displacements of peaks in 2D frequency domain spectra.  The HSQC member of the pair gives a 
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single peak at the center of the four peaks expected in a fully coupled HSQC experiment. The 
TROSY member gives only the sharpest component. The offset in either H or N direction is one 
half (J). Transfer all assignments (or cross peak labels) from a reference isotropic HSQC spec-
trum to TROSY and HSQC spectra obtained under both isotropic and aligned conditions.  Trans-
ferring assignments is usually straightforward because the positions of cross-peaks in the aligned 
HSQC spectrum usually change little with addition of an alignment medium; if they do change, 
there is often a constant offset for all peaks due to changes in the lock resonance.  Corresponding 
peaks for TROSY assignments are diagonally displaced (down and to the right) by 38-58 Hz. 
The isotropic coupling (J) is calculated from the difference in Hz between the 
15
N dimension of 
isotropic HSQC and TROSY spectra (the offset is one half (J), so the final value needs to be 
multiply by 2).  Similarly, the aligned coupling (J+D) is calculated from differences in peak posi-
tions for the aligned HSQC and TROSY spectra.  The Hz values of the corresponding peaks can 
be subtracted to calculate the RDC values. 
The J-modulation is another way to measure RDC. J-modulation is a kind of intrinsic in-
terconvertion of in-phase and anti-phase magnetization, resulting in a combination of absorption 
and dispersive lineshapes which depends on the delay time envolved. An array of the delay is 
applied to obtain a series of 2D spectra. The max delay should be bigger than 3/(2J) to make sure 
the modulation curve crosses zero at least twice. The coupling constant J is obtained by curve 
fitting using Equation 2.13.  
                                                              Equation 2.13 
where f(x) is the intensity and x is the delay time, t is the T2 relaxation time, j is the cou-
pling constant of one-bond N-H in Hz, a is the variable accounting for the imperfection of pi 
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pulses during the experiment, and c is the initial intensity of the peak. See the protocol of the da-
ta processing in Appendix B. 
2.7.3 Molecular hydrodynamic radius 
The pulsed-field-gradient NMR can be used to calculate the hydrodynamic radius by 
Stokes-Einstein equation, where the diffusion coefficient is inversely proportional to hydrody-
namic radius. In this experiment, the temperature and the solvent viscosity affect the measure-
ment of diffusion coefficient. The internal standard, e.g., a small molecule, can be added. So 
there is Rref*Dref=Rpro*Dpro. A series of 40 spectra is collected with the strength of the diffusion 
gradient varying between 5-100% of the max gradient level. See protocol in Appendices A and B.  
2.8 Computer assisted structure model building 
2.8.1 Using delphi to create the electrostatic potential map 
Delphi is used to calculate the electrostatic potential in and around macromolecules(133). 
The chromophore is not a standard amino acid, which is necessary to have one more step to cre-
ate the atomic radii and charge files for the chromophore manually, which are shown below: 
mc-cro.crg 
! united atom amber charges for chromophore of mCherry 
CE    CH6      0.007 
N1    CH6      -0.520      
CG1   CH6      0.090 
CB1   CH6      0.037 
SD    CH6      -0.025 
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CA1   CH6      0.137 
C1    CH6      0.526 
N2    CH6      -0.277 
OH    CH6      -0.368 
CD2   CH6      -0.035 
CE2   CH6      0.100 
CZ    CH6      -0.121 
CE1   CH6      0.100 
CD1   CH6      -0.035 
CG2   CH6      -0.001 
CB2   CH6      0.022 
CA2   CH6      0.245 
C2    CH6      0.526 
O2    CH6      -0.500 
N3    CH6      -0.194 
CA3   CH6      0.246 
C3    CH6      0.526 
O3    CH6      -0.500 
mc-cro.siz 
N1    CH6   1.5      
CE    CH6   1.7 
SD    CH6   1.85 
CG1   CH6   2.0 
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CB1   CH6   2.0 
CA1   CH6   2.0 
C1    CH6   1.7 
N2    CH6   1.5 
OH    CH6   1.4 
CD2   CH6   1.7 
CE2   CH6   1.7 
CZ    CH6   1.7 
CE1   CH6   1.7 
CD1   CH6   1.7 
CG2   CH6   1.7 
CB2   CH6   2.0 
CA2   CH6   1.7 
C2    CH6   1.7 
O2    CH6   1.4 
N3    CH6   1.5 
CA3   CH6   2.0 
C3    CH6   1.7 
O3    CH6   1.4 
 
The parameter file (fort.10) is the one to allow Delphi to configure the library, the protein 
and the environment conditions. The size and charge files (For ) and the protein (pdb) are re-
quired. Other parameters, like grid size and scale, salt concentration, dielectric constant, etc., 
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should be defined by users. One example of the parameter file (fort.10) for running Delphi shows 
below: 
gsize=150                        #grid size 
scale=2.0                        #lattice spacing in number of Angstrom 
in(pdb,file="2h5q.pdb")          #input pdb file  
in(siz,file="parseres-mc.siz    #input atomic radii library 
in(crg,file="parseres-mc.crg")   #input atomic charge library 
indi=2.0                         #dielectric constant inside  
exdi=80.0                        #dielectric constant outside 
prbrad=1.4                       #radius (in A) of the water probe mol 
salt=0.02                        #salt concentration 
bndcon=2                         #2-Debue-Huckel potential of the equ. dipole 
maxc=0.0001                      #potential max change threshold 
linit=800                        #linear iterations 
out(modpdb,file="2h5q_delphi.pdb") # output modified pdb 
out(phi,file="2h5q.phi",format=2)  # output electrostatic density map 
energy(s,c,g)                      # write out energy   
 
Users have four choices for boundary conditions (bndcon): potential zero; Debue-Huckel 
potential of the equivalent dipole to the molecular charge distribution; focusing from a previous 
phi-map calculation; Debue-Huckel potential of all charges (coulombic). The flag of MAXC is 
suggested to be defined by the DELPHI MANUAL, which is the convergence threshold value 
based on root mean square change of potential. A low maximum change in the potential is a sign 
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for a good convergence, for example, 0.001 [kT/e]. The iteration (linit) needs to be sufficient to 
allow the final maximum change less than the maxc value defined. Energy output can be written 
in grid (g), salvation (s), coulombic (c), analytical surface (as) and analytical grid (ag).   
2.8.2 Using Modeller to build the structure model 
Modeller is a tool used to build a structural model based on a given template, which is 
suitable for building the model of mCherry variants. Modeller is written by Python, which can be 
run either in the Python shell or under prompt with the script. The template is necessary for the 
model construct. In our case, the template is the wild type mCherry. The variants were aligned 
with the w.t. mCherry. The alignment file (*.ali) was generated by Modeller, which was used for 
building models. The scripts for alignment and model building are shown below: 
  from modeller import * 
 env = environ() 
 aln = alignment(env) 
 mdl = model(env, file='mcwt', model_segment=('FIRST:A','LAST:A')) 
 aln.append_model(mdl, align_codes='mcwt', atom_files='mcwt.pdb') 
 aln.append(file='variant.ali', align_codes='variant') 
 aln.align2d() 
 aln.write(file='v-wt.ali', alignment_format='PIR') 
 aln.write(file='v-wt.pap', alignment_format='PAP') 
The script for running Modeller is: 
from modeller import * 
from modeller.automodel import * 
env = environ() 
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a = automodel(env, alnfile='v-wt.ali', 
              knowns='mcwt', sequence='variant', 
              assess_methods=(assess.DOPE, assess.GA341)) 
a.starting_model = 1 
a.ending_model = 5 
a.make() 
 
The number of models generated can be defined by user with the flag a.starting_model 
and a.ending_model. The scoring methods of DOPE and GA341 were used in this model build-
ing. DOPE (discrete optimized protein energy) model score is designed for selecting the best 
structure by the satisfaction of global spatial restrains from a collection of models built by Mod-
eller (134). DOPE is derived from an atomic distance-dependent statistical potential from a sam-
ple of native structures independent on any adjustable parameters, which uses the noninteracting 
atoms in a homogeneous sphere as the reference state. As a result, it accounts for the finite and 
spherical shape of the native structure. GA341 is the scoring function based on the compactness 
of the model, a combined statistical potential z-score and the percentage sequence identity of the 
alignment (135).  
The program was run under the cmd in Windows XP by typing the command: 
>mod9v8 aln.py 
>mod9v8 model.py 
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2.8.3 Using AutoDOCK-VINA to dock calcium ion to designed calcium binding pro-
teins 
AutoDOCK-VINA is used to predict the interaction between a ligand and a protein. VI-
NA is the newest version of Autodock, which improves the performance of the old version and 
keep the algorithm. The format of input file of both ligand and protein should be pdbqt, which 
can be generated by Autodock Tools or MGL Tools (The Scripps Research Institute). The polar 
hydrogens should be added first and charge will be assigned and written into the pdbqt file. This 
input file, including the coordinates and the partial charge of each atom, will be generated auto-
matically when choosing the macromolecule in the menu of Grid. The grid size and positions can 
be set in the Grid Box, which is required for VINA.  
To run VINA, the configuration file named conf.txt should be written by the user. The 
input receptor (protein) and ligand pdbqt files are directed, as well as the grid information. One 
example as: 
receptor = MC_P1-min.pdbqt 
ligand = ca.pdbqt 
center_x = 40.819 
center_y = 18.051 
center_z = 13.987 
size_x = 48  
size_y = 54  
size_z = 50 
exhaustiveness = 8 
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The center_x/y/z and size_x/y/z are the parameters of the grid box, which is read from the 
MGL Tools. Under cmd, go to the directory of all pdbqt files, and type: 
“\Program Files\The Scripps Research Institute\Vina\vina.exe” –config conf.txt –log 
log.txt 
2.8.4 Molecular dynamic simulation of CatchER 
2.8.4.1 Preparation of the chromophore using GAUSSIAN and RESP  
RESP (Restrained Electrostatic Potential) charge derivation is used for assign partial 
charges for a “new” molecule. It is a crucial step in the molecular dynamics simulation based on 
AMBER and CHARMM force fields. To obtain the partial charges by this method, quantum 
chemistry calculation is first applied to optimize the molecule to output a stable minimized struc-
ture and subsequently to calculate a molecular electrostatic potential (MEP) in a three-
dimensional grid which is generated by GAUSSIAN or GAMESS. RESP program is then used to 
fit an atom-centered charge to MEP.  
Here, R.E.D. (RESP ESP charge Derive) program was used for derive RESP charges for 
the chromophore. In the R.E.D. program, two steps of the quantum chemistry calculation and the 
final charge fitting are integrated and no format conversion is required. This program is executed 
under LINUX platform. The initial input file of the chromophore in PDB format is directly ex-
tracted from the mCherry structure (PDB ID: 2H5Q). Then Ante_R.E.D. program will generate 
five files for further quantum calculation, including P2N file (.p2n), PDB output (.pdb), 
GAMESS input file (.inp), GAUSSIAN input file (.com), and the file containing atom connec-
tives (.txt).  
The command is: 
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perl Ante_RED.pl cro.pdb > Ante_RED.log 
 
 GAUSSIAN03 was used for the quantum chemistry calculation to generate the input file 
for RESP fitting: 
g03 < cro.com > cro-Gaussian.log 
However, the frequency job in this the QM output file can not be recognized by the fol-
lowing program, so it has to be removed before running RESP fitting (containing “Frequencies”). 
And the filenames of the p2N and GAUSSIAN output should be changed to Mol_red1.p2n and 
Mol_red1.log, respectively. Since the chromophore is the non-standard residue in the middle of 
the peptide, so some charge restriction should be defined, like the peptide backbone N, C, H and 
O. In this case, charges for N, C and H will be defined and one remark will be added into the 
P2N file : 
REMARKS  
…… 
Finally, the RESP charge is fit by the command: 
perl RED-vIII.4.pl > RED-vIII.log 
2.8.4.2 Structure minimization and MD simulation by AMBER  
AMBER package includes several programs for molecular simulation.  In the study of 
mCherry variants, AMBER is used for energy minimization and simulation. AMBER requires 
users to prepare the pdb files for minimization. Sometimes the protein pdb files are involved in 
non-standard amino acids. In these cases, AMBER does not recognize it and ignores it, like the 
chromophore in GFP and mCherry. If we want AMBER to take account for them, the specific 
parameter files have to be created. Antechamber is one of the tools in AMBER package, which is 
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used to deal with the small organic molecules. tLeap can further generate the files of the complex 
of protein and ligand ready for Sander. Protein pdb file should be checked first to avoid the un-
expected errors and all hydrogen should be removed at this step. The chromophore pdb file is 
prepared by extracting the chromophore from the mCherry directly. Antechamber is used to gen-
erate the amber preparation input file in the format of prepi and the bond parameter file in the 
format of frcmod. tLeap is used to generate the library of the chromophore, cro.lib, which is fur-
ther used for building the SANDER input files of the complex (topology and coordinates). All 
the scripts and commands are shown in Appendix A.2. 
2.9 Calcium response monitored by designed calcium binding proteins in situ 
2.9.1 Materials and supplies 
Dulbecco's modified Eagle's medium (DMEM) and Hank's balanced salt solution (HBSS) 
were purchased from Sigma Chemical Co.. Fetal bovine serum (FBS), Opti-MEM reduced serum 
media, and lipofectamine 2000 were purchased from Invitrogen. FuGENE HD Transfection rea-
gent was purchased from Roche. All media and buffer was filtered using the filter unit from Mil-
lipore.  
The SERCA pump inhibitor Cyclopiazonic acid (CPA) and Thapsigargin, the cell mem-
brane permeabilizer digitonin, the IP3R agonist Histamine and IP3, the Ryanodine receptor ago-
nists 4-Chloro-m-cresol (4-cmc) and caffeine, the calcium ionophore ionomycin, as well as the 
solvent DMSO, were purchased from Sigma.  
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2.9.2 Cell culture and DNA transfection 
HEK293 and C2C12 cells were grown on 100 mm culture dishes or glass cover slips 
(0.5-1.0 × 10
6
 cells/dish) in 35 mm culture dishes in DMEM with high glucose for HEK293 and 
C2C12 with 44 mM NaHCO3 (pH 7.2) and supplemented with 10% (v/v) fetal bovine serum 
(FBS), 100 units/mL penicillin, and 0.1 mg/ml streptomycin (Pen/Strep) at 37 °C with 5% CO2 
in a humidified incubation chamber. The cells were seeded and grown overnight before transient 
transfection with Ca
2+
 sensor plasmid constructs.  
Plasmid DNA used for transfection was harvested from transformed E. coli (DH5α) using 
a QIAGEN Miniprep protocol (Qiagen). Each of the mCherry variants was individually and tran-
siently transfected into cells with FuGENE HD Transfection reagent or lipofectamine 2000 and 
serum-free Opti-MEM per the manufacturer's instructions. The plasmid DNA (1.5 μg) with a ra-
tio of DNA to transfection reagent at 1:2 -1:3 (μg/μl) was generally used in a typical transfection. 
The cells were then grown for 2 days in a humidified chamber with 5% CO2 at 37 °C before flu-
orescence microscope imaging. For C2C12 cell line, incubation at 30 °C was favored. 
2.9.3 Cell imaging of calcium calibration and response  
Calibration protocol described by Aldebaran Hofer was used as a standard one here for 
the mCherry-based calcium sensors targeted to ER lumen(83). Mag-Fura-2 AM, which was rec-
ognized to be accumulated in ER, was used for comparison. A variety of drugs, e.g. , 4-Chloro-
m-cresol (4cmc),  Cyclopiazonic acid (CPA), Inositol-1,4,5-trisphosphate (IP3), Thapsigargin 
and Adenosine-5'-triphosphate (ATP), were applied to cells to either activate the calcium chan-
nels such as ryanodine receptor (RyR) and Inositol trisphosphate receptor (IP3R) to release ER 
calcium or inhibit sacroplasmic reticulum Ca
2+
-ATPase (SERCA) pump to reload calcium into 
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ER. Thus, the calcium concentration in ER decreased when treating cells with these drugs. Table 
2.3 summarizes the effect of these drugs on the various calcium channels. 
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Table 2.3 Agonists and antagonists used for induce calcium change 
Agents Stock Conc. Buffer Target 
Anticipated effect 
[Ca2+]ER [Ca
2+]cyt 
ATP 100 mM Steril H2O IP3R Decrase Increase 
Caffeine 40 mM Steril H2O RyR Decrase Increase 
Histamine 50 mM Steril H2O IP3R Decrase Increase 
Thapsigargin 1 mM DMSO SERCA Decrase Increase 
Ionomycin 5 mM DMSO IP3R and Membrane 
Decrase and 
cell death 
Increase 
Digitonin 25 mg/ml Steril H2O Membrane Cell death 
4cmc 20 mM Steril H2O RyR Decrase Increase 
CPA 50 mM DMSO SERCA Decrase Increase 
IP3 10 mM DMSO IP3R Decrase Increase 
 
The standard Ringer’s buffer was prepared using 1xstock buffer (145 mM NaCl, 2.5 mM 
K2HPO4, 1 mM MgCl2, 1.8 mM CaCl2, 10 mM HEPES, pH 7.2) with supplement of 10 mM glu-
cose before use. The intracellular buffer was prepared as 125 mM KCl, 25 mM NaCl, 10 mM 
HEPES, 0.2 mM MgCl2, 200 µM CaCl2, 500 µM EGTA to give a final free [Ca
2+
] of approxi-
mately 100 nM and the addition of 0.5 mM Na2ATP before use; pH was adjusted to be 7.25. KCl 
solution was prepared as 125 mM KCl, 25 mM NaCl, 10 mM HEPES, 0.2 mM MgCl2, pH 7.25, 
which was used for calibration together with the calcium stock (1 M CaCl2) and Nitrilotriacetic 
acid (NTA) stock (1 M). To calibrate calcium indicators targeted in the ER, the membrane is 
necessary to be permeabilized by digitonin at a final concentration of 25 µg/mL in the intracellu-
lar buffer. Calcium buffers were prepared to obtain the low calcium concentration in micromollar 
level. The calcium-NTA buffers for in situ calibration as calculated by the computer program 
(MAXC) developed by Chris Patton (Stanford University)(136, 137).  
2.9.4 Production of lentivirus encoding CatchER 
The lentivirus is a kind of defected virus, which can infect cells and tissues. The 3
rd
 gen-
eration of lentivirus is composed with 3 plasmids, (1) pCMV∆R8.92 encoding HIV-1 Gag/Pol 
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and Tat gene which is essential for replication of wild type HIV-1, (2) pLP/VSVG Vesicular 
Stomatitis Virus Envelope Protein, supplying the helper functions as well as structural and repli-
cation proteins. It is a heterologous coat protein other than native HIV envelope protein, (3) 
pFUGW containing gene of interest flanked with two LTR sequences. The helper lacks the pack-
aging sequence and genes encoding some essential accessory proteins which are required for 
HIV to create a replicative competent lentivirus (RCL) are deleted. Ideally, since the vector 
plasmid lacks any of the other structural genes, it cannot form a replicative competent virus in 
the host cell. 
The HEK293FT contains SV40 large T-antigen, which is commonly used for virus ex-
pression. The cells were cultured with 5 ml DMEM high glucose medium in 100 mm dish at 
37°C under 5% CO2. Cells were split to maintain certain density twice a week. At the day before 
transfection with three plasmids, the cells was divided and keep it around 10
7
 in a dish. Three 
plasmids (pFUGW, pΔR8.92 and pVSV-G) were mixed as the ratio of 2:1.5:1in 0.5 ml OPTI 
medium. A ratio of 2 µl lipofectamin-2000:1 µg DNA will be applied. For a 100-mm dish, 10 µg 
pFUGW is required. The DNA solution (22.5 µg in total) was completely mixed with the 45 µl 
Lipofectamin-2000 pre-diluted in 500 µl OPTI medium, and equilibrated for 20 min. The mix-
ture will be added and culture for 48 – 72 h. The medium was collected and be centrifuged at 
5000 rpm for 5 min. The supernatant was collected and filtered by 0.45 µm membrane to remove 
cells. The lentivirus in the medium will be enriched by ultracentrifigation at 27,000 rpm for 2 h 
with SW-40 Ti rotor. The pellet was resolved in a small amount of sterile PBS buffer. The de-
tailed protocol was in Appendix E. 
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3 RATIONAL DESIGN AND EVALUATION OF CALCIUM BINDING FLUORES-
CENT PROTEINS 
3.1 Introduction 
Calcium ion has been widely known as the secondary messenger, which is associated 
with calmodulin, calbindin, calcineurin and other calcium binding proteins in a variety of organs 
and tissues, to mediate muscle contraction, heart beating, neurotransmitter release, and gene ex-
pression (Figure 1.1) (4, 5, 138-140). As the first messenger, via the calcium sensing receptor or 
group 1 metabotropic glutamate receptors, it controls calcium homeostasis in organs such as par-
athyroid gland, liver, kidney, blood vessels, as well as axon and dendrite outgrowth in nervous 
system (141-145). Calcium signaling is determined by the amplitude and kinetics of calcium 
transients, which is contributed by the activation and kinetics of calcium pumps, channels and 
the buffer proteins. Those calcium binding proteins including calcium channels sophistically 
control the spatial-temporal calcium gradient and transient, resulting in different physiological 
signal transduction.  
Calcium (Ca
2+
) transients originate from the calcium concentration gradients across bio-
logical membranes and are determined by the calcium binding affinity and kinetics of calcium 
channels/pumps as well as intracellular calcium binding proteins. The spatial-temporal calcium 
concentration change results in different physiological signal transduction, including muscle con-
traction, heartbeat, neurotransmitter release, gene expression, etc. (4, 5, 138, 139, 141). The time 
scale of calcium signaling varies from milliseconds to minutes. The fast calcium signaling, espe-
cially associated with action potentials usually occurs with a rapid local calcium rise (millisec-
onds) due to the calcium influx via the membrane voltage gated calcium channel and the calcium 
release from the internal stores, for example, the excitation-contraction coupling (EC coupling) 
 53 
 
in muscle cells and the neuron-transmitter release in neuron cells (21, 139, 146-155). On other 
hand, the slower calcium signaling usually happens in cellular events such as immune response, 
which can last minutes and even hours (7). In those slow calcium signaling pathways, the calci-
um transient is controlled by several factors and second messengers like DAG, IP3 and ATP, in-
volving more complicated regulation mechanisms (156).  
To accurately monitor the calcium transients in terms of the kinetics, amplitude, and du-
ration, calcium indicators/sensors are required to have several key properties. It is necessary to 
match the dissociation equilibrium constant (Kd) of calcium indicators to the resting calcium 
concentration of the sub-cellular compartment. On the other hand, to detect fast action potential 
related calcium release from internal calcium pools such as the endoplasmic reticu-
lum/sarcoplasmic reticulum (ER/SR) in skeletal muscle and neuronal cells, calcium binding af-
finity in the range of 0.1-1.0 mM and a calcium dissociation rate greater than 200 s
-1
 is necessary 
(considered the time constant range of action potential is 1-5 ms). 
Understanding calcium signaling was advanced by the development of calcium dyes and 
genetically encoded calcium indicators (GECIs) (50, 67-72). High-affinity organic calcium dyes 
are often used to monitor calcium transients in the cytosol because the Kd is in the magnitude of 
hundreds of nanomollar. However, the detection of Δ[Ca2+] induced by a train of high frequency, 
especially the rapid release from the ER store, is largely limited by the availability of calcium 
indicators. It has been reported that it is not suitable for the calcium dye Oregon Green BAPTA 1 
to detect the calcium transients upon action potential stimulation of more than 50 Hz because the 
slow decay (koff=2.6 s
-1
) results in the accumulation of signals (67, 73-75).  
The low affinity calcium dyes, with their low affinity and rapid off rate, such as Fluo-5N 
(76-78), Mag-Fluo-4 (79), Calcium-green-5N (80, 81) were used to monitor calcium change in 
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internal calcium stores including the mitochondria and the endoplasmic reticulum (82-84). How-
ever, the reported kinetics and the amount of calcium concentration change during EC coupling 
in skeletal and cardiac muscle cells as well as neurons were largely varied. For example, it was 
reported a broad range from 3.3 to 8.0 ms of the calcium release presented by the full duration at 
half-maximum (FDHM) at room temperature from the mouse fast-twitch fibers upon the action 
potential (85-88). Such variations are likely a result of limitations associated with calcium dyes, 
including the spatial localization of dyes, binding affinity, and kinetics (kon and koff) (71, 89).  
The development of genetically encoded indicators (GECI), such as GCaMP, GECO, TN 
and Cameleon series, enables to probe spatial-temporal cellular events and cell signaling in real 
time (19, 54, 60, 90-97). GECI are composed with a fluorescent protein moiety and native cyto-
solic calcium trigger proteins (CBPs) such as calmodulin (CaM) or troponin C (TnC) that are 
used to sense calcium concentration change and calcium-induced global conformational rear-
rangement. Each CaM or TnC binds four calcium ions cooperatively with a strong calcium bind-
ing affinity (Kd=10
-7
 M) and calcium binding on rates in the magnitude of 10
7
 M
-1
s
-1
 that enable 
them to sense the immediate [Ca
2+
] rise in the cytosol (98-101). Meanwhile, these GECIs have 
slow dissociation rate around 0.1-10 s
-1
 likely due to the cooperativity associated with multiple 
calcium binding sites and multiple layers of conformational change (102, 103). Their slow kinet-
ics of signal decay hampers their applications in probing physiological fast calcium transient es-
pecially in the neuron and skeletal muscle cells (56, 91, 104). Further efforts to reduce the calci-
um binding affinities in Cameleon D1ER results in a multiple Kds around 0.8 and 60 μM and the 
off rate around 256 s
-1
 (38). Such sensor, however, was not able to capture the calcium release 
from SR upon the stimulation in the mouse FDB fibers (105, 106).  
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The statistical analysis of calcium binding geometry and charged residue preference has 
been study by our group (66, 157, 158). The classic calcium binding pocket is consisted with 6-7 
oxygen atoms, and forms a bipyramidal shape, resulting in the high calcium binding affinity and 
selectivity. To obtain different calcium binding capability, alternation of the classic calcium 
binding rule was allowed. For example, to lower the calcium binding affinity, the geometry 
would be modified to form 3/4 or 1/2 shell of the classical bipyramidal; the negatively charged 
residues could be replaced by the neutral glutamine or asparagine and the non-polar amino acids; 
the glutamate and aspartic acid could be substituted with each other to change the side chain 
length.  
To fulfill the unmet need of a fast calcium indicator required for monitoring calcium re-
leases in high concentrations such as the ER/SR, we reported a calcium sensor called CatchER 
without using the native calcium binding domain (66). CatchER was created by designing a cal-
cium binding site into a single enhanced green fluorescent protein (EGFP). The binding stoichi-
ometry is 1:1 and the Kd is 0.18 mM in vitro and 0.8 mM calibrated in situ allowing measure-
ment of basal calcium in different cell lines and their changes in response to different drugs. 
Compared to Cameleon D1ER, CatchER exhibits faster kinetics, allowing it to catch the SR cal-
cium change in the skeletal muscle cells (107). To date, however, there is no sensors available 
for measuring calcium responses at the red wavelength region with an advantage of better tissue 
penetration to complement the green sensors developed by us and others (66). In this chapter, we 
report the achievement of designing calcium binding protein RapidER using a red florescent pro-
tein mCherry by integrating key factors for calcium binding kinetics and metal induced optical 
property change.  We show that the designed red calcium binding sensor RapidER, on the sur-
face of mCherry, is able to report calcium concentration by fluorescence in the range of 10
-4
-10
-3
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M with an unprecedented dissociation rate in the magnitude of 10
3
 s
-1
. Our finding reveals essen-
tial factors needed for future design of fast calcium binding proteins, fulfilling a pressing need 
for monitoring calcium dynamics in fast biological processes.  
3.2 Characterization of the biophysical properties of designed calcium binding proteins  
3.2.1 Structural analysis and design of calcium binding site on the red fluorescent 
proteins 
Calcium binding site candidates were searched on the available crystal structure of 
mCherry(159). The chromophore environment was first mapped out to locate the residues in-
volved in the chromophore hydrogen-bonding network. Figure 3.1 shows the mCherry chromo-
phore environment in the crystal structure 2H5Q, and the potential hydrogen bonds were depict-
ed using dash lines. At neutral pH, mCherry chromophore is deprotonated since pKa of mCherry 
is not more than 4 (109). Direct hydrogen bonds were found between the chromophore tyrosyl 
and the side chain hydroxyl of Ser146 and Gln163 side chain amide group. The side chain of 
Ser146 has double conformer, and the H-bond to the chromophore can be formed by either of 
them. Through Ser146, the chromophore was indirectly hydrogen bonded to Ile197 and Glu144. 
A hydrogen bond network was consisted of the imine nitrogen of the chromophore imidazoli-
none, Glu215, Gln42, Ser69-Lys70, the carbonyl of the chromophore imidazolinone, Arg95 and 
Gln64. The H-bond interaction can be also observed between the side chain amide of Gln213 and 
the thioether sulfur of the chromophore. Among the residues mentioned above, only the residue 
Glu144 interacts with the chromophore through its main chain, while others form H-bonds 
through their polar side chain. Those surrounding residues assist to mount the chromophore in-
side the β-barrel.  
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The potential calcium binding site can be created by constructing an area of high negative 
potential formed by the side chains of glutamate and aspartate (Figure 3.1.Bc). Unlike EF-hand 
motif, in which the calcium binding coordinators are carbonyl or carboxyl from both the main 
chain and side chain located in the loop, the main chain coordinator is avoided since the hydro-
gen bonding between the β-strands is essential for the barrel architecture. Therefore, the residues 
with the side chain pointing outwards and adjacent or close to the residues involved in the elec-
trostatic interaction with the chromophore are taken into account for the candidates of the calci-
um binding ligands as the first step screening. The following screening was carried out to look 
for the residues or stretches which are relatively flexible, estimated by the B-factor of the pdb 
file (Figure 3.1(Bb)). There is the assumption that the less constrained residues are not important 
as much as the rigid ones for maintaining the fluorescence.  
The Cα geometry of several EF-hand motifs (both Ca2+-loaded and Ca2+-free forms) was 
analyzed and compared to our previous designed binding sites. We found that: (1) all the classic 
EF-hand motifs appear to have 5 residues for calcium binding; (2) the distribution of Cα forms a 
trigonal bipyramidal -like geometry, in which a near-planar was formed by four Cα and the fifth 
one hangs up; (3) the distance between any two of Cα located in the “plane” is approximately 6 
angstrom and the longest distance is between the hanging Cα and one of Cα in the “plane”; (4) 
calcium atom is surrounded by these five residues while the positions of five Cα are not changed 
significantly upon calcium binding.  Compared to this, the hanging residue was not included in 
our previous design, which probably is the reason for the low binding affinity. Since the posi-
tions of Cα will not be changed much upon calcium binding, and the geometry of Cα was con-
served to some extent, the Cα can be a good potential sign to define a calcium binding pocket. 
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Figure 3.1. Structural analysis and design of calcium binding sites on mCherry.  
(A) The mCherry chromophore environment (PDB ID: 2H5Q). The chromophore was shown in the stick 
mode. The dash line indicate the hydrogen bond and the cut-off distance for the H-bond is 3.5 Å; (B) a: 
the overall mCherry structure in cartoon; b: the B-factor map and the electrostatic density map of the wild 
type mCherry, showing the most flexible area colored with red and blue indicating the most rigid area; c: 
the electro-density map change from wild type mCherry to MCD1 (RapidER). (C) the Cα geometry of 
MCD1, MCP4 and EF-hand motifs of calmodulin (PDB ID: 3CLN); the dash line together with the num-
ber in the middle indicate the distance between two Cα, and the residue number is labeled at the point of 
Cα for all variants.(D) The oxygen geometry (top) and backbone (bottom) of modeled MCD1. 
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Have taken all together, residues 145, 196, 198, 216 and 218 were selected for the first 
calcium binding site MCD1x. The residue 145 is next to Glu144 and Ser146, both of which con-
nect to the chromophore. Residues 196 and 198 are next to Ile197 and residue 216 is next to 
Glu215. The glutamate and aspartate were shuffled in these five positions to generate a series of 
mutants. The positive potential provided by the residue Arg220 may have negative effect on cal-
cium locating to this binding site, which was also be substituted by glutamate. The second bind-
ing site, MCD2x, includes the residues 144, 198, 200, 214 and 216. Similarly, these positions are 
close the chromophore environment residues and partially overlapped with the first site. The 
third site MCD3 (MCP6), including 92, 94, 108 and 110, was selected, which locates in the op-
posite side of the first and second potential calcium binding sites. The first and second calcium 
binding site candidates are mainly focused to alter the electrostatic hindrance in the chromophore 
tyrosyl, while the third one is aimed to influence the chromophore imidazolinone imine nitrogen. 
Considered the Cα geometry, the forth site was designed in the loop region close to the 
chromophore, including Glu144, as shown in Figure 3.1C. The Cα geometry of Glu144, Arg164, 
Lys166 and Gly142, and Glu144, Arg164, Lys166 and His172, was similar with and even more 
convex than what can be seen in EF-hand motif without the hanging residue. His172, in which 
the nitrogen of imidazol ring was only 2.6 Å away from the carboxyl oxygen of Glu144, was 
mutated to Glu to further perturb the hydrogen bonding between them. The hydrogen bond be-
tween Arg164 and Asp174 was disturbed in both mcEE and MCP4, resulting in the alternation of 
the local electrostatic property and further lower the interaction between the strands β7 and β8.  
Instead of locating the calcium binding site on the convex surface of beta-can by site mu-
tagenesis,  the grafting approach was used to insert a calcium binding motif into the fluorescent 
protein. Unlike the direct calcium binding to the fluorescent protein, introduction of another 
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binding domain requires the corresponding conformational change upon calcium binding which 
will in turn to modify the chromophore environment so as to affect the spectral properties. The 
loop region near chromophore (140-147) was chosen to be the first potential binding pocket, 
where the non-negatively charged residues were replaced for glutamate acid, or the loop was 
substituted with the second EF-hand motif of calbindin D9K (TLDELFEELDKNG-
DGEVSFEEFQVLVKKI) or loop (DKNGDGE). There was evidence showing the calcium bind-
ing to this specific loop triggers the conformational change (Dr. Yanyi Chen’s unpublished data), 
which may alter the original chromophore environment and the fluorescence.  
These design strategies were first modeled using the MODELLER, AUTODOCK-Vina 
and the calcium binding prediction program MUG (160). Figure 3.2 shows the wild type mCher-
ry, the modeled structures of the designed calcium binding proteins and predicted calcium bind-
ing sites. Four cp-mKate variants, 149-148, 154-153, 168-167 and 189-188, were used as the 
templates of the new constructs (161). These four cp-mKate showed the shoulder around 350-
500 nm in the optical spectra and reduced brightness compared to mKate. The stable chromo-
phore environment was affected and open possibilities to manage the chromophore environment 
by mutagenesis. The designed calcium binding pocket is in the equivalent position of CatchER 
and MCD1 (also as RapidER). Table 3.1 summarizes the variants created for the calcium sensor 
screening. 
The electrostatic repulsion in the binding site due to these negatively charged residues 
weakens the hydrogen-binding network among the beta sheets, which will increase the solvent 
accessibility and thus increase the fluorescence quench by solvent. Ca
2+
 binding results in charge 
neutralization in this area, further leading to recovery of the natural stable scaffold structure. The 
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designed binding site was considered to maintain the native folding of the fluorophore to avoid 
the perturbation of the fluorescent activity.  
 
 
Figure 3.2. Predication of calcium binding to the modeled red fluorescent proteins.  
(A) The models of MCD1 (also as “RapidER”) and MCP5 and cp-mKate. The model structures MCD1 
and MCP5 was applied with energy minimization by AMBER9. VINA can find the designed binding site. 
The cartoon structure of cp-mKate-168-167 (PDB ID: 3RWA) was shown and the mutation sites are de-
picted, which is in the equivalent position as CatchER and MCD1. (B) The initial models of MCIN1, 2, 3 
and 4 were built by Modeller. VINA was used to dock calcium. Calcium ion was placed into the expected 
pocket.  
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Table 3.1 Variants and the corresponding mutation sites  
Position Design Strategy Clones Mutation/Insertion 
Pocket 1 To influence the hydrogen 
bonds formed between the 
chromophore tyrosyl and 
WAT1-E144 backbone, 
S146 side chain. (Figure 
3.1). Modification around 
MCD1 is to modify the 
Ca2+ binding affinity and 
the optical properties. 
MCD1 A145E/N196D/K198D/R216E 
MCD14 MCD1+R220E 
MCD14Y 197Y+MCD14 
MCD14YS 197Y/199S+MCD14 
MCD15 MCD14 + D198E 
MCD16 MCD14 + S147D  
MCD17 MCD14 + I197T/K198E/L199S/D200A  
MCD18 MCD14 + K198E/D200A 
MCD19 MCD1 + D198E 
MCD110 MCD15 + L199S 
MCD111 MCD15+D196E 
MCD112 MCD1+E220Q 
Pocket 2 To influence the hydrogen 
bonds formed between the 
chromophore tyrosyl and 
WAT1-E144 backbone. 
(Figure 3.1) 
MCD2 K198D/Y214E/R216E 
MCD22 K196E/Y214E/R216E 
MCD23 MCD2 + D200E 
MCD24 MCD2 + D200Q 
MCD25 MCD2 + D200N 
MCD26 MCD2 + E216D 
Pocket 3 To influence the hydrogen 
bonds formed between the 
chromophore tyrosyl and 
Q163 side chain. (Figure 
3.1) 
mcEE R164E/K166E 
 mcP4 G142E/R164E/K166E 
 mcP5 R164E/K166E/H172E 
Pocket 4 To influence the hydrogen 
bonds formed between the 
chromophore and Q109 
and R95. (Figure 3.1) 
mcP6 K92E/T108E 
Pocket 5 To insert the EF-hand 
away from the chromo-
phore. 
MCIN1 153^154 (Insertion is between residue 
153 and 154.Same as below) 
Pocket 6 To insert the EF-hand near 
the chromophore tyrosyl. 
MCIN2 135V^142G 
 MCIN3 142G^147S 
 MCIN4 143W^147S 
mKate To mount the calcium 
binding site in cp-mKate 
in the corresponding loca-
tion as MCD1 and Catch-
ER. 
cp-mKate_149-148 Corresponding to mKate 
A142E/R198E/V216E  cp-mKate_168-167 
 cp-mKate_189-188 
 cp-mKate_154-153 
 
 
3.2.2 Expression and purification 
Protein folding was dependent on the E. coli. strains and affected by the vectors. Alt-
hough the SDS-PAGE showed the band at the expected position, the protein lost its color if ex-
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pressed in the inappropriate combination of the vector and the cell strain. mCherry variants with 
mutations at the first binding site MCD1x encoded in pRSETb vector were expressed by E. coli. 
BL21 (DE3); while MCD2x encoded in pRSETb were expressed in BL21 (DE3) PlysS strain. 
The gene encoding mCherry and its variants was released from pRSETb and inserted to the vec-
tor pET28α which is used for EGFP and its variants expression. The new construct was trans-
formed into BL21 (DE3) and after overnight expression at 25 °C, the red color culture was ob-
served from the broth. Cell was broken by sonication and after purified by HiTrap chelating col-
umn, the gel showed a lot of other bands although the abundance was the protein of interest 
(Figure 3.3 C and D). The precipitates can be observed when titrating calcium to the protein puri-
fied by the affinity column, resulting in the light scattering when recording the optical spectrum 
(Figure 3.3E). After further purification using Mono-Q column and desalting column (Figure 3.3 
A and B), the impurities was reduced as shown in Figure 3.3 D and F,  and no precipitates 
formed during calcium titration. 
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Figure 3.3. Purification of MCD15 from BL21 (DE3) transformed with pET28a.   
(A) The trace of MCD15 eluted from Mono-Q column. (B) The trace of desalting MCD15 using Se-
phdex-75 (GE Healthcare). (C and D) lane 1: the protein purified from Ni-chelating column; lane 2: the 
supernatant of the MCD15 sample titrated with calcium after spin; lane 3-5: precipitates of the MCD15 
samples titrated with calcium after spin. (E) The optical spectra of the apo MCD15 purified by only the 
affinity column and the one with calcium. (F) The optical spectra of the apo-MCD15 purified by the affin-
ity, Q and desalting columns and the one with calcium.  
        
Alternatively, the vector pRSETb was transformed to Rosetta gami (DE3) PlysS for ex-
pression. Before IPTG induction, the temperature was lowered to 30 °C. After the protein ex-
pression at 30 °C for overnight, bacteria were harvested and the total soluble protein was extract-
ed by sonication and centrifugation. The total protein was loaded to Ni
2+
 column (HiTrap chelat-
ing column, GE Healthcare) and the fractions from HiTrap chelating column were collected and 
the gel showed in the Figure 3.4A was very clean compared to the one purified from pET28α 
(Figure 3.4B). But the amount of the cleaved bands is more than that from pET28α. Compared to 
the previous purification, the percentage of cleaved bands was reduced, but the impurity in-
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creased using the pET28α construct and the yield was lower. Rosetta gami (DE3) PlysS trans-
formed with pRSETb is able to produce protein with a satisfactory yield and also less purifica-
tion steps will be adopted since the purity of the protein after Ni
2+
 affinity column is high. 
 
Figure 3.4.  Comparison of SDS-PAGE pattern of MCD15 purified from different E.coli. strains.  
(A) Different fractions of FPLC purification for protein produced by Rosetta gami (DE3) PlysS, showing 
the full length protein and the cleaved peptides. (B) The protein expressed in E.coli. BL21 (DE3) encod-
ing pET28a and purified from Ni-chelating column; bands other than cleaved peptides can be observed. 
(C) The intensity analysis by ImageJ showed the abundance of MCD15 in the total purified protein in the 
gels A and B. 
 
3.2.2.1 Separation of cleaved peptides 
The cleaved peptides could make the quantitative analysis complicated, although only the 
active form of chromophore was taken into account when all experiments were conducted. As a 
result, attempts were done to obtain the pure full length protein. Considered the size difference, 
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size exclusion chromatography (SEC) was applied and the resulting trace was shown in Figure 
3.5A. Only one symmetric peak was observed, indicating it failed to separate the cleaved pep-
tides. The native PAGE shown in Figure 3.5C and D suggesting that the cleaved peptides were 
tightly associated with each other as an intact protein or with the full length protein. 
To remove the tightly associated cleaved peptides from MCD1 purified from Rosetta 
gami pLysS (DE3) with Ni-chelating column, denaturants such as urea and SDS was added to 
the elution buffer. MCD1 exhibits surprising conformational stability since it cannot be dena-
tured by even 8 M urea. As shown in Figure 3.6A, optical spectra do not change in either 8 M 
urea or 1% (w/v) SDS, compared with the one in the storage buffer (10 mM Tris, pH7.4). The 
SEC then was applied and buffer supplemented with 2 M and 8 M urea was used for elution. As 
shown in Figure 3.5B, 2 M urea elution resulted in two peaks. The SDS-PAGE and native PAGE 
in the Figure 3.5B inset have the similar pattern in Figure 3.5A and 3D, indicating that it was not 
able to remove the cleaved peptides. Similarly, elution with 8 M urea cannot separate the cleaved 
peptides from the full length protein as shown in Figure 3.5E and 3.5F. Getting together, the as-
sociated cleaved peptides are not able to be isolated by 8 M urea. However, the major fraction of 
8 M urea SEC for MCD1 shows a ratio of absorbance at 280 nm to the one at 587 nm more close 
to reference (110), compared to MCD1 before SEC, which demonstrated that SEC with elution 
of 8 M urea removed the peptide involving inactive chromophore as shown in Figure 3.6B.  
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Figure 3.5. Removal of cleaved peptides by size exclusion chromatography (SEC).  
(A) SEC traces for MCD1, which was eluted by 10 mM Tris, pH 7.4. The blue trace indicates UV intensi-
ty at 280 nm and the brown one indicates the conductance. The inset shows the SDS-PAGE of fractions 
as labeled. (C and D) The native gel of SEC fractions of MCD1, MCD1 before SEC, MCD13, MCD14 
and MCD15, before (C) and after (D) coomassie staining.  (B) SEC trace for MCD1, which was eluted by 
the buffer containing 2 M urea and 10 mM Tris, pH 7.4. The sharp peaks with the red blankets was result-
ed by air trapped in the column. And one major and one minor peaks were obtained. The insets show the 
SDS-PAGE of fractions as labeled. (E) SDS-PAGE of MCD1. lane 1: the major peak of SEC with elution 
of 2 M urea; lane 2: the major peak of SEC with elution of 8 M urea; lane 3: MCD1 before SEC. The 
loaded proteins are at the same level of active chromophore, checked by UV-vis spectra (data not shown). 
(F) the native gel of the same samples as (E). 
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Figure 3.6. UV-vis spectra of MCD1 supplemented with denaturants.  
(A) Comparison of the UV-vis spectra of the MCD1 in storage buffer containing 10 mM Tris, pH7.4 with 
MCD1 of the same concentration in 8 M urea and 1% (w/v) SDS. (B) Comparison of the UV-vis spectra 
of MCD1 before loaded to gel filtration column and the fraction 23 of SEC with 8 M urea. The spectra 
was normalized to the same concentration of active chromophore that results in a peak at 587 nm.   
 
Trypsin was suspected to be the enzyme which digested the full length mCherry and 
caused the tightly associated peptides. To understand that, trypsin digestion was carried out. As 
shown in Figure 3.7A, at the first 5 min of digestion, the optical property was not altered and in 
the following 30 min, the fluorescence intensity decreased, suggesting that the active chromo-
phore was reduced. The cleavage pattern of MCD1 was shown in the SDS-PAGE gel in Figure 
3.7B, where the full length protein was totally cut and five bands (30 kDa, 29.5 kDa, 19 kDa, 15 
kDa and 9.5 kDa) can be observed in the lane loaded with MCD1 digested for 16 h. At the end of 
the reaction, the lowest band (9.5 kDa) showing up in the control was fragmentized by trypsin, 
while the second band (19 kDa) remained the same. The difference of the SDS-PAGE patterns 
means the trypsin is not the enzyme resulting in the cleavage issue of mCherry and its variants. 
Here, the fluorescence intensity increased back at the time points of 35 min and 2 h was probably 
due to the fluctuation of the instrument.  
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Figure 3.7. Typsin digestion of MCD1.  
(A) The fluorescence spectra of the trypsin-digested MCD1 at different time points. Trypsin with a final 
concentration of 500 nM was added to 10 µM MCD1 in 10 mM Tris, 20 mM CaCl2, pH 7.4. The reaction 
was incubated at 37 °C.  (B) The SDS-PAGE for the digested product at 3 h, 16 h and MCD1 before di-
gestion as a control.  
 
3.2.2.2 Western blot of mCherry variants in cell lysate  
It is important to understand whether the cleavage issue exists in mammalian cells, which 
can be revealed by Western blot. The HEK-293 cells were collected after 48 hr transfection of 
mCherry variants. The protein concentration was determined by BioRad protein assay. The poly-
clonal anti-DsRed antibody (Clontech) and alkaline phosphatase conjugated with chemilumines-
cent substrate were used for detection of protein of interest. The developed Western-blot film 
was shown in Figure 3.8, clearly showing that no cleavage bands were observed in mCherry var-
iants expressed in HEK-293 cells except the wild type mCherry. The band intensity was ana-
lyzed by ImageJ, and normalized to the wild type mCherry. The expression level of the variants 
was approximately 50% of the wild type, although MCD1 showed the relatively more expression. 
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The minor band in the wild type mCherry sample probably resulted from the non-specific inter-
action with the polyclonal DsRed antibody.  
 
Figure 3.8. The film of western blot for mCherry variants MCD1, MCD14, MCD15 and the wild type.  
For each protein, 20 µg total protein was added to each well. The SDS-gel was electro-transformed to 
PVSF membrane at 21 V, 4°C for 16 h. The exposure time was 1 min.  
 
3.2.3 Spectral properties of designed calcium binding proteins 
Figure 3.9 shows the representative UV/visible and fluorescence spectra of the mCherry 
variants, which were used to evaluate the correct protein folding and determine their optical 
properties. All the fluorescent mCherry derivatives showed the similar optical spectra. MCD14Y, 
MCD14YS,  mcIN2, mcIN3, mcIN4 and all cp-mKate mutants lost the red color and the excita-
tion/emission spectra was blue-shifted to λex=350 nm/λem=430 nm.  For mutants maintaining red 
color, there was no difference in the wavelength of peak maxima (587 nm) and line shape com-
pared to the wild type mCherry. The fluorescence spectra showed no shift as well, in which the 
protein was maximally excited at 587 nm and emitted at 610 nm. The consistency of the spectral 
property demonstrated that introducing negatively charged residues on the β-barrel surface did 
not affect the chromophore conjugated system. For those showing no color, it was suggested that 
                             
0
20
40
60
80
100
120
MCD1 MCD14 MCD15 w.t. mCherry
In
te
n
s
it
y
 (
%
)
Protein (g)
 
 71 
 
opening of the middle of the β-sheet either broke the chromophore environment or affected the 
self-catalysis of the cyclic tri-amino acid formation and protein folding.  However, these mutants 
may fold better in the mammalian system so they can be expressed in HEK-293 cells and the 
study of the expression level as well as optical properties could be continued in the future. 
The fluorescence intensity was increased when adding calcium to MCD1 and MCD2 se-
ries (Figure 3.9B), while it remained no change for others. For the protein mcP4 expressed in 
HEK 293 cells, the protein folded and the fluorescence was detected although it did not show 
any color in the bacterial expressing product. Even though, the fluorescence was too dim for the 
further study. Compared to mcEE and mcP5, the mutation G142E was harsh for the protein fold-
ing, especially in E. coli.. 
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Figure 3.9. The representative optical and fluorescence spectra of mCherry derivatives.  
(A) The UV/visible spectra of MCD1.  (B) The fluorescence spectra of holo (red)- and apo (black)-MCD1. 
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3.2.4 Biophysical properties of mCherry variants sensing calcium 
3.2.4.1 Extinction coefficient,  quantum yield and fluorescence lifetime 
Due to the cleavage of both wild type and mutated proteins, the alkali denaturation assay 
was used for determination of extinction coefficient (110). Taken MCD1 as an example, Figure 
3.10 showed the linear relationship between the absorbance at 587 nm at pH 7.4 and absorbance 
at 455 nm at pH 13.0 using different concentrations of protein, as well as the fluorescence and 
the absorbance. Here, the extinction coefficient and quantum yield of the wild type mCherry at 
neutral pH condition are known as 72,000 M
-1
 cm
-1
 and 0.22, respectively. The unchanged ex-
tinction coefficient at 455 nm at pH 13.0 was determined using the wild type mCherry ε587nm as 
the reference. Equations for the calculation were described in Materials and Methods 2.3.2 and 
2.3.3. The results were summarized in Table 3.2. Figure 3.10 showed the representative spectra 
of MCD1 and the wild type mCherry collected for determining the extinction coefficient and 
quantum yield.  
The decrease in both quantum yield and extinction coefficient of was more or less ob-
served in all mutants, leading to less brightness than the wild type. For all mutants, calcium bind-
ing does not change the extinction coefficient. The MCD1 and derivatives showed higher quan-
tum yield in the presence of calcium, but not in mcEE, mcP5 and mcIN1. It was assumed that the 
designed binding site caused the concentrated local negative potential and in turn diminished the 
packing of the β-barrel by electrostatic repulsion force. Although the chromophore itself was not 
directly affected, the protein matrix providing the electrostatic restriction and steric hindrance 
was changed and quenched the fluorescence. Calcium binding recovers the fluorescence by neu-
tralizing the strong negatively charged area on the β sheets and reducing the repulsion force.  
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The fluorescence lifetime (Figure 3.11) was measured in the absence and presence of cal-
cium for MCD1, MCD14 and MCD15. Compared to the wild type, whose lifetime was reported 
as 1.46 ns (162), the mutation of MCD1 and MCD14 increased the fluorescence lifetime, and 
MCD15 was similar as the wild type. In agreement with the quantum yield calculation, the in-
crease of lifetime was observed upon calcium addition although it is not significant. 
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Figure 3.10. The UV-vis and fluorescence spectra of mCherry and MCD1 at different concentrations.  
The absorbance maxima at 587 nm in UV-vis spectra. The fluorescence emission spectra were collected 
by setting the excitation wavelength 587 nm and emission from 590 – 700 nm. The protein was prepared 
in 10 mM Tris, pH 7.4. All experiments were carried out at room temperature.The fluorescence intensity 
maxima at 610 nm of each sample were plotted. The data was linearly fitted using KaleidaGraph.    
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Figure 3.11. The fluorescence lifetime of MCD1, MCD14 and MCD15 in the absence and presence of 
Ca2+. 
The protein was prepared in 10 mM Tris, pH 7.4. The excitation wavelength was 590 nm and emission 
was at 610 nm. 
 
3.2.4.2 pH profile and pKa determination 
To obtain the pKa of the mCherry mutants, proteins were incubated in buffer at various 
pH (Table 2.1) overnight at 4°C and saturated in presence of 1 mM EGTA or 5 mM Ca
2+
. Data 
from the optical, excitation and emission spectra were collected (Figure 3.12 C and D) and fitted 
with Equation 2.2. The average value was listed in Table 3.2. The chromophore of the wild type 
mCherry and mutants listed in Table 3.2 was colorless when pH<3. The pH profile and curve 
fitting of the wild type mCherry was measured as control and the pKa was consistent with the 
reported one (110). In the cases of MCD1 and mcIN1, introducing negatively charged residues 
acidified the protein to some extent and resulted in the lower pKa. However, the proteins MCD14 
and MCD15 have one more negative charge substitution than MCD1, showing the same pKa as 
the wild type, even around 1 unit higher than MCD1, indicating the chromophore pKa was inde-
pendent of the surface charge number. For MCD1, adding calcium resulted in a higher pKa value, 
suggesting a less population of deprotonated chromophore was expected at neutral pH. Calcium 
binding did not shift pKa of MCD14, MCD15, mcEE, mcP5 and mcIN1 significantly. In general, 
the chromophore was sensitive to the pH from 3 to 6, which was resulted from the perturbation 
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of the charge balance near the chromophore microenvironment and the electronic repulsion 
would enlarge the solvent accessibility surface of chromophore. 
As shown in Figure 3.12A, the effect of pH (ΔF/Fmin) on the fluorescence intensity was 
greater in MCD14, compared with the wild type. Calcium binding even enhanced the influence. 
MCD1 and MCD15 showed the similar performance. Binding of calcium sensitizes the chromo-
phore to pH change, implying that the binding indirectly alters the chromophore environment. 
Generally for all mCherry-based calcium sensors, the pKa of the apo form is lower than its holo-
form and smaller than 5. In the physiological range of most organelles other than lysosome and 
endosome where pH was lower than 6, those sensors are valid to reflect the calcium change 
without the interference of pH.  
 
Table 3.2 Biophysical properties of selected mCherry variants 
Proteins 
ε587  
(mM
-1
 cm
-
1)  
Quantum yield  
Φ 
Average lifetime 
(ns) 
Brightness pKa 
Apo/Holo Apo Holo Apo Holo Apo Holo Apo Holo 
MCD1  64 0.17  0.24 1.52 1.61 0.11 0.15 3.6 5.0 
MCD14 67 0.20 0.22 1.50 1.54 0.13 0.15 4.4 4.8 
MCD15 65 0.21 0.24 1.44 1.47 0.14 0.16 4.4 4.6 
mcEE  58 0.18  0.14 4.3 
mcP5 69 0.18  0.12 ----- 
mcIN1  68 0.21  0.14 4.0 
w.t.MC  72 0.22 1.46 0.16 4.3 
(1) The standard deviation was not shown because they were smaller than 0.01.  
(2) All experiments were taken at room temperature and in 10 mM Tris, pH 7.4. 
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Figure 3.12. pH profile and pKa determination.  
(A) The representative pH profile of 10 mM wild type mCherry and MCD14 in the absence and presence 
of calcium. (B) Summary of pKa of mCherry variants.  The proteins was incubated in buffers at different 
pH as described in methods. Ca2+ with a final concentration of 5 mM was supplemented as the holo form 
and EGTA with a final concentration of 1 mM was added to chelate the free calcium in buffers as the apo 
form. The pKa value was obtained by fitting the curve using Equation 2.2. (C) The UV/visible spectra and 
(D) the fluorescence excitation/emission (587/610 nm) spectra of the wild type mCherry. The spectra for 
other mutants were similar as those of the wild type.  
 
3.2.5 Equilibrium-dialysis assay using ICP-OES to detect calcium amount 
3.2.5.1 The simulation of the equilibrium-dialysis assay 
To obtain an optimal result, the simulation of the dialysis-equilibrium binding assay was 
conducted. The variants in this simulation are the free calcium concentration at the equilibrium 
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state and the total protein input. The readout of ICP-OES (Inductively coupled plasma optical 
emission spectrometry) is the value of the total calcium concentration, which is the sum of the 
free calcium concentration and calcium ([Ca
2+
]free) concentration in the dialysis bag ([Ca
2+
]it). 
The dissociation constant was determined by the calcium titration. There are two assumptions 
here. One is that the initial calcium concentration in the buffer is equal to the free calcium con-
centration in the buffer at the equilibrium state, which is indicated by [Ca
2+
]free. This is assump-
tion was made when the buffer's volume is much larger (>2000 times) than the protein's volume, 
and the Kd is in the sub-µM to mM level. The other assumption is that the protein is in the calci-
um-free form.  
Figure 3.13 shows the three-dimension plot, the ranges of both [Ca
2+
]free and [P]t is 5 to 
1000 µM, the ratio of [Ca
2+
]it/ [Ca
2+
]free is represented by meshgrid. The red color indicates the 
high value. A high ratio is obtained by adding lower concentration of calcium in buffer and using 
higher concentration of protein inside the dialysis bag. From the plot, the highest ratio is 2.98, 
and the corresponding [P]t and [Ca
2+
]free is 1 mM and 5 µM, respectively. However, 1 mM pro-
tein is less practical. Also, the contamination of the trace amount of calcium in ddH2O is approx-
imately 2 µM, determined by ICP-OES.  As a result, the experiment can be conducted using 500 
µl 100 µM protein and 10 µM calcium buffer, which will result in an expected ratio of 1.5 when 
Kd is 180 µM. 
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Figure 3.13. The 3D plot of the ratio of [Ca2+]it/ [Ca
2+]free as a function of [P]t and [Ca
2+]free. 
The dissociation constant was set to be 0.5 mM. The highest point is [Cafree, Pt, Cait/Cafree] = [1000, 5, 
2.98]. 
 
3.2.5.2 The equilibrium-dialysis assay 
To determine the intrinsic calcium binding affinity of the protein, equilibrium-dialysis as-
say was applied. The equilibrium was reached after 48 h-long dialysis with stirring at 4°C. The 
UV spectra were record before and after dialysis for calculate the protein concentration in case of 
the possible volume change. The calcium standard, along with the solution inside and outside the 
dialysis bag collected after equilibrium reached was used to measure the total calcium concentra-
tion by ICP-OES. The ICP-OES is a technique for detecting the trace amount of metals. The 
temperature of argon plasma reaches approximately 8000°C and thermally excites all elements. 
Each element emits light at its characteristic wavelengths, which is collected by spectrometer. 
Here, spectra of light at seven wavelengths
 
(220.861, 219.779, 317.933, 370.602, 373.690, 
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396.847, 643.907 nm) emitted by calcium was collected and finally five of them were used since 
the dynamic range at 219.779 and 220.861 nm is too low (~300 for 3 ppm [Ca
2+
] increase). The 
standard curves were fitted by linear equation. Calcium concentrations of different samples were 
back-calculated based on standard curves. Protein concentrations before and after dialysis did not 
significantly change.  
The protein folding quality can be indicated by the ratio of A587/A280 suggested that pro-
tein since the extinction coefficients at both 280 and 587 nm for all the variants are quite similar. 
The UV spectra implied that MCD14 and MCD15 were mixture of well-folded forms with active 
chromophore, which contribute to absorbance at 587 nm, and partially-unfolded protein lacking 
chromophore. Compared to MCD1 and the wild type, MCD14 and MCD15 had less fraction of 
folded protein. The cleavage issue of all mCherry protein was not taken into account because the 
previous studies have shown that the cleaved peptides associate with each other tightly (see Sec-
tion 3.2.2.2). One more negatively charged residue on MCD14 and MCD15 than MCD1 may 
cause the loosely packed β-barrel, which in turn affect the critical micro-environment for the 
formation of the chromophore. Proteins which did not successfully form chromophore may con-
tribute to calcium binding with a different binding affinity, which caused the result reflecting on-
ly the general observed calcium binding affinity. Here, to simplify the problem, we assume that 
all the fractions have the same calcium binding capability. Therefore, the total protein concentra-
tion was used for calculation, which was determined using absorbance at 280 nm. 
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Figure 3.14. Equilibrium-dialysis assay for calcium dissociation constant determination.  
(A) The calculated Kd. (B) The average of calculated calcium concentration. For comparison convenience, 
the calcium concentration was back-calculated assuming the protein concentration was the same. Using 
extinction coefficients ε280=38.9 mM
-1 cm-1, the concentrations  of total protein w.t.mCherry, MCD1, 
MCD14, MCD15 and mcP6 at equilibrium were 15 µM, 11 µM, 45 µM, 38 µM and 30 μM. The black 
bar indicates protein sample in the dialysis bag, and the white bar indicates the buffer samples which were 
collected outside the dialysis bags. All experiments were carried at 4C and in 10 mM Tris, pH 7.4. 
         
As shown in Figure 3.14B, in two negative controls, at equilibrium, calcium concentra-
tion inside or outside the dialysis bag appeared no significant difference. The calcium concentra-
tion inside the dialysis bag at equilibrium was even a little higher than that outside in the blank 
control, implying the non-specific adhesion of calcium on the dialysis bag. α-Lactalbumin served 
as the positive control, which showed great value of the  ratio of [Ca
2+
]in/[Ca
2+
]buffer at equilibri-
um. And the binding affinity is in the range nM, in agreement with the literature reported value. 
Both the negative and positive controls validate this approach.  
The calculated Kd of mCherry variants were shown in Figure 3.14A. MCD14 appeared to 
have the highest calcium binding affinity (Kd=4.3 μM). MCD15 has only Glu-to-Asp mutation of 
MCD14, resulting in a 6-fold greater dissociation constant (29.4 μM). The binding affinity of 
MCD1, with two less formal charge around the designed calcium binding site, was 1/3 MCD15. 
mcP6, which had four formal charge designed to coordinate calcium ion, had no fluorescence 
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change in addition of calcium, but the equilibrium-dialysis assay confirmed its calcium binding 
ability. 
The Kd value calculated from this assay was generally larger than those calculated using 
either fluorometer or the stopped-flow spectrometer. The dissociation constants given by equilib-
rium-dialysis assay is 10% -50% of the values obtained using other methods. This is mainly ac-
counted for the involvement of the total protein in the final calculation in the equilibrium-dialysis 
assay, while fluorescence is monitored in other methods, which was only contributed to the well-
formed chromophore. In principle, the equilibrium-dialysis assay is more accurate for determina-
tion of binding constants for the pure protein. However, this assay can only provide the averaged 
value for the total protein including the isoform or unfolded protein.  
3.2.6 Calcium binding affinity of mCherry variants 
Calcium response was measured using the fluorometer by titrating Ca
2+
 to proteins in 10 
mM Tris buffer (pH7.4).  The data was fitted using Equation 2.6 and 2.7 assuming the binding 
stoichiometry was 1:1 (131), as shown in Figure 3.15. For MCD1, although it seemed to have 
another binding phase beyond 1 mM calcium, MCD1 was 90% saturated in the presence of ~1 
mM calcium (Figure 3.15A). Except MCD1, other calcium sensor did not show the “second 
phase” during titration. One more mutation of MCD1/R220E, MCD14, facilitated the calcium 
binding and increase the binding affinity. However, with the same charge distribution as MCD14, 
MCD15 had lower calcium binding affinity. Compared to MCD14, the Glu-to Asp substitution 
in MCD15 changed the side chain length of one expected calcium coordinator, resulting in only 
20% of the calcium binding affinity. The mutation 197Y of MCD14, which was designed for the 
aromatic stacking effect over the chromophore, showed the stronger binding affinity than 
MCD14. However, the protein was unstable at room temperature causing the color loss. mcEE 
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was the intermediate product of the designed calcium binding pocket 4 (mcP4) and pocket 5 
(mcP5). Upon calcium binding, the fluorescence intensity of mcEE decreased by 15% (Figure 
3.15B). In the conditions of the intracellular buffer including 130 mM KCl and 1 mM Mg
2+
, add-
ing calcium showed no effect on fluorescence, which suggested mcEE can not be used in cell 
imaging. Table 3.3 summarized the dissociation constants of mCherry variants and CatchER 
measured in different buffers. The calcium-triggered increase of fluorescent intensity of MCD1 
in high salt buffers indicates the possibility of its application in living cells.  
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Figure 3.15. The curve fitting for Kd of (A) MCD1 and (B) mcEE.  
The inset shows the fluorescence intensity change upon titrating calcium in the absence of salt. For 
MCD1, the data fitting from 0 to 5 mM Ca2+, the Kd was calculated as 0.40 mM. For mcEE, the data fit-
ting from 0 to 3.0 mM Ca2+, where Kd  was calculated as 0.18 mM. All experiments were carried out at 
room temperature and in 10 mM Tris, pH 7.4. 
 
 
Table 3.3 The dissociation constant and dynamic range of mCherry variants 
Sensors Buffer/concentrations Kd (mM) Dynamic range  
MCD1 10 mM Tris, pH 7.4 0.10 ± 0.03 1.40 ± 0.06 
MCD2 10 mM Tris, pH 7.4 0.033 ± 0.003 1.14 ± 0.01 
MCD23 10 mM Tris, pH 7.4 0.11 ± 0.01 1.18 ± 0.01 
MCD14 10 mMTris, pH 7.4 0.085 ± 0.004 1.40 ± 0.01 
MCD14Y 10 mMTris, pH 7.4 0.06 ± 0.01 1.33 ± 0.01 
MCD15 10 mMTris, pH 7.4 0.48 ± 0.08 1.17 ± 0.01 
mcEE 10 mMTris, pH 7.4 0.18 ± 0.02 1.13 ± 0.02 
CatchER 10 mMTris, pH 7.4 0.33 ± 0.03 1.51 ± 0.03 
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Here, the dynamic range was defined by the ratio of the Ca
2+
-saturated to the apo protein 
fluorescence (Fmax/Fmin) or the brightness ratio (Bholo/Bapo) (131). For the first site (MCD1x), 
among MCD1, MCD14, MCD15, the calcium-free form suppresses the fluorescence and calcium 
binding recover the fluorescence to the same level as wild type. For the second site (MCD2x), 
among MCD2, MCD23, the fluorescence can not reach the same level as wild type by calcium 
binding, although suppression of fluorescence by the pocket 2 variants was comparable with 
pocket 1. Steric hindrance reduces dynamic range but its effect was not in coincidence with bind-
ing affinity. Yang et. al. discussed the effect of calcium binding on the dynamic properties of the 
designed calcium binding pocket, and one conclusion was that the residues adjacent to the lig-
ands play important role in the dynamic changes and even larger than the ligands themselves 
(163).  In this aspect, residues 197 and 144 probably have bigger impact on the chromophore en-
vironment upon calcium binding. Also, the crystal structure analysis showed the disturbance of 
the chromophore by the corresponding position of 197 in holo-CatchER, compared to the apo-
form. 
The salt condition is a key determinant for the calcium binding affinity. In the [KCl] 
range of 0 – 0.5 M, both the calcium binding affinity and the fluorescence dynamic range de-
creases as increased [KCl] (Figure 3.16 A, B and C). The starting fluorescence intensity in-
creased as increased KCl concentration while the end point of fluorescence intensity remained 
the same. In the presence of 0.5 M KCl, addition of calcium did not induce fluorescence intensity 
change. In the [KCl] range of 1.5 – 2.0 M, addition of calcium resulted in decrease of fluores-
cence intensity. The maximum decrease was about 10% for 1.0, 1.5 and 2.0 M KCl. The starting 
fluorescence intensity was the same for 1.0, 1.5 and 2.0 M KCl (Figure 3.16D). Such observation 
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was similar as the KCl effect on Ca
2+
 binding to Calbindin D9K as well as small Ca
2+
 chelators 
EDTA and EGTA (164).  
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Figure 3.16. The salt-dependent Kd determination.  
(A) The fluorescence of calcium titration at different salt concentrations, 0, 0.05, 0.10, 0.15 and 0.30 M, 
as colored red, blue, green, black and pink. (B) The log Kd plotted as a function of [KCl] (M); (C) The 
dynamic range of calcium response in the [KCl] range of 0-0.3 M, and the inset shows the ΔF/F0 during 
calcium titration in the presence of 0.5 M KCl; (D) The fluorescence spectra of calcium free and loaded 
MCD1 in [KCl] range of 0.5-2.0 M.  
 
3.2.7 Tb3+-tryptophan fluorescence resonance energy transfer (FRET) 
 Tb
3+
 is the ion which has the similar effective ionic radius as Ca
2+
, and the preference for 
oxygen as the coordinator (165). In addition, there is no restricted coordination number require-
ment for both ions. There is overlap between the emission spectrum of tryptophan and excitation 
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spectrum of Tb
3+
. One tryptophan Trp 143 was found around the designed calcium binding site, 
which is located in a short loop region in the middle of β7. Therefore, Tb3+-FRET was applied to 
further verify calcium binding to the designed sensors. As shown in Figure 3.17, in comparison 
with wild type mCherry, all of these sensors exhibited the energy transfer after the addition of 
low concentration Tb
3+
 (< 100 µM) reflected by the significant increase of the peak at 545 nm, 
suggesting that Tb
3+
 was bound to the designed proteins. When Tb
3+
 was greater than 100 µM, 
precipitates was observed in wild type mCherry and the peak at 545 nm started growing due to 
the adherence of Tb
3+
 ion to the protein. This non-specific binding can also be found in the de-
signed sensors after precipitates formed due to high concentration of Tb
3+
. Before precipitates 
formed, a plateau can be observed during titrating Tb
3+
 to either MCD1 or MCD15. The dissoci-
ation constants can be fitted using the equation 5, and Kd, MCD1 and Kd, MCD15 were less than the 
value obtained by calcium titration due to the larger charge to ionic radius ratio of Tb
3+
. MCD14 
was precipitated by Tb
3+
 at >30 µM, and a linear relationship was found when [Tb
3+
] was in the 
range of 0-20 µM, suggesting a large Kd which was estimated to be greater than 100 μM.  Sur-
prisingly, MCD15 was able to tolerate higher concentration of Tb
3+
 up to 2 mM.  
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Figure 3.17. Tb3+-FRET titration of mCherry and its variants.   
Tb3+ stock (10 mM and 100 mM) was titrated into proteins with a final concentration of 5 µM in 10 mM 
PIPES, 10 mM KCl, pH 6.5. Panels A, C, E and G show the spectra at different concentrations of Tb3+ of 
MCD15, MCD14, MCD1 and w.t.-mCherry, respectively, which were record from 500 to 570 nm by flu-
orescence spectrophotometer with excitation at 282 nm. Panel B and F shows the titration curve of 
MCD15 and MCD1 fitted using Equation 2.6 and 2.7 and the dissociation constant was 0.27±0.01 mM 
and 0.04±0.01 mM, respectively.  Panel D and I showed the fluorescence intensity of MCD14 and wt-
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mCherry at different concentrations of Tb3+; the shadow indicates the precipitates. Panel H is the compar-
ison of the fluorescence intensity of MCD1 (black) and wt-mCherry (pink) at low Tb3+ concentration. pH 
value was checked before and after titration.   
 
Tb
3+
-FRET suggests that Tb
3+
 mimicking Ca
2+
 accessed the designed calcium binding 
site. Among the sensors, the dynamic change of fluorescence intensity of MCD1 at 545 nm was 
smaller than MCD14 and MCD15, indicating a relatively lower energy transfer efficiency. The 
FRET efficiency is determined by the distance between the donor and acceptor. Hence, by in-
creasing the negatively charged solvent accessible area with substitution of R220 with glutamic 
acid, the position of Ca
2+
 may shift in MCD14 and MCD15.   
3.2.8 Determine the distance between metal and chromophore using Tb3+ lifetime 
To understand the distance between the chromophore and calcium in MCD1/CatchER, 
we used the FRET efficiency to determine the distance between the FRET donor and acceptor. 
Terbium (Tb
3+
) served as the energy donor, mimicking Ca
2+ 
to be bound in the designed calcium 
binding spot. MCD1 served as energy acceptor, mimicking CatchER. MCD1ggg, of which the 
chromophore MYG was mutated to GGG, was the protein folded the same as MCD1 but was not 
fluorescent. Here, the actual donor was the Tb
3+
-MCD1ggg because when Tb
3+
 binds to proteins, 
its lifetime may change as well as the quantum yield.  
The relationship between the FRET efficiency and the lifetime of the donor with and 
without the acceptor was shown as Equation 3.1. The ratio of the distance between the acceptor 
and donor r to the critical distance R0 was also related to the efficiency E. R0 was determined by 
the quantum yield of the donor Φ, the refractive index n, the orientation factor κ and the spectral 
overlap degree between of the donor and acceptor J (Equation 3.2). In Equation 3.3, FD(λ) is the 
 89 
 
donor fluorescence intensity as a fraction of the total integrated intensity, and εA(λ) was the ac-
ceptor absorbance spectrum normalized to its maximum molar extinction coefficient. 
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Figure 3.18 illustrated that the lifetime of terbium was shorter when the acceptor chro-
mophore was present. The FRET efficiency was 94% calculated using the Equation 3.1 and the 
ratio r/R0 was 0.6. The critical distance was obtained following the protocol by Hink and Visser 
(166, 167). The quantum yield of the protein bound Tb
3+
 was 0.04 (168). The bandpass was 7 nm. 
So the calculated critical distance and the distance between the chromophore and Tb
3+
 ion was 
29 Å and 17 Å, respectively. As shown in Figure 3.18B, the measured distance from Ca
2+
 to the 
chromophore was in the range of 11-17 Å, in agreement with the calculated one. It is conclusive 
that the calcium ion locates in the designed calcium binding site. 
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Figure 3.18. The calculated distance between ion and the chromophore.  
(A) The spectra overlap between the emission of 10 mM Tb3+ and excitation of 10 μM MCD1 in 10 mM 
PIPES, pH 6.5. (B)The Tb3+ lifetime of the free form and in the FRET pair. The average lifetime was ob-
tained by the double exponential fitting. (C) The distance of Ca2+-CRO measured in the crystal structure 
of Ca2+-CatchER. (D) The distance of Ca2+-CRO measured in the model structure of Ca2+-MCD1. 
 
3.2.9 Metal selectivity 
  mCherry-based calcium sensors exhibit a good calcium selectivity over other metals in 
the physiological concentration. Figure 3.19 shows the fluorescence intensity of 10 μM MCD1 
as a representative, in the present of 1 mM Ca
2+
 and 125 mM K
+
, 25 mM Na
+
, 5 µM Cu
2+
, 5 µM 
Zn
2+
, 1 mM Mg
2+
, 0.2 mM ATP, 0.1 mM GTP and 0.1 mM GDP. The fluorescence intensity was 
not influenced by the tested metals and nucleotides other than copper ion. The fluorescence of 
mCherry variants can be quenched by Cu
2+
. However, in the physiological condition, the free 
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[Cu
2+
] is much less and close to zero. Thus, Cu
2+
 quench effect can be ignored when it is applied 
to the living cells.   
 
 
Figure 3.19. Metal and nucleotides selectivity of MCD1.  
All metals and small molecules were added to 5 µM MCD1 pre-loaded with 1 mM Ca2+ in 10 mM Tris, 
pH7.4. The excitation was at 587 nm and emission was collected from 590-700 nm. 
 
In addition, the detailed analysis of the metal selectivity will be performed to obtain the 
binding affinity of Mg
2+
, Zn
2+
, Gd
3+
 and Fe
2+
 by calcium titration monitored by both fluores-
cence and equilibrium-dialysis-ICP assay. The information is essential for the design of the spe-
cific metal binding sites in the future.  
3.2.10 Kinetics study of calcium binding to MCD1  
The kinetics of calcium binding is essential for a calcium indicator. The value of kon and 
koff reflect the binding on-rate and off-rate. An ideal biosensor is required to have the fast on- and 
off-rate so as to be able the capture a whole biological event. MCD15 purified from pET28α in E. 
coli. BL21 (DE3) was used for the kinetics study. The calcium binding kinetics was monitored 
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by the stopped-flow fluorimeter equipped with the mercury-Xe lamp. The intensity was first cal-
ibrated by the samples with the lowest and the highest fluorescence and scaled to 0-100%. The 
fluorescence dye x-Rhod 5F was used to optimize instrument conditions including to determine 
the fluorescence intensity has linear relationship with the concentration. 
Before experiments, the fluorescence intensity was calibrated using the calcium saturated 
x-Rhod-5F (Invitrogen) to make sure the linear relationship between the fluorescence and con-
centration (Figure 3.20D). In Figure 3.20A, mixing MCD1 with different concentrations of cal-
cium solutions resulted in the rapid increase of the fluorescence signal. However, the binding 
process was totally lost in the dead time. There is less likelihood to fit kobs at even the lowest cal-
cium concentration applied. Similarly, the off rate was too fast to be captured. As shown in Fig-
ure 3.20B, the overlaid stopped-flow traces indicated that the fluorescence signal fell back to the 
basal level upon EGTA chelating Ca
2+
. Considered the 2 ms dead time of this instrument, four 
half lifetime was finished. koff can be estimated to be at least 1.9×10
3
 s
-1
. Assuming calcium 
binding to MCD1 follows the simple 1:1 binding mode, kon can be estimated to be at least 
2.72×10
7
 M
-1
s
-1
 according to Equation 2.9. The dissociation constant was fitted using the ampli-
tudes, which was consistent with the Kd value independently determined by the calcium titration 
monitored by a spectrofluorometer with the error in an acceptable range. As the positive control 
(Figure 3.20C), the off rate of x-Rhod-5F was determined by mixing 2 µM x-Rhod-5F pre-
loaded with 5 µM calcium with 10 mM EGTA. The process of calcium dissociation from the dye 
was lost in the dead time and only the plateau was observed. Similarly, the off rate of x-Rhod-5F 
was estimated to be at least 2.1×10
3
 s
-1
. For more accurate determination, T-jump may be applied; 
however, the present data suggested that the fast response of MCD1 to calcium enable it to detect 
most physiological events.  
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Figure 3.20. Kinetics analysis of association of Ca2+ with MCD1.  
(A) The amplitude of the fluorescence increase observed in the panel A as a function of calcium concen-
tration. Inset shows the stopped-flow traces of fluorescence increase upon rapid mixing of MCD1 at a 
final concentration of 10 µM with Ca2+ at different concentrations. (B) The stopped-flow traces of the 
fluorescence change upon (a) mixing of 20 µM MCD1 with 0.6 mM Ca2+, (b) mixing of 20 µM MCD1 
preloaded with 0.6 mM Ca2+ with 10 mM EGTA and (c) mixing of 20 µM MCD1 with buffer. (C) The 
stopped-flow traces of calcium-saturated x-Rhod-5F mixing with 10 mM EGTA. (D) The intensity cali-
bration for the stropped-flow fluorescence spectrometer using x-Rhod-5F. 
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Table 3.4 Calcium and terbium binding affinity calculated using different methods 
MCDx 
Ca2+(mM) 
Tb3+ (mM)d 
Titrationa Stopped-flowb Eq.-Dialysisc 
MCD1 0.10±0.03 0.07±0.01 0.07±0.04 0.04±0.01 
MCD14 0.08±0.01 NA 0.004±0.001 NA 
MCD15 0.47±0.12 NA 0.03±0.01 0.27±0.01 
aThe proteins were excited at 587 nm and the maximum fluorescence emission intensity at 610 nm was 
used for calculation.  
bThe excitation/emission was set as 587/610nm, respectively. The average fluorescence intensity at the 
plateau was used for calculation.  
cThe average value was obtained from five Ca2+ signature emission wavelengths: 317.933, 370.602, 
373.690, 396.847, 643.907 nm.  
dThe experiment was carried out at 10 mM PIPES, pH 6.5, 10 mM KCl. The excitation was at 350 nm and 
the emission was collected from 420-600 nm. 
 
3.2.11 NMR spectroscopy 
To understand the structural change upon calcium binding in mCherry variants, NMR 
was set up for 1D and 2D analysis.  
15
N labeled MCD14 was expressed and purified as described 
before. Here, all fid data was collected using Varian INOVA 600 MHz spectrometer at the de-
partmental facilities.  The 1D H-NMR of MCD1 and MCD14 was acquired using water gate 
pulse sequence. The 2D 
1
H-
15
N spectra of MCD14 was acquired using gNhsqc pulse sequence. 
Before running sample, D2O of the final concentration of 10% (v/v) was added. Pulse-field gra-
dient diffusion experiment was run using MCD1 sample. One more run should be carried out us-
ing lysozyme as the standard in the same condition to obtain the hydrodynamic radius. 1D spec-
tra of calcium titration were taken using MCD1 sample to find the saturation point. There was no 
significant change upon calcium titrated MCD1 as shown in Figure 3.21. When [Ca
2+
] was high-
er than 2 mM, the peaks were not dispersed well. So holo-protein mentioned in this section 
means protein sample supplemented with 2 mM Ca
2+
. Clearly, the 1D proton spectra were not 
enough to demonstrate whether the protein was saturated with calcium. 
 95 
 
Temperature-dependent HSQC experiments were conducted at 25, 30, 35 and 40°C. The 
result shown in Figure 3.22 suggested that at higher temperature the spectrum was less crowded 
in the middle and peaks in general were sharper, which was resulted from the faster molecule 
tumbling. There were minor peaks observed near the major peaks, implying two conformations 
were in present in the protein sample. 
The spectra overlay of calcium-free and loaded forms of MCD14 were shown in Figure 
3.23, where the difference clearly indicated the partial structural change due to calcium binding. 
The overall peak intensity decreased upon adding 2 mM Ca
2+
. Here, EGTA was not supplement-
ed in the apo form, which may cause the disturbance of the trace amount of calcium and other 
metals. The chemical exchange of MCD14 was altered in addition of calcium, which is shown in 
the panel b, c and d as examples. In the panel a in Figure 3.23, the presence of calcium slowed 
down the rotational rate of the residue and stabilizes one state, which is indicated by the peak 
splitting. The residue Q69 in CatchER also exhibits the similar peak splitting induced by calcium 
binding. The inset d showed two effects of calcium binding, the chemical shift change and the 
peak splitting.  The panel e showed the double peak merged to one upon adding calcium, sug-
gesting the calcium binding induced the residue to rotate faster and becomes more flexible. If 
those residues experiencing chemical shift and line width change upon calcium addition could be 
assigned and understood, the insight will be gained that the molecular mechanism of calcium 
binding induced the fluorescence change. Although the assignment has not been done at this 
moment because of the difficulty to get the pure non-cleaved mCherry variants and the limited 
time, the calcium binding induced regional conformational change of mCherry variant MCD14 is 
confirmed by the NMR spectroscopy.  
 96 
 
 
Figure 3.21. The stacked 1D proton NMR spectra of calcium titration to MCD1 at 37C. 
The top, the middle and the button ones were 100 µM MCD1 in buffer 10 mM Tris, pH 7.4, 10% D2O, in 
addition of 2 mM,  100 µM, and 0 Ca2+ respectively.  
 
 
Figure 3.22. HSQC spectra of MCD14 at 25 °C and 40°C.  
The experiment setting was the same except the temperature. The buffer was 10 mM Tris, pH 7.4. 
MCD14 concentration was 100 µM. 
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Figure 3.23. The overlaid 1H-15N-HSQC spectra of calcium-free (blue) and loaded (red) MCD14.  
The buffer was 10 mM Tris, pH 7.4. MCD14 concentration was 100 µM before adding calcium.  
 
3.3 Cell imaging and calcium response in situ 
3.3.1 Drug response  
To evaluate the designed calcium binding proteins in high calcium environment in situ, 
the proteins were fused with the calreticulin ER tag in the N-terminal and the ER retention se-
quence KDEL in the C-terminal. The recombinant DNA was transfected to cells and express for 
36-48 hours before calcium imaging. The reticulum-network was observed (Figure 3.24) around 
the DAPI-stained nucleus.  
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Figure 3.24. The confocal image of ER-tagged MCD1 expressed in C2C12 cells. 
The blue color indicated the DAPI. The red color was the fluorescence produced by ER-tagged MCD1. 
 
Four cell lines: HEK-293, BHK, HeLa, and C2C12 were used for validation. The cell im-
aging was collected from a LSM 510 laser confocal microscope (Carl Zeiss Inc., Thornwood, 
NY) using a 40 × oil immersion objective (Zeiss, Fluar, 1.30 n.a.). The whole cell is selected as 
the region of interest (ROI). The most common drugs, which are activators of ryanodine receptor 
(4-cmc), the inhibitor of SERCA pump (CPA) and the calcium ionophore (ionomycin), were ap-
plied and calcium response was monitored by the designed calcium binding proteins. The conse-
quence of treatment of these drugs is calcium release from ER. The signal of ER-targeted calci-
um sensors is expected to be reduced upon adding these drugs.  
Since ionomycin can form the calcium ionomycin salt and transport across the biological 
membranes, it is commonly used for equilibrium of intracellular and extracellular calcium. Ap-
pling ionomycin under the low calcium background leads to the calcium efflux out of the ER, 
which is not cell type dependent and thus used to test and calibrate the calcium dyes in all kinds 
of cell lines. However, the treatment of ionomycin is not physiologically significant. As shown 
in Figure 3.25A, C2C12 cells transfected with MCD1x were treated by ionomycin. The fluores-
cence intensity decreased once the ionomycin was added and it was recovered by changing the 
solution to Ringer's buffer containing 10 mM Ca
2+
. MCD15 was saturated by ER calcium be-
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cause the fluorescence intensity in the condition with high calcium did not differ from the one 
before any treatment. Figure 3.25B demonstrated the average fluorescence of MCD1x in the 
three phases of 0 Ca
2+
, ionomycin and 10 mM Ca
2+
 in HEK 93 and C2C12 cells. It is clear that 
MCD15 has the largest fluorescence change. As a result, MCD15 was selected for the further 
tests by applying ER calcium channel activator and inhibitor. 
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Figure 3.25. Comparison of MCD1x responding to ionomycin. 
(A) The average fluorescence time traces of the MCD1x in the treatment of ionomycin. (B) The fluores-
cence intensity in the panel A of MCD1, MCD14, MCD15 and MCD111 in the treatment of ionomycin. 
The student test was applied to validate the difference between the un-treated and the ionomycin-treated 
states.  
 
Treatments of all reagents mentioned above for all cell lines expressing MCD15 resulted 
in reduce of fluorescence intensity as expected. In HEK 293 cells, calcium release from ER trig-
gered by ionomycin was monitored by MCD15er and Fura-2 simultaneously (Figure 3.26A). 
[Ca
2+
]ER was decreasing upon addition of ionomycin, while [Ca
2+
]cyt was increasing. Since no 
extracellular calcium was supplied, calcium was pumped out after the early stage of calcium ac-
cumulation in cytoplasma. When calcium was supplemented, both cytoplasmic and the ER [Ca
2+
] 
increased. Unlike cytosolic calcium, even if extracellular calcium was up to 10 mM, calcium in 
ER was only recovered to its resting level. Both the RyR and IP3R agonists 4-cmc and histamine 
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triggered fluorescence intensity decrease as calcium release (Figure 3.26E and F). Similar phe-
nomenon of fluorescence change rising from the addition of reagents that induce calcium release 
from ER can be observed in BHK, HeLa and C2C12 cells expressing MCD15 as shown in Fig-
ure3.27-3.29.  
The fluorescence change of MCD15 upon 4-cmc treatment was compared in Figure 
3.30A, which was greater in C2C12 and HEK 293 cells than the other two. Even though, the 
maximum fluorescence change was only 6%, far away from the desired dynamic range for a 
qualified calcium indicator. The limitation is possible to be overcome by either further suppress-
ing the quantum yield of the calcium-free form or enhancing the brightness of the calcium-
loaded form. It would be promising to have such a red fluorescent protein with the property of 
calcium triggered-fluorescence enhancement.  
Figure 3.26B shows the calcium dynamics in response to extracellular calcium change in 
the HEK cells cotransfected with MCD15 and CaR. The intracellular calcium was monitored by 
Fluo-4. The calcium oscillation was observed and meanwhile the fluorescence of MCD15 de-
creased, suggesting that [Ca
2+
]ER decreased. CPA induced calcium release from the ER in HEK 
293 showed no significant difference in the cells over-expressing CaR although there is 39% in-
crease of the released calcium amount calculated in Figure 3.30B. The statistical significance 
was not obtained due to the limited amount of data collected. 
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Figure 3.26. Calcium dynamics monitored by MCD15-transfected HEK293.  
(A) The treatment of 10 μM ionomycin and 10 mM Ca2+. The intracellular calcium was monitored by 
Fura-2. (B) The treatment of 3 mM extracellular calcium in the HEK 293 cell stably expressing CaR. The 
intracellular calcium was monitored by Fluo-4. (C) The treatment of 15 μM CPA, (D) Treatment of 15 
μM CPA in the HEK 293 cell transiently transfected with CaR. (E) The treatment of 200 μM 4-cmc. (F) 
The treatment of 200 μM histamine. 
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Figure 3.27. Calcium dynamics monitored by MCD15-transfected BHK cells.  
The black bar indicates the cells were immersed in the standard Ringer's solution. The white bar showed 
the time course with addition of drugs. The number of cells for average was shown in N.  
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Figure 3.28. Calcium dynamics monitored by MCD15-transfected HeLa cells. 
The black bar indicates the cells were immersed in the standard Ringer's solution. The white bar showed 
the time course with addition of drugs. The number of cells for average was shown in N. 
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Figure 3.29. Calcium dynamics monitored by MCD15-transfected C2C12 cells. 
The black bar indicates the cells were immersed in the standard Ringer's solution. The white bar showed 
the time course with addition of drugs. The number of cells for average was shown in N. 
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Figure 3.30. Comparison of MCD15 responding to 4-cmc and CPA induced Ca2+ release from ER. 
 (A) The fluorescence change of MCD15 due to the200 μM 4-cmc induced calcium release in different 
cell lines. (B) The fluorescence decrease of MCD15 due to the treatment of 15 μM CPA in the HEK 293 
cells and the HEK 293 cells transiently transfected with CaR. N indicates the number of experiments. 
 
The fluorescence of MCD1 between ionomycin and 10 mM calcium did not change sig-
nificantly in Figure 3.25, although it shows good dynamic range in vitro. MCD15, with double 
mutations K198E and R220E on MCD1, showed the dynamic range of 1.10 C2C12 myoblasts. 
Although Mag-Fura-2 has the largest dynamic change over 0-10 mM Ca
2+
, which is approxi-
mately 200%, the change induced by 4cmc still small (~3%) (not shown). The calcium concen-
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tration change is beyond the sensitive range of the sensor because the Kd of Mag-Fura-2 is ap-
proximately 50 µM, about 10-fold lower than MCD15.  The fluorescence intensity change in-
duced by CPA is comparable; probably due to the calcium change in the ER is in the similar sen-
sitive range of those sensors. This result emphasizes the importance of the diversity of calcium 
binding affinities, which allows the calcium signal monitor in different compartments. In general, 
the dynamic range of ER-tagged MCD15 in situ was 30% of that of CatchER when ionomycin 
and 4-cmc were applied. 
3.3.2 Calibration 
Given that the protein folding can be different in the bacteria and the mammalian cells, 
protein expressed in the HEK 293 cells was used for the calcium titration to further verify the 
calcium binding. To exam the calcium binding affinity of MCD15 expressed in mammalian cells, 
non-tagged MCD15 was transfected and over-expressed in the cytoplasm in HEK 293 cells. RI-
PA buffer was used to lyse cells and the crude soluble protein including MCD15 was extracted 
by centrifugation. The buffer was changed to 10 mM Tris, pH 7.4 for the calcium titration. As 
shown in Figure 3.31, calcium addition induced immediate fluorescence emission increase and 
no photo-bleaching was observed during the whole experiment (~20 min). The kinetics of calci-
um binding was not able to be caught at the 1/sec data record rate. The average fluorescence in-
tensity at each plateau was used to calculate the Kd. The calcium binding affinity of MCD15 ex-
pressed in HEK 293 cells was around 2 times lower than the protein purified from E.coli.. As the 
negative control, there is no calcium triggered fluorescence change found in the wild type 
mCherry (Figure 3.31B).  
Considered the basal ER calcium concentration is cell-type dependent and the ER condi-
tion is difficult to be mimicked, the in situ calibration for MCD15 was conducted. Digitonin is 
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used to specifically permeabilize the cytoplasma membrane, leaving the ER membrane intact to 
maintain MCD1x in the ER lumen. Ionomycin is used to reach the equilibrium of calcium con-
centration across membranes. Figure 3.32 shows the calibration curves in BHK, HeLa and 
C2C12 cells. The dissociation constant Kd was consistent, around 1.0 mM in these three cell 
lines. The lower apparent affinity obtained in ER lumen may be caused by its ion strength, the 
different diffusion rate due to the viscosity and competition with other calcium buffers like 
calsequestrin.  
Although the dynamic range and binding affinity of the first generation of mCherry-based 
calcium binding proteins is not good enough for the physiological application, these pieces of the 
preliminary results give the strong support that the principle of this design strategy enables the 
quantitative detection.  
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Figure 3.31. Calibration for MCD15 expressed in HEK 293 cells.  
To mimic the cell imaging conducted by the microscope, the excitation wavelength was set as 550 nm. 
The data collection was paused when calcium was added in. MCD15 was extracted as the soluble protein 
after the cell lysis by RIPA solution and the total soluble protein was used in this calibration. (A) The rep-
resentative time course of calcium titration to the MCD15. The inset shows the normalized fluorescence 
intensity increased as a function of [Ca2+], which is averaged from two experiments.  Kd was fit using 
equation 2.7, 0.7 ± 0.1 mM. (B) The wild type mCherry was titrated by calcium in the same experimental 
condition. 
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Figure 3.32. In situ calibration for MCD15er transfected in BHK, HeLa and C2C12 cells.  
The average ΔF/Fmin is calculated from N cells. The average value at each plateau was calculated for Kd 
fitting. The Kd was fit by Equation 2.7. 
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3.4 Discussion 
3.4.1 Design strategy of MCD1 (RapidER) 
MCD1 was designed based on several considerations including features of calcium bind-
ing geometry and charged residue preference obtained from statistical analysis of different clas-
ses of calcium binding proteins (66, 157, 158) and fast kinetics and calcium induced florescence 
change. We hypothesize that negatively charged ligand residues in a hemisphere coordination 
geometry with good solvent accessibility, electrostatic binding energy change, and the hydrogen 
bonding network of the chromophore are the key factors to control calcium binding affinity, ki-
netics, and calcium binding dependent change of optical properties. First, red florescent protein 
mCherry was chosen because of its noted photo-stability, fast chromophore maturation rate and 
low pKa(109) that is important for reduce pH sensitivity when measuring calcium binding.  Sec-
ond, we used the “half shell” with reduced coordination number to create the calcium binding 
site on the surface of the beta barrel to allow easy entry and release without the spatial barrier 
from the calcium binding site. With the half shell calcium binding site composed primarily of 
Asp and Glu residues as the most predominant calcium binding ligands, the calcium binding af-
finity was expected to be lower than that of the classic EF-hand motifs. Differing from the clas-
sic calcium binding pocket that is consisted with 6-7 oxygen atoms, and forms a bipyrimidal 
shape with high calcium binding affinity and selectivity, it has less coordinator number and 
forms an open bowl-like geometry. Third, to couple calcium binding with optical property 
change without interfering with chromophore formation, we finally decided to mount the calci-
um binding site in pocket 1 according to located in the chromophore hydrogen-bonding network 
at the corresponding position in CatchER (Figure 3.1A and 3.32).  Residue 145 is involved in 
flanking E144 and S146. The main chain oxygen of E144 forms a hydrogen bond with the chro-
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mophore tyrosyl through a bridging water molecule, and the side chain hydroxyl group of S146 
has two conformers, serving as the hydrogen bond donor for the chromophore tyrosyl directly. 
Fourth, based on the kinetic study of the electrostatically driven interaction between protein and 
ligands (169-171), we further reason that mCherry with a larger negatively charged surface 
around the designed calcium binding site may exhibit a faster calcium association rate than 
CatchER. Compared to CatchER, the calculated electrostatic binding energy change of MCD1 
was greater than that of CatchER (Table 3.5). The calculated negatively charged solvent accessi-
ble surface area (SASA) using PyMol in the designed calcium binding site was also larger in 
MCD1 than in CatchER. 
 
Table 3.5 The electrostatic binding energy calculation 
Proteins ΔGelec_binding (kT) Negatively charged SAA (Å
2) 
MCD1 -73.03 655 
CatchER -59.48 589 
 
 
Figure 3.33. Comparison of the electrostatic surface between (left) MCD1 and (Right) CatchER. 
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3.4.2 Key factors for binding affinity and kinetic properties 
Calcium binding accepts a flexible range of the coordination number ranging from 3-8. 
Because it is a soft metal, oxygen is preferred to be the coordinator.  From the statistical analysis 
of the calcium binding sites in protein data bank, aspartic acid, glutamic acid, and water are the 
top three residues providing oxygen to bind calcium ion (157). The bipyrimidal shape formed by 
the oxygen atoms coordinating calcium is the classic one found in EF-hand motif. For the organ-
ic calcium chelators or dyes, EGTA and Fura-2 have four carboxylate groups, where the calcium 
is coordinated by 8 atoms including two nitrogen atoms. In either EF-hand motif or tetracarbox-
ylate compounds, calcium is surrounded by oxygen/nitrogen atoms and there is also a steric bar-
rier formed by the “arms” of the coordinators. Such steric hindrance may limit the calcium disso-
ciation rate and contribute to the high affinity. Renner and the co-workers also reported that in 
the EF-hand loop the side chain length and acidity affected the Ca
2+
 dissociation rate due to the 
steric block and electrostatic barrier, respectively (172). The calcium binding geometry made of 
fewer coordinating ligands is observed in proteins shown in Figure 3.1 such as 1FZC and 1BJR. 
For the single calcium binding site in 1FZC, the number of oxygen ligand from the protein/water 
is 5/1, and 4/4 and 5/0 for two calcium binding sites in 1BJR. In both proteins, the ligands from 
protein moiety form a bowl-like geometry and the calcium ion is partially exposed to the solvent. 
For organic compounds, the calcium binding moiety was modified with less coordinators in or-
der to increase the calcium dissociation rate such as Mag-Fura-2. In Mag-Fura-2, the calcium 
binding pocket contains three carboxylate groups with 3 formal charges, and there is a channel 
available for calcium to escape. Thus, the calcium binding affinity of Mag-Fura-2 and other tri-
carboxylate compounds is lower than those analogs with four carboxylate groups attributed by 
the higher calcium dissociation rate.  There is another strategy to increase the koff of calcium 
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dyes, which is to add the electron attractive group like -NO2 or -F in the 5 position of o-
aminophenoxy ring. Such calcium dyes ended up with 5N or 5F in their name and have calcium 
binding affinity around 1-10 μM which is lower than the original tetracarboxylate calcium dyes 
but higher than those with tricarboxylate. The calcium binding association rate of these calcium 
dyes is in the magnitude of 10
8
 M
-1
s
-1
. Therefore, the variance in Kd mainly results from the dis-
sociation rate koff as shown in Table 1.1. Clearly, the coordination number and the number of 
formal charge have a stronger effect on both koff and Kd by determining the geometry and steric 
hindrance. 
The calcium binding features of protein-based calcium indicators are mainly determined 
by the calcium binding moiety (calmodulin or troponin C) involved. The calcium binding affinity 
of both CaM and TnC is around 10
-6
-10
-7
 M. The stoichiometry for both calmodulin and troponin 
C is 1:4, two calcium ions in each terminal domain. The calcium binding follows a cooperative 
manner in each domain, which may contribute to the slow calcium dissociation rate around 0.2-
20 s
-1
. In addition, the two domains are relatively independent, resulting in the biphasic calcium 
binding curve observed in Cameleon (38).  
Efforts have been taken to reduce the Kd of these GECIs. In Cameleon 3, the mutation 
E104Q locating in the third EF-hand motif in CaM domain eliminated the high calcium binding 
component of the CaM C-domain and the Kd value is 4.4 µM.  For Cameleon 4, the mutation 
E31Q located in the first EF-hand motif further decreases the binding affinity in CaM N-domain 
but does not significantly affect the high affinity C-domain. The resulting Kd of Cameleon 4 is 
83 nM and 700 µM with a Hill coefficient 1.5 and 0.87 respectively (54). Palmer and co-workers 
switched the charged residue in the interface between M13 and CaM which decreased the appar-
ent Kd (0.8 and 60 µM) and increased the koff (256 s
-1
) although the original purpose was to elim-
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inate the perturbation of the normal calcium signaling by interaction with their intrinsic target 
proteins (38). A similar situation was observed in the recent version 6 of GCaMP, which was 
generated by altering the interface between M13 and CaM as well as the one between CaM and 
cpEGFP. GCaMP6f exhibited faster calcium response to action potentials in neuronal activity 
than other GCaMPs (91). This evidence shows that the apparent Kd of the calcium indicators in-
volving CaM and M13 peptide is not only determined by the calcium binding motifs but also the 
linker and domain interface.   
In a different scenario of TnC involved GECIs, TnC also has two terminal domains like 
CaM and N-terminal domain binds Ca
2+
 with lower affinity than C-domain, which is a regulatory 
site. The TnC molecule undergoes structural rearrangement after Ca
2+
 binding (173). TN-XL 
with faster kinetics than TN-L15 was created by switching the residue N and D at position 109, 
111, 145 and 147 at the third and forth EF-hand motifs in C-terminal domain of TnC, where the 
calcium binding affinity was lowered (Kd=2.2 µM, Hill coefficient 1.7) and magnesium interfer-
ence was abolished (174). The resulting off rate of TN-XL measured by stopped-flow spectrome-
ter was around 5 s
-1
, which was approximately 5-fold greater than TN-L15 and TN-XXL.    
The cooperative binding, the slow dissociation kinetics and the high calcium binding af-
finity were signatures for native Ca
2+
 binding protein involved GECIs. In addition, the Kd was 
not controlled by the Ca
2+
 binding alone due to the multiple steps required for fluorescence sig-
nal change. Therefore, it is difficult to tune the binding affinity and kinetics as well as avoid co-
operativity in the same construct by rational design. In contrast, CatchER was successful in fast 
kinetics, low calcium binding affinity and 1:1 stoichiometry by avoiding the native calcium bind-
ing moiety. In such a simplified calcium indicator as CatchER, the calcium sensing relies on the 
local dynamics in the calcium binding site. As a starting point, the simple calcium binding site in 
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CatchER was modified to increase the kinetics further by reducing the positively charged resi-
dues around the binding site.  
Compared with CatchER, RapidER had a higher calcium binding affinity as well as faster 
kinetics, which is in agreement with the calculation of the electrostatic binding energy change 
and the negatively charged solvent accessible surface area. The faster calcium dissociation rates 
found in both CatchER and RapidER than in the EF-hand motif sensors is attributed to the ge-
ometry of the designed half-shell calcium binding site, where there is little steric barrier for cal-
cium release. A similar comparison was also observed in tetracarboxylate and tricarboxylate cal-
cium dyes fura-2 and mag-fura-2.  As we discussed above, the electrostatic attractive functional 
group such as NO2 and halide was added in the compound to reduce binding affinity and increase 
koff without changing the coordination number and geometry. But it cannot be applied in proteins 
because the conjugated system was not able to form throughout the side chains.  However, there 
were three positively charged residues K74, K166 and R220 around the calcium binding site in 
MCD1 compared to CatchER where there was only one K42 nearby (Figure 3.31). The edge of 
the enlarged negative circle may also be neutralized by these positive residues and thus increase 
the dissociation rate. The evidence for the role of the positive residues around the binding site 
can be found in the crystal structure of Ca
2+
-CatchER, where there were two populations of cal-
cium ion positions observed and both of them are coordinated by E147 but away from E223 and 
E225 which were close to K42. We hypothesized that the positively charged residues around the 
calcium binding site attracted electron density to reduce the electrostatic barrier.   
3.4.3 Positions of calcium binding sites 
RFP has a larger conjugated system than that in GFP, which was extended to the back-
bone of F65 before the cyclized tri-peptide (175, 176). The GFP was modified with several mu-
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tations to improve the oligomer character, brightness, photostability and maturation time (177). 
Like GFP, the chromophore environment of RFP plays important roles in maintaining the fluo-
rescence. The side chain orientation of the neighboring residues in the β sheets is usually oppo-
site. Those projecting to the interior of the β-can form hydrophobic or electrostatic interactions to 
participate in or protect the chromophore environment, while the others facing the solvent assist 
to keep the protein from aggregation or degradation. The residues with side chains in the interior 
of the protein have more direct contact with the chromophore so as to affect the optical property 
directly. For example, mutation of the E215 in mCherry resulted in the blue shift of the spectrum, 
where the original E215 was protonated and formed a hydrogen bond between the protonated 
carboxyl group and the imidazolinone ring nitrogen (159, 178). mBanana has the mutation I197E 
based on mTangerine, which may contribute to the increase of pKa from 5.7 to 6.7 due to the 
redistribution of the chromophore electron density (110). However, calcium binding in the sur-
face of the β-barrel mainly involves the side chains protruding outside. In order to change the 
spectral properties by calcium binding, the calcium coordinators need to influence those residues 
in the chromophore environment.   
As shown in Figure 3.1, in the chromophore of mCherry, the chromophore phenol hy-
droxyl group was close to the opening of the β-barrel, where a loop region is located. The corre-
sponding location in GFP served as a tunnel to allow proton migration during excited state pro-
ton transfer. This phenolate oxygen formed the H-bonds to the side chain of S146 (both states), 
to the main chain of E144 through a bridging water molecule (wat1), and to the side chain of 
Q163. As mentioned above, E215 in mCherry was proposed to be protonated to form H-bond 
with the imidazolinone nitrogen. The position of this residue was relatively rigid because a net-
work was observed among the chromophore, E215, Q42, S69 and a water molecule (wat4 in 
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Figure 3.1). Both main chains and side chains of these three residues together with the chromo-
phore had contact with each other, leading to a tight association. H-bonds were found from the 
side chains of R95 and Q64 to the imidazolinone oxygen. Since the peptide bond connecting F64 
and the chromophore was part of the conjugated system in mCherry, the main chain oxygen in 
F64 was also under consideration, which formed H-bonds with the side chain Q109 and S111 via 
water molecules.  
We selected three potential calcium binding sites to affect the phenol group. RapidER in 
pocket 1 was one of them, including the mutation A145E in between E144 and S146. The pocket 
2 included E144 and the pocket 3 had the mutation E164 adjacent to Q163. Both pocket 1 and 2 
had mutations R216E next to E215. Pocket 4 was located near R95 and Q109, including muta-
tions K92E and T108E. The results suggested that only the variants in pocket 1 and 2 showed the 
calcium dependent fluorescence change. The equilibrium-dialysis assay confirmed that mcP6 
(K92E/E94/T108E/D110), belonging to the pocket 6 variants, also bind calcium with the compa-
rable binding affinity as ones in pocket 1 and 2. The lifetime of Tb
3+
-MCD1 FRET verified the 
calcium went to the expected position in MCD1. Calcium binding increase the lifetime of MCD1 
and thus the quantum yield was enhanced.  Therefore, the phenol hydroxyl group was more sen-
sitive than others to the change of the electrostatic environment.  It is the hot spot that has the 
major potential to affect the optical property. 
The calcium dependent fluorescence change was decreased when it was expressed in the 
mammalian cells. Further modification was done to increase the dynamic range. For MCD15 
(RapidER’), the mutation R220E on MCD1 outside the designed calcium binding pocket made 
the calcium induced fluorescence change detectable in situ, without altering the in vitro optical 
and biophysical properties. However, the dynamic range of MCD15 (10%) is lower than other 
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low-affinity calcium sensors (~30%). The limitation is possible to be overcome by either further 
suppressing the quantum yield of the calcium-free form or enhancing the brightness of the calci-
um-loaded form. It would be promising to have such a red fluorescent protein with the property 
of calcium triggered-fluorescence enhancement.  
3.5 Summary and conclusions 
This chapter introduces the strategy for designing a calcium binding site in the red fluo-
rescent protein. To make the calcium binding affinity lower than that of those classic EF-hand 
motif involved binding proteins, the half shell is applied to the surface of β-barrel in mCherry. 
Several positions were selected to locate calcium binding sites. Only two in proximate to the 
chromophore tyrosine phenol (Pocket 1 and 2) showed the calcium dependent fluorescence 
change, although the variants in Pocket 3 4 and 5 can bind calcium based on the equilibrium-
dialysis assay. The fluorescence change induced by Ca
2+
 binding in MCD2x is too small to be 
applied to detect [Ca
2+
] change. The insertion in Pocket 6 and all mutation in cp-mKate, as well 
as MCD14Y, MCD14YS and MCP4, are too harsh to reserve the protein folding, leading to loss 
of fluorescence. Further mutation based on MCD15 was carried out to improve the dynamic 
range in situ, but not substantial enhancement was obtained unfortunately.  
In this chapter, MCD1 (RapidER), MCD14 and MCD15 (RapidER’) were analyzed in 
detail to illustrate the biophysical property, the binding affinity and potential application in situ. 
This class of calcium binding proteins is featured with the calcium binding affinity of sub-
millimoalr range, the pH independent calcium induced fluorescence change in physiological 
range, Ca
2+
 preference over the other common metals in vivo and the fast calcium associa-
tion/dissociation rates close to diffusion limit. The calcium binding was further confirmed by us-
ing Tb
3+
 as a probe and NMR, which also suggested the local conformational change upon metal 
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binding. The distance between the metal and the chromophore was determined by Tb
3+
 lifetime 
change in the Tb
3+
-CRO FRET pair and the result was consistent with the measured distance in 
the modeled MCD1 structure and the crystal structure of the analog Ca
2+
-CatchER. The ER-
targeted MCD1xs were successfully expressed in HEK 293, BHK, HeLa and C2C12 cells at 37 º. 
The fine reticular network was observed indicating the correct the ER localization. The calcium 
sensing capability was evaluated by applying calcium ionophore ionomycin, RyR activators 4-
cmc and caffeine, IP3R activator histamine and SERCA pump inhibitor CPA. The expected fluo-
rescence decrease was observed in all cell lines, suggesting the designed calcium binding pro-
teins can be used as a probe to detect calcium change in the ER.  
Even MCD15 has the largest fluorescence dynamic range compared to other designed 
proteins, the measurable fluorescence change is not as large as the GFP-based Ca
2+
 sensor 
CatchER. The underlying mechanism of calcium induced fluorescence change in CatchER may 
provide us the information to improve its dynamic range, which will be discussed in the Chapter 
4 and 5. 
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4 THE DYNAMIC AND STRUCTURAL ANALYSIS OF THE GREEN FLUORES-
CENT CALCIUM INDICATOR CATCHER 
4.1 Introduction 
Green fluorescence protein (GFP) is a β-barrel protein consisted of 11 β strands and a he-
lix passing through the interior of the can-like architecture. In the middle of the helix, there are 
three amino acids Ser, Tyr and Gly, undergoing an auto-catalytic cyclization to form the chro-
mophore. The chromophore is a conjugated system with two aromatic rings, the tyrosine phenol 
ring (R) and the imidazolinone ring (R'), connected by the (R)C-C=C(R') bond. The tyrosine 
phenol hydroxyl may be deprotonated to from the chromophore anion, leading to the absorption 
at around 488 nm, while the absorption band was around 395 nm in the neutral form (179). It has 
been found that the absorption spectrum of the chromophore analogue hydroxy-benzylidene-
imidazolidinone (HBDI) in the solution was generally blue-shifted (180), and the free rotation of 
the bridge of the two aromatic moieties in the excited state causes the lack of fluorescence (181). 
The native protein matrix is responsible for the fluorescence of GFP. 
Thanks to the development of the crystallography, NMR spectroscopy, time-resolved flu-
orescence spectroscopy, ultrafast Raman spectroscopy, and other high-end techniques, the under-
lying mechanism of the interaction of protein and chromophore has been investigated for years. 
It is known that both the steric and electrostatic effects contribute to the bright fluorescence. The 
compact packing of the native protein restricts the photo-isomerization of the chromophore in the 
excited state. The presence of the intrinsic proton wire enables the excited proton transfer 
(ESPT), leading to the emission of the anionic chromophore at 510 nm.  Mutagenesis was ap-
plied to analyze the key residues contributing to the proton transfer pathway and the conjugated 
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system. By mutating the residue S65T, the chromophore anion is predominated and the proton 
wire was rearranged for the new chromophore environment. There were many evidences for such 
an adaptive protein matrix. 
The re-routing proton wire has been found in the mutant S205A and S205V where the 
proton transfer pathway had T203 instead of S205 involved (182, 183), in the mutant T203I 
where the absorption originated from the anionic form was suppressed while in the mutant 
E222G where the anionic form was predominant (184).  The color may be changed due to the 
alternation of the π electron density. The most important exploration was the yellow fluorescent 
protein (YFP) with T203Y providing the Y203-chromophore π-π stacking to increase the elec-
tron density. Many examples of the photo-switchable and photo-activated GFP derivatives can 
be found like the mutant E222Q (185) and T203H (186). Taken the advantages of those studies, 
the GFP variants were widely used in the fluorescence imaging and the development of biosen-
sors. The spectral property varies in the circular permutated GFP/EGFP with different new ter-
minus (187, 188). GCaMP is the cpEGFP 149-144 fused with M13 peptide and calmodulin 
(CaM) (189). The calcium binding to CaM triggered conformational change of CaM, which in 
turn formed the complex with M13 peptide and induced the global conformational change in 
which the change of cpEGFP moiety led to the increase of the fluorescence.  
CatchER is the calcium sensor based on EGFP, which was designed to be targeted to the 
high calcium environment like the intracellular calcium store endoplasmic reticulum (ER) (66, 
190). To create the calcium binding site on the β-barrel of the EGFP, five residues were replaced 
by the negatively charged aspartic acid or glutamic acid without changing the β stranded struc-
ture. The calcium binding site, including Glu147, Asp202, Glu204, Glu223 and Glu225, located 
in proximity to the chromophore hydroxyl group. There were two absorption peaks of CatchER 
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in the neutral pH, 398 nm and 488 nm. Unlike EGFP, the protonated chromophore was dominat-
ed. The calcium binding resulted in the decrease of the 398 nm peak but increase of the 488 nm 
peak. In the absence of calcium, the fluorescence brightness was around 30% of EGFP. When 
calcium ion bound to the protein, there was about 50% enhancement of fluorescence observed.  
The mechanism of calcium binding induced fluorescence enhancement was studied by 
crystallography, steady and dynamic fluorescence spectroscopy. The hypothesis was that calcium 
binding altered the local dynamic property of the calcium binding site by neutralizing the nega-
tive potential, which in turn changes electrostatic interaction in the chromophore environment, 
resulting in the fluorescence increase. The crystal structures of calcium free, calcium bound and 
gadolinium bound CatchER were solved. Different conformation of Thr203 and Glu222 was ob-
served from wild type EGFP. Calcium binding to CatchER may lead to the rotation of the side 
chain of Glu222, which was considered to be responsible for the change of the optical properties. 
The dynamic fluorescence was investigated by the lifetime measurement, which providing evi-
dence showing that the calcium binding inhibited the geminate quenching during the proton 
transfer and increased the lifetime of ESPT, which was consistent with our hypothesis. The crys-
tal structure showed the double conformer of Glu222 in Ca
2+
-CatchER but only one confor-
mation without calcium, and raised the possibility that one conformer of Glu222 was deprotonat-
ed to maintain the neutral form and the other one was protonated so as to increase the portion of 
the anionic chromophore. However, it was not sufficient to explain how the calcium binding 
changed the electrostatic interaction around the chromophore. In this chapter, we reported that 
the calcium binding to CatchER lead to less fluctuation of the designed binding coordinators by 
NMR dynamic study and molecular dynamic simulation. The MD simulation further showed that 
the proton wires were altered in the presence of calcium ion. 
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4.2 Results and discussion 
4.2.1 Paramagnetic relaxation enhancement for probing the calcium binding site in 
CatchER 
The gadolinium ion is a paramagnetic ion and was used for the line broadening effect for 
recognizing the metal binding center of CatchER. A series of ratio of Gd
3+
: CatchER was 
screened using Varian 600 MHz NMR spectrometer. To avoid the precipitation caused by Gd
3+
, 
the buffer maintaining a lower pH was applied. The pH effect can be seen in Chapter 5 Figure 
4.1. The assignment for the cross peaks in pH 6.5 buffer was traced and done (Figure 4.1). The 
titration of Gd
3+
 followed the ratio of [Gd
3+
]:[CatchER] as 0:1, 0.1:1, 0.2:1, 0.5:1 and 1:1. Figure 
4.2 shows the spectra overlay of Gd
3+
-free and 1:1 equivalent CatchER. Figure 4.3 shows the 
HSQC spectra of CatchER without and with Gd
3+
 at 0.5 and 1 equivalent concentration as our 
protein. Since there is no pseudo-chemical shift change occurred by gadolinium, the disappeared 
cross peaks were resulted from the broadened line due to the R2 relaxation enhancement.  
 
Figure 4.1. The 1H-15N HSQC spectra overlay of CatchER in different buffer solutions. 
(Red) 20 mM Pipes, pH 6.5, 10 mM KCl, 20% D2O; (Blue) 10 mM Tris, pH 7.4, 10 mM KCl, 10% D2O. 
The experiment was carried out at 37C. 
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The intensity of all peaks decreased in a certain level by adding 0.5 equivalent amount of 
Gd
3+
, about 30%, due to the dilution effect and some other systematic effects. There are 138 res-
idues assigned in the metal-free CatchER 
15
N-
1
H HSQC spectrum, of which 77 residues were not 
influenced by the line broadening effect of Gd
3+
. In the spectrum of CatchER with 0.5 equiva-
lents Gd
3+ 
(Figure 4.3 middle), several residues including Thr9, Glu90, Asp102, Phe130, Glu132, 
Tyr143, Phe165, Asp190, Asn198 and Gly228 showed the decreased height by more than 55%, 
while overall decrease was approximately 30%. However, the neighboring residues did not show 
decreased intensity. Here, two phenylalanines have the side chains protruding inwards. Thus, all 
residues have oxygen atoms exposed to the solvent and can interact with the positively charged 
Gd
3+
 ions but not specifically. In the spectrum of Gd
3+
 and CatchER at 1:1 equivalence (Figure 
4.2 and 4.3 right panel), 109 peaks disappeared, in which among the 62 un-assigned peaks in the 
metal-free CatchER spectrum 48 of them were disappeared. 
                         
Figure 4.2. The 1H-15N HSQC spectra overlay of CatchER with (Cyan) and without (Red) Gd3+. 
The final Gd3+ concentration was 200 µM, the same as [CatchER] in 20 mM Pipes, pH 6.5, 10 mM KCl, 
20% D2O. The experiment was carried out at 37C. 
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Figure 4.3. The 15N-1H HSQC spectra of Gd3+ titration to CatchER. 
The ratio of metal to protein 0:1 (red), 0.5:1 (blue) and 1:1 (cyan). The ornaments indicate the assignment 
for cross peaks. Cat is short for CatchER. The experiment was carried out at 37C and the protein was 
prepared in 20 mM Pipes, pH 6.5, 10 mM KCl, 20% D2O. 
 
 
Figure 4.4. The histograms of the chemical shift change in Gd3+ titration. 
The decreased intensity and disappeared peaks due to the broadening effect is presented by the frequency 
count as a function of the peak volume (A) and height (B) ratio of the Gd3+-CatchER to the metal-free 
sample. Cat is short for CatchER. 
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The histogram of peaks with decreased intensity was obtained by the signal ratio (height 
or intensity) of the one with Gd
3+
 to the original CatchER without Gd
3+
, where the ratio=0 indi-
cated the disappeared peak and raito=1 indicated the unaffected peak. Using either the height or 
the volume to calculate the ratio, the statistical trend is similar (Figure 4.4). The first column in 
both volume and height ratio histograms suggests the population of the disappeared residues. 
Figure 4.5 depicts the distribution of residues of assigned, unassigned, and disappeared in the 
presence of the different amount of Gd
3+
 by colors. 
As shown in Figure 4.5, the green residues were assigned, taking up to 60% of the sur-
face of CatchER crystal structure. This area was in the opposite side of the designed calcium 
binding side (left in Figure 4.5A). Unfortunately, most residues in our designed calcium binding 
pocket were not able to be assigned, leaving this area in white color (right in Figure 4.5A). How-
ever, in the presence of 1 equivalent Gd
3+
 ions, the red color circles around the calcium binding 
pocket, which dominates the disappeared peaks, providing the boundary of the calcium binding 
area. In addition, Table 4.1 shows that 77% un-assigned peaks were gone in the presence of 1 
equivalent Gd
3+
. The pieces of information can not indicate which residues, but implies abundant 
un-assigned residues in the calcium binding area disappeared.  
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Figure 4.5. Mapping residues affected by Gd3+ PRE in the calcium loaded CatchER crystal structure.  
(A) Gd3+:CatchER=0:1; (B) Gd3+:CatchER=1:1. The region colored by white (un-assigned residues), 
green (assigned residues), red (disappeared peaks in CatchER HSQC spectrum with 1 equivalent Gd3+), 
and magenta (disappeared peaks in CatchER HSQC spectrum with 0.5 equivalents Gd3+) which are also 
labeled except Phe165 because its side chain faces to the interior of the barrel. The grey dot in B is calci-
um ion.  
 
Table 4.1 The statistics of the cross peaks during the Gd3+ titration to CatchER. 
[CatchER]:[Gd3+] 
Number of the assigned peaks Number of the un-assigned peaks 
Remained Disappeared Remained Disappeared 
1:0 138 NA 62 NA 
1:1 77 61 14 48 
  
In conclusion, the gadolinium titration resulted in the line broadening in CatchER HSQC 
spectra. In the CatchER spectrum with 1 equivalent Gd
3+
 ions, 44% assigned and 77% un-
assigned residues were disappeared due to relaxation enhancement. Based on the disappeared 
circle around the calcium binding side and the distribution of un-assigned residues, the calcium 
binding pocket is the major area affected by the addition of Gd
3+
. The result supports the crystal 
structure of holo-CatchER and also indicates a non-specific binding site (Asp19, Glu95, Glu124) 
with local high negative potential (Figure 4.5B colored in red). 
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4.2.2 The dynamics analysis of CatchER 
CatchER was uniformly labeled by growing E. coli in the SF9 minimum medium sup-
plemented with 
15
NH4Cl. The protein was purified by Ni chelation column and prepared in 10 
mM Tris, 10 mM KCl, pH 7.4, 10% D2O and 1 mM NaN3. All NMR data were collected in 
VARIAN 600 MHz at GSU facility at 37°C. Three serials of spectra were obtained separately. 
Each serial was recorded using the same gain and number of scans. For calcium loaded form, 10 
R1 experiments with various relaxation delays were used: 0, 0.01, 0.06, 0.13, 0.23, 0.34, 0.48, 
0.74, 1.0, 1.5, and eight relaxation delays were performed for R2 experiments: 0.01, 0.03, 0.05, 
0.07, 0.09, 0.11, 0.13, 0.15. For NOE experiments, the proton recovery period d1 was set to 4.0 s.  
The molecule tumbling ranged in pico-sec to nano-sec motion can be studied by collect-
ing T1, T2 relaxation and intensity ratio of steady-state NOE. From R1, R2 and NOE, the dy-
namic parameters like J(0), J(ωN), J(0.87ωH), R2/R1, the order parameter S
2
, correlation time τc 
and exchange rate Rex can be obtained by reduced spectral density function mapping. The greater 
internal motion can be reflected by decrease of J(0) and J(ωN) and increase of J(0.87ωH). The 
chemical exchange is reflected by significantly increased J(0). R2/R1 decreases in residues 
where if there is the conformation change occurs. S
2
 is the square of the generalized order pa-
rameter characterizing the amplitude of the internal motion, which can be used to justify the de-
gree of the internal motion, ranged in 0-1. If S
2
=1, it will stay in the same orientation at any time, 
meaning that this residue is completely rigid. The correlation time is the measure of how fast a 
molecule tumbling in the liquid, or the rate of molecule motion, which is different from the iso-
tropic rotational correlation time τm. The exchange rate Rex is a function of exchange rates, popu-
lations and chemical shifts of different conformations.  
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For either apo or holo CatchER, the R2/R1 is basically uniformly distributed as shown in 
Figure 4.6 within an acceptable error range (±2), indicating no specific conformational or solvent 
exchange occurring. The overall correlation time τm was estimated from the average R2/R1 (11.3 
and 11.4 ns) was consistent with the optimized one by ModelFree program, 10.30±0.02 and 
10.37±0.03 ns for apo and holo CatchER, respectively.  
 
Figure 4.6. Comparison of the ratio R2/R1 of apo and holo CatchER. 
 (A) the difference between holo and apo CatchER. Residues with only R1 or R2 available were excluded. 
(B) the absolute value of both apo and holo CatchER.  
 
Figure 4.7 shows the comparison of the ratio NOEon/off between apo and holo CatchER. 
The overall NOE ratio in apo form was smaller than the holo CatchER, suggesting calcium bind-
ing restrains the backbone flexibility and makes it more constricted, although the difference is 
not significant. In both apo and holo forms, it exhibits the flexibility in the stretch of 60-70 in-
cluding the chromophore, and the terminus. There is exception including the regions 30-32 (SGE) 
and 42-45 (LTLK), and residues E95, A110, L125, L141, H181, which are less rigid in the pres-
ence of calcium.  
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Figure 4.7. Comparison of the ratio NOEon/NOEoff of apo and holo CatchER. 
(A) the difference between holo and apo CatchER, (B) the absolute value of both apo and holo CatchER, 
 
The order parameter S
2
 reflecting the degree of internal motion, was fit by Modelfree us-
ing experimental R1, R2 and NOE and the crystal structures as templates. Residues resulting in 
big errors in fitting were excluded in the final model. The ranges of S
2
 for apo and holo forms are 
0.809-0.994 and 0.701-0.994, respectively. As shown in Figure 4.8, the overall S
2
 value of holo 
CatchER is higher than the apo form, indicating that calcium binding makes the protein more 
rigid. In the pair comparison, substantial differences in the order parameter are observed in resi-
due V12 (0.256), C48 (0.142), K126 (0.264) and A154 (0.170).  
Since the amount of residues (39) remained in the final comparison is only 17% of the to-
tal residues (232), and 28% of the assigned residues (138), it is better to look at stretches or re-
gions with a continuous trend instead of individual residues. Thus, the regions 82-88 (α-helix, 
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DFFKSAM), and 190-196 (loop, DGPVLLP) are constrained by calcium binding, while regions 
33-40 (loop, GEGDATYG) appears more dynamic.  
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Figure 4.8. Comparison of the simulated S2 value calculated by Modelfree 4.0 of holo (red, solid) and apo 
(black, dash) CatchER. 
 
Unfortunately, the designed calcium binding coordinating ligand residue Glu147 locating 
in the stretch 140-155 (β-strand, KLEYNYNEHNVYITAD) and the other four calcium coordi-
nators (Asp202, Glu204, Glu223, Glu225)  at the β sheets 201-206 and 221-226 are not able to 
be concluded here due to the big error during the fitting and simulation. However, the NOE dif-
ference between holo and apo forms is positive in the long segment of 200-228, implying the 
calcium binding freezes the designed coordinators to some extent. 
The residue Q69 is the residue has two states and undergoes the change chemical ex-
change upon calcium binding according to Shen Tang's calcium titration: the slow exchange in 
the calcium loaded form while the fast exchange in the calcium free form. However, the NOE 
data did not show significant difference between the apo and holo CatchER, both of which sug-
gest a flexible Gln69. The H-bond network around the chromophore involved in Gln69 is shown 
in Figure 4.9, where this residue interacts indirectly with the chromophore through water mole-
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cules through the H-bond network, Ser72, Gln94 and Glu222. There are proton wires existing in 
the interior of CatchER, formed by chromophore phenolic hydroxyl group, Ser205, E222, Ser72, 
Gln69, Asp82 and Glu5. Only Gln69 and Asp82 were assigned in the spectra, and Asp82 locates 
far away from the chromophore. Therefore, Q69 becomes the most representative one to indicate 
the dynamics of the chromophore environment.           
       
Figure 4.9. The flexible and rigid regions in the crystal structure of Ca2+-CatchER. 
(A) The Q69 H-bond network around the chromophore. Q69 indirectly contacts with E222 and Q94, both 
of which are key residues involved in the chromophore H-bond network. (B) The proton wires of the 
chromophore. (C) The summarized dynamics of CatchER: regions more rigid after calcium binding (blue), 
regions more flexible after calcium binding (magenta), alternative conformations in X-ray structure 
(green). The calcium coordinators are shown in stick-and-ball format. 
 
Glu222 is the key residue involved in the proton wire of the chromophore and it has two 
conformations in both apo and holo CatchER. Basically, its side chain swings over 9.4° and 11.4° 
along the bond C-CA, in apo and holo forms, respectively. The larger degree in swinging in the 
Ca
2+
-CatchER shortens the distance for the H-bonds between water molecules and Ser72 and 
Gln69, so that those residues are tied up more closely. In the calcium titration experiment ob-
served by NMR, Gln69 showed the slow chemical exchanged in the presence of 6 mM calcium, 
which may be the result that Q69 is governed by the motion of Glu222. The X-ray structure re-
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flects the average position of thousands of structure. Therefore, the dynamics of Q69, with the 
correlation time around 10
-10
-10
-9
 s, is not necessary to be observed in the X-ray structure. 
In the crystal structure of apo, Ca
2+
 and Gd
3+
 forms, residues showing two alternative 
conformations of side chains, include Leu15, Leu18, Ser30, Arg73, Gln80, Lys131, Glu132, 
Arg168, Glu172 and Thr186 and Glu225. The side chains of those residues protrude towards 
solvent and appear flexible. For the loop 155-159, two conformations are observed in 50% popu-
lation each in the apo and metal binding CatchER. In NMR dynamic studies, this region also 
shows decreased steady-state NOEs in both apo and holo forms when compared with the neigh-
boring residues, suggesting a flexible backbone, in agreement with the crystal structure. The 
NOEs of Leu15 and Glu172 in apo but not holo CatchER are smaller than the adjacent residues 
and lower than the average 0.790. For the other residues with alternative conformation, Leu18 
was not assigned in apo CatchER; the NOEs for Ser30, Lys131 and Thr186 in both forms are 
greater than the average level, the resonances for Arg73, Gln80, Glu132, Arg168 and Glu225 
were not assigned. The terminus and the other residues, for example, Gln69, are obviously more 
flexible in solution than in crystal.  
4.2.3 Line-shape fitting for on and off rate of calcium-CatchER complex 
The chemical exchange caused by interaction between the ligand and the protein results 
in the change of line shape due to the change of T2 relaxation. It is called fast exchanged if the 
exchange rate is far greater than δA-δB. Line broadening effect could be observed when the 
chemical exchange rate changes from the fast to the intermediate one because the T2 relaxation 
is affected. As a result, the line width change during the intermediate and fast exchange has a 
relationship with the exchange rate as Equation 4.1, which was rearranged to Equation 4.2 (191). 
The Lorentzian line shape was used for peak integration and line width determination. The scien-
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tific computing package NumPy was used for koff fitting with the Levenberg-Marquardt algo-
rithm. Equation 4.2 and 4.3 was referenced to NMR of Macromolecules A Practical Approach 
(Gordon C. K. Roberts, IRL Press 1993, ISBN 0-19-963224-3). 
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where pf and pb are the relative population of free protein and the calcium bound protein; 
Kd is the dissociation constant; kon and koff are the on and off rate of calcium binding, respective-
ly; ν0 is the spectrometer frequency of the observed nucleus in MHz; Δδ (ppm) is the chemical 
shift change between the calcium free and bound states at the concentration of [Ca2+]; ν1/2 is 
the line width at half-height.  
The fluorescence increase of CatchER is calcium dependent. The chemical shift change 
was also observed in some resonances by adding calcium, which underwent the intermediate to 
fast chemical exchange process. Residues Leu42, Thr43, Leu44, Phe46, Gln69 and Thr153 
showed the significant resonance change, among which the line width change was observed in 
Leu42, Leu44 and Thr153. Figure 4.10C shows the selected peaks and the peak volume and line 
width was integrated and measured by Gaussian fit using NMRpipe. The chemical shift change 
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and line width exchange was plotted in Figure 4.10 A and B and the fitting result was shown in 
Table 4.2. The dissociation constant of Leu42 and Leu44 was consistent with each other, but al-
most double as Kd of Thr153 and triple as Tyr143. The dissociation constant fitted using the flu-
orescence titration data was in agreement with Try143, 0.3 mM, which is the residue closest to 
the designed binding coordinator Glu147. It was assumed that the fluorescence enhancement by 
calcium binding was due to the local conformational change and the hydrogen bonding network 
alternation. The non-consistency of Kd calculated from different resonances indicated the sensi-
tivity of residues to the calcium binding, which may reflect their correlation with the designed 
binding site. There was a hydrogen bond pair from the backbone of Leu42 and Glu222 observed 
in the crystal structure. Glu222 has been known as a key player in the chromophore hydrogen 
bond network and involved in the ESPT process. The chemical shift perturbation of Leu42 indi-
rectly confirmed the calcium binding change affected hydrogen bonding in the chromophore en-
vironment.  
The off rate fitted using the current data resulted in the big fitting error due to the lack of 
enough titration points. The averaged off rate was around 100 s
-1
, which was only 1/7 as the one 
estimated from the stopped-flow experiment monitored by fluorescence signal. Because those 
residues were not directly involved in calcium binding, it can not rule out that the higher off rate 
may be observed in the calcium binding coordinators.  
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Figure 4.10. Titration of calcium for CatchER monitored by 1H-15N HSQC.  
(A) The chemical shift change of Leu42, Leu44 and Thr153 resonance was fitted to obtain Kd using Equa-
tion 4.4. (B) The exchange line width at different calcium concentration, calculated using Equation 4.3.(C) 
The selected resonance at overlaid 1H-15N HSQC spectra of calcium titrated CatchER at 40º using 600 
MHz VARIAN NMR spectrometer.  
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Table 4.2 Summary of off rate and binding constants of resonance L42, L44 and T153. 
Resonance koff (s
-1
)  Kd (mM)  
L42  123 ± 23  1.23  
L44  55 ± 20  1.24  
T153  73 ± 41  0.67  
 
4.2.4 Molecular dynamic simulation of calcium-free and loaded CatchER  
CatchER is the fluorescence protein EGFP based calcium sensor. The stoichiometry of 
calcium binding is 1:1, verified by Job’s plot. The protein is consisted with 11 β strands and the 
chromophore was buried inside connecting two short α helices. The chromophore, p-
hydroxybenzylidene-imidazolinone, is formed by automatic self-catalytic cyclization of three 
amino acids Thr, Tyr and Gly. It has been found that the fluorescence of CatchER is dependent 
on the calcium concentration. CatchER was derived from EGFP, with five site-mutagenesis resi-
dues in the β barrel in proximity to chromophore. The NMR spectra of calcium titration to 15N 
labeled CatchER showed the chemical shift change of the residue Tyr143 which was close to one 
of the designed calcium binding site Glu147, and the chemical exchange from fast to intermedi-
ate of the residue Gln69, which is in the hydrogen bonding network of the chromophore. How-
ever, there was no significant difference observed in the crystal structure of calcium-free and 
loaded forms of CatchER with resolution of 1.66 and 1.10 Å, respectively. The X-ray crystal 
structure is the average one from thousands and even more individual structures, not reflecting 
the dynamic feature. Identical conformation of Gln69 and Tyr143 in the crystal structures of apo 
and holo CatchER can not rule out the possibility that the calcium binding site as well as chro-
mophore has different dynamic feature in solution in the two states.  
NMR is able to monitor the internal motion including molecular tumbling (ps) and pep-
tide plane motion (ns), and the secondary structure and larger domain motion in μs to ms time 
scale, by different programs. The internal motion was illustrated by T1, T2 relaxation and NOE. 
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As discussed in 4.2.1, the calcium binding to CatchER reduced the backbone internal motion as 
the order parameter S
2
 was generally greater in the holo form. However, under the experimental 
condition, not all cross peaks were assigned, leaving gaps of 49-76, 142-152, 187-216,  and 218-
231,  as shown in Figure 4.1-4.3. Unfortunately, the key residues the hydrogen bonding network 
of the chromophore falls in these regions including Gln69, Ser72, Thr203, Ser205 and Glu222, 
as well as the designed calcium binding site. In addition, the lack of information of the side chain 
in the NMR makes the major gap to understand the interaction between protein matrix and the 
chromophore. The molecular dynamics (MD) simulation is a complementary tool to the conven-
tional experiments to find out the dynamic information of the microscopic interaction in a de-
sired time scale up to microsecond. To investigate the effect of calcium binding on the dynamics 
of those residues, we used MD simulation to reveal the global conformational dynamics, back-
bone fluctuation, hydrogen bonding network and the torsion of the chromophore plane.  
The GFP chromophore was extracted from crystal structure of CatchER. Gaussian 03 was 
used to optimize the geometry and calculate the electrostatic potential at the hf/6-31G* level for 
AMBER ff99SB force field. The complete structures of apo and holo forms were built by tLEAP 
module. The 10 Å water box was applied and the structures were minimized in an implicit gen-
eralized Born solvation model. The structures were heated to 300 K and relaxed for 50 ps. The 
simulation was carried out with ff99SB parameter set. SHAKE algorithm was used to restrain 
hydrogen vibration following a 2 fs timestep for equilibrium of 20 ns long at 300 K. Temperature 
was regulated by Langevin thermostat method. Trajectories were analyzed by PTRAJ module 
and VMD program. 
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4.2.4.1 Root mean square deviation (RMSD) and fluctuation (RMSF) 
The global RMSD was calculated to find out the conformational change during the period 
of equilibrium. The global conformational change can be observed by backbone Cα, N and H 
using the first structure as reference. The fluctuation of RMSD during the simulation time sug-
gests the conformation dynamics change. As shown in Figure 4.11A and C, both apo and holo 
forms of CatchER deviated 1.2 Å from the initial structure within first 3 ns. After that, the struc-
tures maintained in a steady state over 10 ns. A rise of RMSD value to 1.5 Å at approximately 
the 15th ns occurred in both structure although a delay of about 1 ns was observed in the holo 
form. In conclusion, in 20-ns simulation, there was no large conformational change (Cα RMSD > 
2Å (192)) occurring in either apo or holo CatchER. 
The Cα RMSF was calculated to find out the residues and areas with high fluctuation dur-
ing the simulation time. In the original structure of EGFP, the electrostatic balance is one of the 
determinants to maintain the β barrel architecture. By introduction of the calcium binding site 
with the high negative potential, the local electrostatic repulsion force formed between the side 
chains of the mutated residues, which competed with the attraction force of the hydrogen bonds 
between the backbones of the neighboring β sheets. The fluctuation would occur due to the com-
petition of the electrostatic force from the main chain and side chain, which may be diminished 
when calcium binds to neutralize the local negative potential. Figure 4.11B and D showed that 
RMSF from the apo, holo and the difference between them. The observation of Cα RMSF was 
consistent with the hypothesis that the fluctuation of fragments 143-150 and 198-209 decreased 
in the calcium-bound CatchER, where the designed calcium binding sites Glu147, Asp202 and 
Glu204 were included. It was not surprising that the fluctuation of 210- 230 backbone between 
apo and holo forms did not differ because the designed calcium coordinators Glu223 and Glu225 
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contributed less than the other 3 residues for calcium binding according to the crystal structure of 
the holo CatchER. Other than the β sheets directly involved in calcium binding, the fragment 
163-181, which was in neighbor with β sheet 143-150, was also affected by the mutation indi-
rectly.  
In contrast, the RMSF for the whole residue in holo-CatchER was generally larger than 
the apo form. The fragments stabilized by calcium binding were indicated in Figure 4.11B, 
which were in agreement with the S2 calculation in Section 4.2.2. The effect of calcium binding 
on the whole residue also suggested that calcium binding reduced the fluctuation of the coordina-
tor 147 and the neighboring β strand 168-177, as well as mainly increased the other regions. The 
Cα RMSF of Gln69 Cα in apo or holo form were 0.44 and 0.48, which was in the basal level. 
The simulation data suggested this residue did not fluctuate in 20 ns simulation at 300 K. How-
ever, the RMSF for the whole residue in apo and holo CatchER was 0.74 and 2.83, indicating 
that the calcium binding enhanced the fluctuation of the side chain.  
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Figure 4.11. The RMDS and RMSF of 20-ns MD simulation.  
(A) Backbone [Cα, N, H]-RMSD and (B) Cα RMSF differences for calcium-free and bound CatchER 
during 20-ns MD simulations. (C) All atom RMSD and (D) RMSF for each residue for calcium-free and 
bound CatchER during 20-ns MD simulations. 
 
4.2.4.2 Hydrogen bonds in the chromophore environment 
Hydrogen bonds of the trajectory were checked by PTRAJ module for the residues in-
volved in the chromophore environment. The hydrogen bonds with occupancy greater than 5% 
was taken into account and will be discussed in the following paragraphs. Figure 4.12A shows 
the residues directly hydrogen bonding to the chromophore. The occupancy of the H-bond be-
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tween the water molecule (WAT1) and chromophore tyrosine hydroxyl in Ca
2+
-CatchER was as 
600% as the apo form. In addition, the chromophore tyrosyl served as the hydrogen bond donor 
in the presence of calcium ion, while it was the acceptor without calcium. The pair of His148-
ND1 and CRO-OH was found in the apo form, which was common in the GFP and EGFP, but 
not seen in the holo CatchER. The opposite way was observed for the residue Gln94 side chain 
and the CRO-O3, which was only present in the holo form.  The tyrosyl group of Tyr92 and 
Tyr145 serves as the hydrogen bond donor, providing hydrogen to the chromophore O3 and OH, 
respectively. These two hydrogen bonds were not found in the crystal structure since the distance 
was beyond the H-bond cut-off. In the Ca
2+
-CatchER, Gln94 and Tyr92 appeared to form H-
bonds with either CRO-O3 or Gln69-OE1 dynamically, as shown in Figure 4.12B. In the apo-
CatchER, the hydrogen bonds involving Gln69 were in a steady state with Ser72, a water mole-
cule and Gln183 through the whole 20 ns long simulation, while in the presence of calcium 
Gln183 was substituted by Tyr92 and Gln 94 in the second 10 ns (See Appendix C).  
Appendix C summarized the hydrogen bonds formed among the residues in the chromo-
phore hydrogen bonding network, not directly with the chromophore. H-bonds involving Ser205 
and Glu222 were similar between the apo and holo forms of CatchER, although the occupancy of 
H-bond pair Glu222-OE2 and Ser205-OG was 15.9% more in the presence of calcium. In both 
apo and holo forms, the backbone of Thr203 and His148 formed hydrogen bonds. In addition, 
the side chain of Thr203 served as H-bond donor to Leu201, which also accepted a hydrogen 
from a water molecule. In the calcium bound form, another water molecule can also share the 
electro-density with the backbone of Thr203 like His148. The hydrogen bond pair of His148-
NE2 and Arg168-O was found in CatchER with and without calcium, and the side chain guani-
dine group of the latter one can also hydrogen bond to Glu147  main chain oxygen and side chain 
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hydroxyl group in the apo form.  Instead of association with the chromophore tyrosyl in the cal-
cium free form, in the presence of calcium His148 and Asn146 formed the H-bond with the oc-
cupancy of 48%. The guanidine group of Arg73 can form hydrogen bonds with the side chain of 
the calcium coordinators Glu223 and Glu225 in both apo and holo forms, but the occupancy was 
higher in the apo form.  
 
 
Figure 4.12. The snapshots of CatchER during 20-ns MD simulation.  
The hydrogen bonds in the chromophore environment of calcium free (left) and calcium bound (right) 
CatchER. The hydrogen bond cut off was set as <3.0 angstroms, >120 degree, and >10% occupancy.  
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4.2.4.3 Torsion of chromophore planarity 
The dihedral angle between the chromophore imidazolinone ring and tyrosine phenol ring 
reflected the torsion of the chromophore. The chromophore is a conjugated system, and the free 
energy is less if it is more planar. However, the protein matrix restricts the geometry of chromo-
phore by both the electrostatic and hydrophobic interaction. Figure 4.13 showed the dihedral an-
gle distribution along the time course. The two aromatic planes fluctuated within the angle of 13º.  
In the presence of calcium the imidazolinone ring and the phenol ring were evenly distributed in 
both folded (positive) and extended (negative) modes, while the extended mode dominated in the 
apo form. The histogram of the ratio of counts of the extended and folded mode was shown in 
Figure 4.12B. The extended mode was favored in the apo-CatchER in the 10th-18th ns.  
 142 
 
-200
-100
0
100
200
0 5 10 15 20
PSI_apo
PSI_holo
P
S
I
Time (ns)
A
 
0
5
10
15
20
2 4 6 8 10 12 14 16 18 20
Apo
Holo
P
S
I 
N
e
g
a
ti
v
e
 #
/P
o
s
it
iv
e
 #
 
Time Bins
B
 
 
Figure 4.13. The dihedral angle between the chromophore imidazolinone and tyrosine phenol.  
(A) The dihedral angle defined by four atoms, CA2, CB2, CG2 and CD2, which was processed by PTRAJ 
module. (B) The ratio of the counts of negative to positive PSI angle in every 2 ns.  
 
4.2.4.4 Conclusion 
In the presence of calcium ion, the probability of hydrogen bonding was 98% between 
Ser205 to Glu222, 15% higher than that in the apo-CatchER. In the Ca
2+
-CatchER, the water 
molecule close to the chromophore hydroxyl and Ser205 served as the H-bond acceptor with the 
occupancy of 92% to the chromophore hydroxyl. It was the bridging molecule to connect the 
chromophore, Ser205 side chain (6.5% occupancy) and Thr203 main chain (43% occupancy). 
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However, it was the hydrogen bond donor for the chromophore hydroxyl with the occurrence of 
15.5%, for the main chain of Thr203 (5%) and for the His148-ND1 (8.5%) in the apo form. The 
proton wire consisted of the chromophore tyrosine hydroxyl, the bridging water, Ser205, Glu222 
and the chromophore threonine hydroxyl, was disrupted by the introduction of the calcium bind-
ing site, which was known to be pivotal for the ESPT. Calcium binding rescued this proton trans-
fer pathway.  
There was a possible extended proton transfer pathway consisted of the side chain of 
Glu222, one or two water molecules and the hydroxyl of Thr203. The probability of this pathway 
was estimated to be 4.2% and 1.6% in the Ca
2+
-bound and apo CatchER, respectively. It was 
likely that this extended proton wire reduced the electrostatic repulsion between the deprotonated 
Glu222 and the anionic chromophore, and affect the excited state proton transfer. The conse-
quence was the increase of the anionic form in the optical spectrum and the longer fluorescence 
lifetime in the presence of calcium. 
Regarding the calcium binding coordinators, Glu147, Asp202 and Glu204 contributed to 
the calcium binding. The association between side chains of Glu147 and Arg168 was diminished 
when calcium was bound. Glu223 and Glu225 in the calcium binding site were not actually in-
volved in the calcium binding. Instead, the salt bridges formed between the side chains of 
Glu223, Glu225 and Arg73.  
4.3 Summary and conclusions 
In this chapter, I used NMR and MD simulation, as well as comparison of crystal struc-
tures to illustrate the Ca
2+
 binding effect on the structure and dynamics of CatchER. PRE exper-
iment using Gd
3+
 as a probe was applied and successfully confirm the Ca
2+
 binding site. Later on, 
the crystal structures of both apo and holo-CatchER was obtained and showed the calcium ion 
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present in the holo-CatchER, but there is no substantial structural difference observed between 
them.  
NMR is the first choice to study the protein dynamics when the molecular size is less 
than 30 kDa. The T1, T2 and NOE data of CatchER was collected in the absence and presence of 
Ca
2+
 using VARIAN 600 MHz NMR spectrometer.  There is no conformational or solvent ex-
change upon Ca
2+
 binding based on R2/R1 values. Heteronuclear NOE data suggests the overall 
structure is more rigid when calcium binds, which is consistent with the order parameter S2. The 
analysis of line width change upon Ca
2+
 titration provided the information of dissociation rate in 
the range of 100 s
-1
 according to L42, L44 and T153. 
Due to lack of the complete peak assignment and missing information of the designed 
calcium binding site, molecular dynamic simulation was carried out to look into the effect of 
Ca
2+
 binding on the dynamics of CatchER. It was found that Ca
2+
 binding reduced the fluctuation 
of the designed calcium binding site and the hydrogen bonding network was altered. Particularly, 
the introduction of five negatively charged residues breaks the proton migration path and it is 
recovered by Ca
2+
 binding. It also provides evidence to support the findings in the Ca
2+
 effect on 
the fluorescence lifetime, which will be discussed in Chapter 5. 
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5 THE FLUORESCENCE LIFETIME OF THE GREEN FLUORESCENT CALCIUM 
INDICATOR CATCHER 
5.1 Introduction 
5.1.1 Fluorescence lifetime of green fluorescent proteins 
The lifetime of fluorophore refers to the time between the photon absorption and emis-
sion. Basically, it is the average time of the fluorophore stays in its excited state. The lifetime is 
an important property of an individual fluorophore because it is directly determined by the decay 
rate constant kr which determines the quantum yield. The relation of the lifetime, the decay rate 
constant and the quantum yield can be revealed by the following equations (Eq. 6.1-Eq.6.2). 


k
k f
    Equation 5.1 
nrESPTf kkkk 


11
   Equation 5.2 
fk      Equation 5.3 
 
The fluorescence emission is a kind of radiation emission, which is in first-order reaction 
kinetics. The photon number at the excited state at any time t is N(t), and at the t=0 is N(0). So 
there is N(t)=N(0)*e
(-kt)
. The fluorescence decay follows the single or multi-exponential function, 
including the spontaneous radiation emission and non-radiative decay. Non-radiative decay in-
cludes quenching by dynamic collision, dipole-dipole energy transfer (chromophore cis-trans 
isomerization), internal conversion, excited state proton transfer, etc. The observed decay curve 
is the accumulated effect of spontaneous radiative and non-radiative decays.  
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GFP has attracted research interest for decades and is still shining (193). In 1996, Chat-
toraj and co-workers first proposed there were different forms (the protonated neutral chromo-
phore as A form, an intermediate I form and the deprotonated anionic chromophore as B form) in 
GFP, which can convert to each other by proton migration (194). In the same year, the crystal 
structures of wild type GFP and its S65T mutant which was known as enhanced green fluores-
cent protein (EGFP) (195, 196). In 1997 and 2000, Palm and Remington reported the crystal 
structures of several mutants and summarized the spectral relevance to the three forms, and also 
described the residues that affected the proton transfer and further altered the spectra, respective-
ly (197, 198).  
Many pieces of evidence showed that the protein matrix maintains the bright fluorescence 
of GFP by providing the chromophore restrictions through hydrogen bonding network and steric 
hindrance. Usman and co-worker provided evidence to show that the synthesized GFP chromo-
phore HBDI undergoes twisting of phenolate and imidazolidinone moieties upon excitation (S0-
S1 transition) by detecting vibration of HBDI C=O stretching (181). Maddalo and co-workers 
also illustrated that the planarity of the chromophore is not energetically favored in the excited 
state (199). Fang and co-workers use the femtosencond Raman Spectroscopy to discussed the 
correlation between the native vibration of the chromophore triggered by photoexcitation and the 
protein transfer and suggested that a concerted chromophore motion in the time scale of 280 fs 
initiated ESPT (200).  
The photodynamics of GFP was studied closely with the chromophore structure and con-
formation. The ultra-fast excited state dynamics was mapped out using the transient infrared 
spectroscopy (TIR) and Raman spectroscopy, suggesting the ESPT pathways and the conforma-
tional change of the chromophore. Using Raman spectroscopy and TIR, Bell, He, and Shellen-
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berg and co-workers assigned the vibration modes and the bond stretching and formed a basis for 
the later study by those techniques (201-203). Stone-Ma and co-workers found out that the 
Glu222 was the final proton acceptor in ESPT (204). Armon and Leiderman and co-workers ex-
tended the view of the proton conduction in the protein matrix along proton wires and described 
the proton pathways including the proton exiting the beta-barrel by rotation of Thr203 and the 
slow re-entry (µs) from the other side of GFP (205, 206). Agmon later on provided the evidence 
by kinetics study to conclude the proton escape via Thr203 rotation was irreversible and changes 
the decay behavior from t
-1/2
 to t
-3/2
 (207). Residues involved in the classic ESPT pathway, in-
cluding the chromophore phenolic hydroxyl group, Ser205, a water molecule and Glu222, are 
not necessary for GFP fluorescence. The S205A and S205V mutants adopted an alternative pro-
ton wire substituting Ser205 with Thr203 and enabled the proton transfer (182, 183). 
Calcium transients are essential for intracellular calcium dependent biological process-
es(4). The amplitude, the duration and the kinetics of calcium concentration change, composite 
the code to regulate the downstream signaling. Such calcium signals are determined by the calci-
um gradients, the native calcium binding proteins and the calcium channels as well as pumps. 
Calcium indicators with a wide range of calcium binding affinities are needed to probe the spa-
tial-temporal calcium dynamics in different sub-cellular compartments. The quantitative meas-
urement is critical to understand [Ca
2+
] change and the resting calcium level in intracellular cal-
cium stores and subcellular compartments.  
For imaging calcium changes in biological systems, much effort has been taken to devel-
op the fluorescent calcium biosensor toolkit (54, 59, 91, 96, 208, 209). There are a broad range 
of choices for organic calcium dyes, including the ratiometric indicators like Fura and Indo series 
and the single wavelength indicators BAPTA, Fluo and Rhod series (210). These organic dyes 
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have dissociation constant Kd ranged from 0.2-20 µM and are widely applied to monitor the in-
tracellular calcium transients.  However, some major challenges for quantitative monitoring cal-
cium cellular responses using the static fluorescence microscopy remain, including uneven dye 
loading, leakage and photobleaching. The fluorescence lifetime imaging (FLIM) overcomes 
these limitations with its advantage of being independent of the concentration of fluorophore as 
well as the excitation light intensity and better quantitative(211, 212). In FLIM, lifetime meas-
urement takes place at each pixel, revealing the spatial distribution of the fluorescent molecules 
and thus allowing a simultaneous recording of multiple fluorescent labels with reliable discrimi-
nation (213). In addition, it is sensitive to the change of the microenvironment such as pH, the 
ion strength, hydrophobocity, oxygen concentration and interaction with other macromolecules, 
and protein-protein/protein-ligand interactions in situ(214-217). Thus, it provides insights into 
the local environment of the fluorophore.  The in vivo lifetime imaging utility is being developed 
for living small animals to monitor the treatment of diseases especially cancers(212, 218-220). 
The lifetime imaging of calcium indicators, Quin-2, Calcium Green 1 and Oregon Green BAPTA 
(OGBs) have been used to monitor intracellular calcium transients(221-223). 
Genetically encoded calcium indicators (GECIs) based on fluorescent proteins benefit the 
calcium concentration detection in specific cellular compartments. The chimera proteins consist 
of calcium binding domains and fluorescent moieties, including GCaMP, Cameleon, Prericam 
and troponin C (TN) series, taking advantage of the intrinsic calcium binding properties of cal-
modulin or troponin C to induce the fluorescence intensity change upon calcium binding(54, 56, 
60, 74, 95, 189). These calcium indicators with the Kd in the magnitude of 10
-7
 - 10
-6
 M and slow 
calcium dissociation rates are suitable to detect a calcium rise in cytosolic space but not for the 
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calcium concentration change in the internal calcium stores such as the endoplas-
mic/sarcoplasmic reticulum (ER/SR). 
To address the pressing need to detect the calcium concentration in a high-calcium envi-
ronment such as the ER/SR, we have designed CatchER (Calcium sensor for detecting high con-
centration in the ER) as a sensitive fluorescence calcium probe(66). CatchER is created  by the 
addition of a calcium binding site formed by five calcium ligand residues (residues 147, 202, 204, 
223, and 225)  in the beta-barrel in proximity of the phenol group of the chromophore from the 
single enhanced green fluorescent protein (EGFP) carrying the deprotonated chromophore (CRO) 
with resolution 1.20 (Figure 5.1). The excitation of both the neutral and anionic chromophore 
leads to the dominating anion emission at 510 nm, indicating the occurrence of the excited state 
proton transfer (ESPT). The fluorescence increase accompanied by the increasing calcium con-
centration, follows a 1:1 binding curve. The absorbance spectra showed that the population of the 
neutral form (ROH) decreased while the anionic form (RO
-
) increased when calcium concentra-
tion increased. The fluorescence studies showed that the fluorescence intensity of the Ca
2+
-bound 
CatchER increased when CatchER was excited at both neutral (abs 395 nm) and anionic (abs 
488 nm) forms.  CatchER exhibits unprecedented Ca
2+ 
release kinetics with an off-rate estimated 
around 700 s
-1
 and appropriate Ca
2+ 
binding affinity for detecting high concentration in the ER. 
We have shown that CatchER is able to measure the calcium concentration change in various 
cell types and monitor SR luminal Ca
2+ 
in flexor digitorum brevis muscle fibers to determine the 
mechanism of diminished SR Ca
2+ 
release in aging mice using the intensity-based fluorescence 
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imaging(106). 
 
Figure 5.1. The crystal structure of apo (PDB ID: 4L1I)) and holo CatchER (PDB ID: 4L12).  
The residues shown in stick are the designed calcium binding site (147, 202, 204, 223, 225). Residues 
164-168 were shown with 50% transparency. The residue shown in green is the chromophore. The atom 
shown in grey is the calcium atom. The oxygen atoms and nitrogen atoms are indicated in red and blue, 
respectively. 
 
The dynamic properties of the excited CatchER, including its photophysical and photo-
chemical properties, are still unknown.  Indeed, the resulting apparent fluorescence lifetimes of 
both excited ROH (R*OH) and RO
-
 (R*O
-
) are in direct connection with the steady-state fluores-
cence measurements commonly used in molecular biology. In this chapter, we conducted the 
time-resolved fluorescence measurement to understand the fluorescence dynamic property 
change of CatchER induced by calcium. The goal of this study is to reveal the effect of Ca
2+
 on 
the ground state and the ESPT of CatchER. Our result shows that calcium binding alters the ioni-
zation state of CatchER chromophore and reduces the non-adiabatic proton geminate recombina-
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tion (quenching) in the excited state to increase the apparent lifetime of indirectly excited anionic 
chromophore. It is the first protein based calcium indicator with the single fluorescent moiety to 
show the direct correlation between the lifetime and calcium binding. Our finding provides im-
portant insights into the strategy for designing calcium sensors and calcium-induced optical 
property changes.  
5.1.2 Lifetime imaging 
Since the fluorescence lifetime imaging (FLIM) was developed by Lakowicz in 1992, 
this technique has been widely used to image biological systems in complimentary with the static 
fluorescence microscopy (212). Fluorescence lifetime imaging takes advantage of being inde-
pendent of the concentration of fluorophore and the excitation light intensity (211). In FLIM, 
lifetime measurement takes places at each pixel, revealing the spatial distribution of the fluores-
cent molecules and thus allowing simultaneous recording of multiple fluorescent labels with reli-
able discrimination (213). In addition, it is sensitive to the change of the microenvironment such 
as pH, the ion strength, hydrophobocity, oxygen concentration and interaction with other mac-
romolecules (214). Thus, it provides our insights into the local environment of the fluorophore. 
The in vivo lifetime imaging utility is being developed for living small animals to monitor the 
treatment of diseases especially cancers (212, 218-220).  
For imaging calcium change in the biological systems, much effort has been taken to de-
velop the fluorescent calcium biosensor toolkit. The photostability and the calibration for each 
specimen make the major challenges for quantitative calcium imaging using the frequency-
domain approach. The FLIM technology enables the more straightforward quantitative imaging 
to study the protein-protein interaction in situ by virtue of the fact that the lifetime measurement 
avoids the influence of fluorophore concentration. Calcium indicators, Quin-2, Calcium Green 1 
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and Oregon Green Bapta (OGBs), were applied to study the calcium transients using the lifetime 
imaging (221-223). The calcium binding induced the conformational change and the resulted do-
nor lifetime decrease was observed in the FRET pair based calcium indicator TN-XXL, which 
was promising to be applied in FLIM (224). We conducted the lifetime measurement to under-
stand the dynamic fluorescence property change of CatchER induced by calcium. The lifetime of 
excited state proton transfer was increased upon calcium binding. It is the first protein based cal-
cium indicator with the single fluorescent moiety to show the correlation between the lifetime 
and calcium binding.  
5.2 Results 
5.2.1 pH effect on the ground and excited-state prototropic behavior of CatchER 
The pH titration for the apo-CatchER monitored by absorption spectroscopy is shown in 
Figure 5.2. At pH 5.0, a single peak with the maximum at 395 nm was observed demonstrating 
the presence of only neutral Cro at these conditions. As the pH increased, the anionic chromo-
phore peak at 488 nm rose at the expense of the neutral form. At neutral pH, CatchER showed 
the presence of both the neutral and anionic forms of chromophore (Cro) in the ground (detected 
by absorption spectroscopy) and in the excited (detected by emission spectroscopy) states. At pH 
9.3, the neutral to anionic peak ratio was 0.74. At a pH higher than 9.3, the peak of the anionic 
form began to decrease and a shoulder around 465 nm was observed (not shown). At the same 
time, the peak maximum of the neutral chromophore was red-shifted and a shoulder was ob-
served around 425 nm, indicating the degradation of protein at pH > 9.3. The pKa of CatchER 
chromophore of 7.6 was determined using the equation (1).  Thus the anionic form of the chro-
mophore was expected to be predominant at pH 10. However, the intensity of the neutral peak 
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absorption was 60% of that at pH 5.0, implying that the portion of neutral chromophore was sol-
vent-inaccessible. Similar behavior is known for the fluorescence of wild-type GFP (wt-GFP) 
that shows very weak pH dependence from 6-10 (225, 226). Alternatively, we propose that neu-
tral Cro exists in two environments differing in the arrangement of the proton network around 
them.  One such population can be easily titrated (we name it Cro1), while the other (Cro2) pro-
tects the Cro from the pH changes in the outside medium.  From known extinction coefficients of 
the ROH and RO- in the GFP-type proteins and their synthetic chromophores(180) we estimate 
the relative populations of Cro1 and Cro2 as very close. Such splitting of the ROH population for 
the number of GFP variants has been already reported (227, 228). 
 
Figure 5.2. The pH profile of the absorbance of CatchER. 
(A) the pH titration from 5-9.3; (B) the pKa fitting by equation 2.10. The pH titration was carried out us-
ing 5 M KOH in a buffer cocktail consisted of 10 mM MES, 10 mM MOPS and 10 mM CAPS, pH 5.0. 
(C) The fluorescence spectra of CatchER in H2O at different pH from 5-9.3. 
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Figure 5.3. The emission spectra of CatchER in the pH cocktail buffer at different pH.  
The excitation wavelength was 395 nm (blue) and 488 nm (black), and the emission spectra were collect-
ed in the range of 420-600 nm and 500-600 nm, respectively. Ex is short for excitation. 
 
Figure 5.3 shows the emission spectra of CatchER at various pH levels.  At pH 5.0 the 
excitation of CatchER led to a two-peak emission spectrum, the high energy band at 465 nm be-
longing to the neutral Cro (R*OH), while the band at 510 nm, due to the anionic Cro (R*O
-
), 
formed via ESPT.  With pH increase, the relative contribution of the 465 nm emission band de-
creased together with the relative population of the neutral Cro in the ground state (Figure 5.2). 
The emission maxima of the directly and indirectly excited anions (excited at 488 nm and 395 
nm, respectively) are the same within the experimental error.   
Fluorescence decay curves of R*OH at various pH are presented at Figure 5.4. The decay 
of R*OH at pH 5.0 belongs only to Cro2 which still exists in the neutral form at pH 9.6 (Figure 
5.2).  The non-exponential decay could be caused by the ESPT geminate recombination and non-
homogenous distribution of Cro conformers in the protein(229). 
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Figure 5.4. CatchER fluorescence decay at pH 5.0, 7.6 and 9.6.  
The excitation wavelength was 372 nm and the emission wavelengths were 440 nm (A) and 510 nm (B). 
 
5.2.2 The ground and excited-state prototropic behavior of CatchER 
Fluorescence decay curves of R*OH and R*O- at pH 7.4 are shown in Figure 5.5.  The 
decay of R*OH and the directly excited R*O
-
 form followed the double or triple-exponential 
curve with the average lifetime of 0.19 ns and 2.61 ns, respectively. For the indirectly excited 
R*O
-
 form, there was a fast quenching component detected within the first 2 ns, followed by the 
long time asymptotic decay closely approaching the lifetime of the directly excited R*O
-
 (Table 
5.1). To make sure that our observation is not an artifact caused by the experimental/instrument, 
we have measured the fluorescence kinetics of several GFP variants (wt-GFP, wt-GFP/S72V) 
and reproduced the published data. None of the known GFP variants exhibit such fluorescence 
kinetic behavior of the indirectly excited R*O
-
.  
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Figure 5.5. The decay of CatchER at pH 7.4. 
The three forms are shown including R*OH (excited at 372 nm and emission at 440 nm), the directly 
R*O- (excited at 467 nm and emission at 510 nm) and indirectly excited R*O- (excited at 372 nm and 
emission at 510 nm, colored in red) at pH 7.4. Ex and Em are short for excitation and emission, respec-
tively. 
 
Upon calcium addition, the fluorescence decay of the directly excited R*OH and R*O- 
did not differ significantly. These results are in agreement with the previous observation that the 
quantum yield of CatchER was not affected by calcium when excited at 488 nm(66).  
Meanwhile, the amplitude of the initial fast decay component observed in the indirectly 
excited R*O- was dramatically reduced and the lifetime for the long-time asymptotic decay in-
creased in the presence of calcium (Figure 5.6). The average lifetime of the indirect excitation of 
anionic form was increased by 44% from 1.51 ns to 2.18 ns when calcium bound to CatchER. 
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Figure 5.6. Fluorescence decay traces of apo-CatchER (dash line) and CatchER supplemented with 10 
mM Ca2+ (Holo, solid line) in H2O (black) and D2O (grey).  
(Left) CatchER was excited at 372 nm and emitted at 440 nm in the time range of 10 ns; (Middle) Catch-
ER was excited at 372 nm and emitted at 510 nm in the time range of 15 ns; (Right) CatchER was excited 
at 467 nm and emitted at 510 nm in the time range of 15 ns. Ex and Em are short for excitation and emis-
sion, respectively. 
 
   At pH 7.4, both the neutral and anionic chromophores are present in the absorption 
spectra, with the peak height ratio ARO-/AROH of 0.43, as shown in Figure 5.7. The emission max-
ima was observed at 510 nm when excited at either 395 nm or 488 nm, where the intensity of the 
indirectly excited R*O
-
 was 45% of the directly excited species. With the addition of calcium, 
the population of the neutral and the anionic chromophore was changed, where the absorbance at 
488 nm increased and the peak at 395 nm decreased, leading to the ratio ARO-/AROH increase to 
Table 5.1 Values of the time constants (i) and normalized (to 1) pre-exponential factors (Ai) 
 of the multi-exponential function ﬁtting the ps-emission transients of CatchER in various solvents. 
In H2O 1 (ns) A1 2 (ns) A2 3 (ns) A3 ave(ns) 
Ex372;Em440 Apo 0.150.01 0.810.01 0.370.01 0.190.01 NA 0.190.01 
Holo 0.170.01 0.810.01 0.410.01 0.190.01 0.220.01 
Ex372;Em510 Apo 0.160.03 0.470.03 0.730.24 0.090.04 3.140.03 0.440.02 1.510.10 
Holo 0.210.01 0.370.02 3.340.03 0.630.02 NA 2.180.06 
Ex467;Em510 Apo 2.010.14 0.750.11 4.470.87 0.250.11 NA 2.610.06 
Holo 2.090.03 0.770.01 4.730.10 0.230.01 2.540.19 
In D2O 1 (ns) A1 2 (ns) A2 3 (ns) A3 ave(ns) 
Ex372;Em440 Apo 0.120.01 0.790.08 0.310.06 0.210.06 NA 0.160.01 
Holo 0.140.01 0.870.01 0.400.01 0.130.01  0.170.01 
Ex372;Em510 Apo 0.100.02 0.670.07 0.390.10 0.170.07 3.060.04 0.150.01 0.610.03 
Holo 0.130.01 0.600.04 0.410.10 0.150.05 3.420.01 0.250.01 0.990.05 
Ex467;Em510 Apo 2.180.24 0.810.01 5.240.10 0.190.02 NA 2.550.16 
Holo 1.810.03 0.560.16 3.620.46 0.440.16  2.600.07 
a
The amplitude-weighted average lifetimes of ave were calculated as (ave 
1
1
n
i i
n
i
i
i
A
A





).  
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0.58. The static fluorescence spectra showed that the R*O
-
 intensity was increased by 50% and 
30% upon calcium binding when excited at 395 nm and 488 nm, respectively 
 
 
Figure 5.7. The UV/optical and fluorescence spectra of CatchER in H2O (black) and D2O (grey), in the 
absence (dash line) and presence of Ca2+ (solid line). 
 Protein samples were prepared in 10 mM Tris, pH 7.4. For fluorescence spectra, two sets of excita-
tion/emission were applied: (1) excited at 395 nm and emission ranged from 420-600 nm, and (2) excited 
at 488 nm and emission ranged from 500-600 nm. Ex is short for excitation. 
 
     
At the same time, in the emission spectra where the fluorescence intensity at 510 nm was 
normalized to unity (Figure 5.8), it was observed that the peak height ratio IR*OH/IR*O-  1/(kd ’), 
where kd is the proton dissociation rate during ESPT and ’ is average lifetime of the indirectly 
excited R*O
-
 (230), was higher in the absence of calcium than that supplemented with calcium. 
The broad shoulder around 465 nm was originated from the emission of the neutral chromophore 
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R*OH. The emission at 510 nm was resulted from the indirectly excited R*O
-
 of CatchER 
formed via ESPT. The higher ratio IR*OH/IR*O- in apo-CatchER than holo-CatchER indicated the 
larger population of R*O
-
 remained in the excited state in addition to the calcium. Therefore, the 
calcium binding affects the acid-base equilibrium of the CatchER Cro in the ground state, caus-
ing increase of the anionic chromophore. On the other hand, the calcium binding reduces the pro-
ton geminate recombination therefore inhibiting the deactivation of the R*O
-
.  
 
 
Figure 5.8. The normalized fluorescence emission spectra of apo (dash line) and holo CatchER (solid line) 
in H2O (left) and D2O (right). 
 CatchER was excited at 395 nm and emission spectra were collected from 420-600 nm. All spectra were 
normalized to the emission maxima at 510 nm. 
 
 
5.2.3 H/D kinetic isotope effect 
The fluorescence lifetime of CatchER with and without calcium was measured in D2O to 
obtain the H/D kinetic isotopic effect (KIE), in order to gain information about the ESPT-related 
rate-limiting steps in the photo-induced proton transfer cascade. No kinetic H/D isotopic effect 
was found in the fluorescence decay of the directly excited neutral and anionic forms at room 
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temperature meaning that rates of proton dissociation as well as the decay of the R*OH and 
R*O- are non-sensitive to H/D exchange. However, the substantial H/D isotopic effect was ob-
served for the indirectly excited R*O- (Figure 6), for which the average lifetime was 1.5 ns in 
H2O and 610 ps in D2O. Interestingly, the amplitude of the quenching component was larger in 
D2O than in H2O (Table 5.1). It is known that the diffusion constant of the deuterium ion is 1.4-
fold lower than the proton (231, 232). As a result, the deuteron could be restricted in the Cro en-
vironment, facilitating the reprotonation of the latter. We hypothesize that while in H2O, the pro-
ton is prone to escaping from the Cro vicinity, causing less geminate recombination. Therefore, 
in the static fluorescence spectra the higher ratio IR*OH/IR*O- of CatchER in D2O (Figure 8) 
does not mean slower proton dissociation, which leads to H/D KIE about 5 in wt-GFP for  the 
lifetime of the indirectly excited R*O
- 
(194).  On the contrary, larger geminate proton quenching 
of R*O
-
 was observed in D2O which resulted in the decreased average fluorescent lifetime. Alto-
gether, the H/D KIE and the Ca
2+
 effects on the non-adiabatic geminate recombination were sim-
ilar. 
5.2.4 Analysis of hydrogen bond by molecular dynamics simulation 
To provide the structural basis for our observed optical and prototropic behavior of 
CatchER, we have performed the MD simulation in the static state using our recent determined 
X-ray structures of calcium free (PDB ID: 4L1I) and calcium loaded (PDB ID: 4L12) CatchER 
(190). Table 5.2 shows the probability of hydrogen bonds (H-bonds) formed in the chromophore 
environment including Cro, H148, T203, S205 and E222 and bridging water molecules labeled 
as in Figure 5.9. In Ca2+-CatchER, the hydrogen-bond network can be found from the Cro tyro-
syl (Cro-OH), WAT1, S205-OG and finally to E222-OE2. The Cro tyrosyl served as a H-bond 
donor to the bridging water molecule WAT1 connecting S205 with an occupancy of 92%. The 
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probability to form the H-bond between S205 side chain (S205-OG) and WAT1 is 6.5%, and 
98.5% for the H-bond between S205 and E222. In contrast, WAT1 was the H-bond donor for the 
Cro tyrosyl with the occurrence of 15.5% in apo-CatchER, and the H-bond between the S205 
hydroxyl and the bridging water (WAT1) was missing. Instead, the Cro tyrosyl served as the H-
bond donor for the H148-ND1 with the occupancy of 41.5%.  
 
 
 
Table 5.2 Hydrogen bond analysis in the chromo-
phore environment by MD simulation 
Donora Acceptora 
Occupancy  
Apo  Holo  
CRO-OG1  E222-OE2  88.5  91.5  
WAT1  CRO-OH  15.5  N/A  
CRO-OH  WAT1  N/A  92.0  
CRO-OH  H148-ND1  41.5  N/A  
WAT1  S205-OG N/A  6.5  
S205-OG E222-OE2  85  98.5  
H148-N T203-O  44.5  54.5  
WAT2 E222-OE1 16.5 NA 
WAT2  T203-OG1 10.5  31  
WAT3  E222-OE1 43  40  
WAT2  WAT3  24.5  35.5  
Q69-NE2 WAT2 40.5 68.5 
aThe residue and atoms names of H-bond donors 
and acceptors were given based on the pdb files. 
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Figure 5.9. The comparison of crystal structures of (A) apo-CatchER (PDB ID: 4L1I), (B) Ca2+-CatchER 
(PDB ID: 4L12), (C) GFP (PDB ID: 2WUR) and (D) EGFP (PDB ID: 4EUL).  
The H-bonds are shown in the black dash line with the cut off of 3.5 . Only side chains were shown in 
S72, T203, S205 and E222. 
 
In the other side from the side chain of Q69, proton can migrate to E222. Here, water 
molecules including WAT2 and WAT3 connected side chains of E222, Q69 and T203. In both 
apo and Ca
2+
 loaded CatchER, the water molecule WAT2 served as the proton donor for both 
T203 side chain and WAT3. Although the probability of WAT2-WAT3-E222 was higher in 
Ca
2+
-CatchER, it was found that WAT2 can directly form the H-bond to the E222 side chain 
with the occupancy of 16.5%, resulting in the comparable possibility of proton migrating to the 
E222 side chain with and without Ca
2+
.  
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5.3 Discussion 
5.3.1 Calcium effect on CatchER fluorescence lifetimes 
Previously, we discovered that optical properties CatchER resemble those of several GFP 
mutants. Excitation of both the neutral and excited forms resulted in a single wavelength of max-
imum emission at different pH as shown in Figure 5.3. Therefore, in contrast to the wt-GFP, 
there is no need to introduce intermediate anionic states(194), and the simplest kinetic scheme 
describing the prototropic behavior of CatchER could be depicted as shown in Scheme 5.1.   
ROH            RO
-
 + H
+
R*OH           R*O
-
 + H
+
h k
0
k
0
'
k
a
k
d
pK
a
, nm   395      460                       488        510
  
Scheme 5.1. Simple two-level ESPT kinetic scheme. 
 
 Here 1/k0 = 0 and 1/k0’=0’ are the fluorescence lifetimes of the excited protonated 
(R*OH) and deprotonated (R*O
-
) Cro, kd and ka are the apparent rate constants of the excited-
state dissociation and reprotonation. The ground state population of CatchER is represented by 
Cro1 and Cro2, differing in their pH-susceptibility, and not existing in the dynamic equilibrium 
(otherwise both population would be deprotonated at pH 9.3). These chromophores are spectrally 
indistinguishable in both absorption and emission spectra, therefore the observed ROH, RO
-
, 
R*OH and R*O- spectral bands are the superposition of Cro1 and Cro2 spectra.  The excited-
state R*OH decay lifetimes of pure Cro2 at pH 9.6 and 1/1 Cro1-Cro2 mixture at pH 5.0 (Figure 
5.4) do not differ by more than a factor of two, demonstrating similar ESPT dissociation reactivi-
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ty for both forms. Although the Cro1 and Cro2 cannot be differentiated in the apo-CatchER crys-
tal structure(190), Ca
2+
-CatchER, and the side chain of E222 in Ca
2+
-CatchER shows double 
conformer in a 1:1 occupancy, probably responsible for Cro1 and Cro2 populations.  
The non-exponential fluorescence of the indirectly excited R*O
-
 found in CatchER 
shown in Figure 5.4B has also been observed in a number of “super” photoacids (233, 234). The 
fast quenching component was interpreted as the non-adiabatic proton geminate quenching.  This 
mechanism proposed by Agmon and co-workers(235-238) expands the Scheme 5.1 into two re-
action steps. The photo induced protolytic dissociation of R*OH, with an intrinsic rate constant 
kd, leads to formation of the contact ion pair (CIP) R*O-…H
+
, whereas adiabatic recombination 
with rate constant k may re-form the excited acid. Additionally, back protonation may proceed 
also by a non-adiabatic pathway, involving proton quenching with a rate constant kq. Separation 
of a CIP from the contact radius to infinity is described by the transient numerical solution of the 
Debye-Smoluchowski equation (DSE). As in Scheme 5.1, all excited species decay to the ground 
state, but the decay rate k0” for the CIP is usually much slower than all chemical and diffusion 
processes and can be ignored. Therefore, our work is the first observation of the fluorescent pro-
tein with non-adiabatic proton geminate recombination.   
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Scheme 5.2.  Two-step diffusion-influenced ESPT kinetic scheme. 
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The ESPT dissociation rate kd as well as both k0 and k0’ were calcium-independent. The 
average fluorescence lifetime of directly excited anionic chromophore was consistent with the 
reported lifetime of EGFP (2.54 ns)(239) in an acceptable error range. However, the non-
adiabatic geminate recombination rate kq was inhibited by Ca
2+
. As a result, a larger population 
of R*O
-
 remained in the excited state, resulting in a higher ratio IR*O- /IR*OH, which was in 
agreement with the observation shown in Figure 5.8. Calcium binding also leads to the increase 
of the long-time asymptotic decay 0' when the anionic form R*O
-
 was indirectly excited. 
5.3.2 Structural effect in CatchER on the ground state spectra 
The unique optical properties of GFP has attracted extensive research interest for decades 
(193). In 1996, Chattoraj and co-workers first proposed there were different forms (the protonat-
ed neutral chromophore as A form, an intermediate I form and the deprotonated anionic chromo-
phore as B form) in GFP, which can convert to each other by proton migration(194). The ESPT 
occurs in the wt-GFP, allowing it to emit as an anionic form when the neutral chromophore is 
excited. In the same year, the crystal structures of wt-GFP and its S65T mutant, known as en-
hanced green fluorescent protein (EGFP), were published (195, 196). The spectral property has 
been altered due to the mutation S65T in EGFP, where the anionic chromophore with the absorp-
tion maximum wavelength at 395 nm dominates, while wt-GFP has a larger population of neutral 
chromophore at pH 7.0.  
It was proposed that E222 in EGFP was protonated to avoid the electrostatic clash with 
the anionic chromophore because the hydroxyl group of chromophore T65 side chain formed the 
H-bond with the main chain O of V61 as mentioned by Ormö (196). In addition, the pKa of the 
acidic amino acids buried inside the protein was found to be larger than those in solution(205). 
Therefore the carboxyl group of E222 is protonated to serve as the H-bond donor to the T65 side 
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chain. On the other hand, the phenolate moiety of the of the EGFP Cro is deprotonated, forming 
three H-bonds with T203 side chain hydroxyl, H148 ND1 and a water molecular, three of which 
function as the H-bond donors. In wt-GFP, the neutral chromophore tyrosyl forms three H-bonds, 
with T203, H148 and a water molecular as well. However, the chromophore tyrosyl serves as the 
H-bond donor to the water molecular here, shown in the crystal structure with the atomic resolu-
tion of 0.9 Å (PDB ID: 2WUR) (Figure 9)(240). 
With five mutations on the β-barrel surface of EGFP, the spectral property of CatchER is 
closer to wt-GFP than EGFP, where the protonated neutral chromophore is dominated at pH 7.0. 
As shown in Figure 5.9, the crystal structure of CatchER recently determined by us(190) demon-
strates that the side chain of T203 projects the opposite direction of the chromophore tyrosyl. 
Therefore, the H-bond between T203 and chromophore existing in both wt-GFP and EGFP is no 
longer in CatchER. In addition, the H-bond network with the cut-off of 3.5 Å was found in the 
E222 side chain carboxyl, Q69 side chain amide, T203 side chain hydroxyl and water molecules 
(WAT2, WAT3) as shown in Figure 5.9. The less H-bond donors around the chromophore of 
CatchER lead to the tyrosyl group being prone to be protonated, which is also observed in 
cpEGFP 149-144 (189, 241). 
The pH profile of apo and holo-CatchER suggested the pKa of holo-CatchER was a little 
lower than the apo form, implying the chromophore is more deprotonated upon calcium bind-
ing(66). This is in agreement with the optical spectra of CatchER in the absence and presence of 
calcium, showing the shift of the acid-base equilibrium. Since calcium binding does not alter the 
conformation of T203, perhaps such acid-base equilibrium shift originated from other residues in 
the chromophore H-bond network. It is observed that the distance between H148-ND1 and the 
tyrosyl of chromophore is 3.3 and 3.2 Å, a reasonable range for a H-bond formation in both apo 
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and holo forms of CatchER, respectively. Upon calcium binding, the electrostatic neutralization 
of one ligand E147 resulted in the redistribution of electron density through bonds by inductive 
effect, which in turn may increase the pKa of the H148 side chain. Thus, the protonated side 
chain of H148 can help to stabilize the deprotonated Cro tyrosyl.  This assumption was in 
agreement with the MD simulation results that the deprotonated H148-ND1 was the H-bond ac-
ceptor in the pair (Cro-tyrosyl)-(H148-ND1) in apo-CatchER, but not in the holo form. 
5.3.3 Effect of calcium binding site and calcium binding on excited state proton 
transfer in CatchER 
The photodynamics of GFP was studied closely with the chromophore structure and con-
formation. In 1997 and 2000, Palm and Remington reported the crystal structures of several mu-
tants and summarized the spectral relevance to the three forms, and also described the residues 
that affected the proton transfer and further altered the spectra including Y66, H148, T203, S205 
and E222(197, 198). The ultra-fast excited state dynamics was mapped out using the transient 
infrared spectroscopy (TIR) and Raman spectroscopy.  By these techniques, the vibration modes 
and the bond stretching were assigned, which formed a basis for the later study by those tech-
niques(201-204). The S205A and S205V mutants adopted an alternative proton wire substituting 
S205 with T203 and enabled the proton transfer(182, 183, 242), suggesting that the chromophore 
can be adaptive to the new environment. 
The ESPT pathway was revealed as the tyrosyl of the chromophore, the bridging water 
molecule, S205 and E222, where E222 was the final proton acceptor in ESPT(204). The excita-
tion at neutral Cro leads to the protolytic photo-dissociation which releases a proton. The proton 
randomly migrates through the GFP proton wires to either escape to the protein or recombine 
with the chromophore. In the wt-GFP the proton can exit the protein from the small hole near the 
 168 
 
Y66 phenol hydroxyl group by the rotation of T203, where the proton diffuses to the solvent 
(206). Agmon and co-workers extended the view of the proton conduction in the protein matrix 
along 1D proton wires and described the proton pathways including the proton exiting the beta-
barrel by rotation of T203 and the slow re-entry (µs) from the other side of GFP(205, 206). They 
later concluded that the 1D proton diffusion accompanied by the escape via T203 rotation was 
irreversible and changes the long-time asymptotic behavior of R*OH fluorescence from t-1/2 to 
t-3/2 (207). In their proposed proton transport pathway(205), T203 was switchable and enabled 
the proton to exit the protein matrix instead of protonation of E222. In this theory, T203 hydrox-
yl in the anionic B-state of GFP accepts the proton of Cro-OH and donates the H-bond to the 
main chain of H148, so called the "out state" of T203. The "out state" was observed in the Ca2+-
GCaMP2 (PDB ID: 3EVR) and EGFP (PDB ID: 4EUL)(241, 243), as well as in the wt-GFP 
crystal structure of higher resolution (PDB ID: 2WUR) where there was only one conformer of 
T203 observed. In the acid A-state of GFP, T203 adopts the "in" conformer, in which the side 
chain of T203 rotates 120° from the "out” state and T203-OH is not able to form the H-bond to 
Cro-OH. The wt-GFP (PDB ID: 1GFL) and circular permutated EGFP (PDB ID: 3EVP) show 
the conformation of T203 as the "in” state.  
As mentioned in section 5.3.1, only “in” state of T203 side chain was observed in both 
apo and Ca
2+
-CatchER crystal structures.  Based on the MD simulation, the water molecule 
WAT2 served as the H-bond donor for both T203 hydroxyl and indirectly for E222 via the other 
water molecules. The H-bond between Q69-WAT2-T203 can stabilize the side chain position 
and make the rotation less possible. Such the absence of the “threonine switch” proposed by 
Agmon (205) would prevent the proton from escaping the beta-barrel, and increase its probabil-
ity to recombine with the parent R*O
-
.  
 169 
 
The longer average lifetime of indirectly excited anionic chromophore (caused by retard-
ed proton geminate recombination) measured in the presence of calcium versus the apo-CatchER 
is proposed to arise from the different arrangement of the proton wire with and without calcium 
binding. In the 20 ns MD simulation, it was observed that the proton wire consisting of the 
chromophore tyrosyl, the bridging water (WAT1), S205 and E222, was disrupted by the intro-
duction of the negatively charged Ca
2+
 binding site, which was known to be pivotal for ESPT. 
Ca
2+
 binding rescued this proton transfer pathway. Such a disturbed proton wire (Cro-WAT1-
S205-E222) in apo-CatchER can explain the larger population of the geminate recombination 
phenomenon due to the lack of an efficient proton migration path.  
The broken proton migration pathway also explains the inverse H/D kinetic isotope effect. 
As mentioned earlier, the H/D KIE is probably not related to the inhibition of kd like in the wt-
GFP where the ESPT was five times slower in D2O (194). Instead, the slow diffusion of deuteri-
um makes it easier to reprotonate the protonated chromophore (both adiabatically and non-
adiabatically), especially in the situation where the deuterium has little chance to travel to the H-
bond acceptor, leading to the shorter average lifetime of indirectly excited R*O
-
. 
5.3.4  Calcium effect on proton-entry in CatchER 
Ca
2+
-CatchER and Gd
3+
-CatchER provide the view to understand the structure relevance. 
E222 is the key residue involved in the proton wires of the chromophore described by Agmon 
and Leiderman. In CatchER’s crystal structure, it has two conformations in all apo, calcium and 
gadolinium bound CatchER. The crystal structure only reflects the average static status, suggest-
ing the occupancies by E222 are possible. The angle between the two possible locations of the 
side chain of E222 is 9.4° and 11.4° (CB-CA, in apo and Ca
2+
 forms, respectively. The larger 
degree in swinging in the Ca
2+
-CatchER shortens the distance for the H-bonds between water 
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molecules and S72, so that those residues are tied up more closely. In the calcium titration exper-
iment observed by NMR, Q69 showed the slow chemical exchange in the presence of 6 mM cal-
cium, while the intermediate chemical exchange without calcium. Q69 is bonded to E222 
through S72 and two water molecules only when the side chain of E222 is in the proximate posi-
tion. As calcium bound, the length of the proton wire through E222 to E5 was shortened and the 
force was strengthened, facilitating the proton re-entry. 
5.4 Summary and conclusions 
In summary, binding of Ca
2+
 to CatchER results in the increase of the dominating green 
emission from this protein.  Such fluorescence increase is caused by the combination of thermo-
dynamic (change of the ground-state acid-base equilibrium) and the kinetic factors.  The latter is 
mostly based on the unusual dependence of the non-adiabatic proton geminate recombination on 
Ca
2+
 binding and H/D isotope exchange. Our results demonstrate that CatchER is the first exam-
ple of proton geminate recombination in fluorescent proteins. Such unusual utilization of this 
photoinduced process in metalloproteomics opens new horizons in this rapidly expanding area.   
Our finding here opens new strategy to tune the fluorescence properties of the metalloproteins by 
metal binding that alters the intraprotein photo-induced proton transfer. CatchER is also the first 
GECI of the single wavelength calcium detection that has the feature of calcium dependent life-
time change.  For the FRET pair based calcium indicator TN-XXL, the donor lifetime decrease 
was observed upon calcium binding. However, the small dynamic range of the donor lifetime 
change (10-20%) and the complexity of the multiexponential decay were not optimal for the 
FLIM (97, 224). Harvey and the co-workers showed that the lifetime decrease from 3.1 to 2.2 ns 
(by 30%) was able to be detected by FLIM (215).  Hence, such an increase (>40%) of the aver-
age lifetime (caused by the change of the amplitude ratio for two decaying components) of indi-
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rectly excitation of R*O
-
 enables CatchER to quantitatively monitor calcium dynamics by life-
time imaging in the future.   
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6 THE SPECIFIC TARGETING CATCHER TO THE CYTOSOLIC SIDE OF ENDO-
PLASMIC RETICULUM MEMBRANE 
6.1 Introduction 
The calcium homeostasis is required for the normal calcium signaling and maintained by 
calcium pumps, buffers and channels in sub-cellular compartments. For the electrically excitable 
cells, Ca
2+
 induced calcium release (CICR) from the SR/ER is closely related to the action poten-
tial in skeletal and cardiac myocytes, as well as neural cells. Many diseases have been found to 
be related with mutants of ryanodine receptor and SERCA which can cause the abnormal ER/SR 
calcium content, calcium leaking, or altered channel kinetics. The excitation contraction coupling 
in skeletal muscles relies on the coupling of activation of ryanodine receptor 1 (RyR1) and 
the dihydropyridine receptor (DHPR), leading to CICR from the SR. There are evidence showing 
that mutants of SR calcium transport ATPase (SERCA) and RyR account for the Malignant Hy-
perthermia (MH) and the Central Core Disease (CDD) (244-246). The activation of cardiac myo-
cytes requires the addition of ~100 µM Ca
2+
 in cytosol, from the calcium source SR(23). The 
cardiac ryanodine receptor (RyR2), IP3R and SERCA2a are three pivotal channels for the Ca
2+
 
mobilization from SR to cytosol during this agonist-induced process. Dysfunction of these pro-
teins has been proved to be the leading cause of heart failure with increasing evidence collected 
both from animals and humans (24, 25). The prolonged increase of the cytosolic Ca
2+
 level in 
cardiac myocytes will result in down regulation of Ca
2+
  signaling proteins in cardiac hypertro-
phy, leading to defects of muscle contraction and relaxation and ultimately heart failure(26). 
Alzheimer’s disease (AD) is the worldwide aged disease that is characterized as extensive synap-
tic and neuronal loss. Although the cause of AD still remains unclear, abnormal expression level 
of calcium signaling proteins has been found from animal models and postmortem brain samples. 
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The increased Ca
2+
 level in neuron cells due to the extensive release of calcium ion from ER 
triggers a series of signaling process and affect the synaptic stability and neuronal health (27).  
To understand the calcium signaling, calcium indicators have been widely used. The tool 
kit of organic calcium dyes almost covers the requirement for the calcium binding affinity from 
hundreds of nano-molar to sub-millimolar and the color palette has extended to the spectrum 
from blue to far-red. One feature limiting the application of calcium dyes is the lack of specific 
targeting. The genetically encoded calcium indicators (GECIs) were developed to fulfill the gap. 
Even though, most of them are still expressed without the targeting sequence and located in the 
cytoplasm, where the calcium transient is the overall outcome of both inward and outward flux. 
It is an important step forward to illustrate the calcium signal required for the downstream pro-
cess. However, it will be powerful if one can  deconvolute the total calcium change, because the 
upstream calcium pumps and channels are the determinants. Targeting the probe is not only to a 
sub-cellular domain like ER/SR and mitochondria, but also the membrane in proximity to calci-
um channels.  
On one hand, the heterogeneity of calcium channel distribution on SR membrane was 
found in skeletal muscle by Ma and Blatter and co-workers in 1995 and 1996 (247, 248). The 
uneven structural distribution causes functional heterogeneity as well. Thus, it is more elaborated 
to investigate the spatio-temporal calcium release through RyR channels to illustrate the calcium 
signaling and kinetics. On the other hand, the kinetics of calcium release is mainly governed by 
the activation of RyR.  It is believed that the kinetics of CICR is related to the coupling of DHPR 
and RYR1 for the skeletal muscle and the resulted EC coupling rate is affected, which was ob-
served in the slow-twitch and fast-twitch muscle (155). The calcium has both activation and in-
activation effect on RyR. The calcium dependent channel activity exhibits a bell shape as func-
 174 
 
tion of calcium concentration. In the low calcium concentration around 10-100 nM, RyR1 is ac-
tivated but closed when its concentration reached 100 μM (155). The calcium stimulation speed 
and the resting calcium level would affect the CICR rate due to the competition between the ac-
tivation and inactivation sites. The altered CICR rate will in turn affect the downstream actions. 
The DHPR and RyR1 coupling is a key factor for the EC coupling. The cleft between the 
T-tubule and SR membrane is narrow and the fast calcium accumulation during CICR in a short 
time around milli-second results in a locally high calcium concentration, which is considered to 
account for the following activation of troponin and RyR1 deactivation. The calcium concentra-
tion change in such space attracts interest. Here we explored the targeting sequence from the 
segments of the transmembrane domains of RyR1, and used FKBP12-CatchER chimera protein 
to anchor CatchER to the ER membrane and allow CatchER to face cytoplasm, in order to inves-
tigate the amplitude and kinetics of calcium release from the SR during CICR.  
6.2 Results 
6.2.1 Molecular cloning 
To obtain the clone of CatchER-FKBP fusion protein, the FKBP12 was fused to the C-
terminal of CatchER without any targeting sequence in pcDNA3.1(+). A linker of Gly-Gly-Ser-
Gly-Gly, along with the restriction enzyme ClaI site was inserted between CatchER and FKBP12. 
The rabbit ryanodine receptor 1 (GenBank: X15209) transmembrane domain M5 and M10, 
based on Zorato’s RyR1 topology model (249), were applied as the ER membrane anchoring se-
quence. Taylor and co-workers reported that the extended Z5 (4551-4597) only can anchor GFP 
to the ER membrane (250). Z10 (4907-4943) is composed of 37 amino acids, which is the last 
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transmembrane (TM) domain in Taylor’s models and also covers the last TM domain in Zorato’s 
model. 
The extended Z5 and Z10 was fused to the C terminal, or N terminal of CatchER with 
neither calreticulin targeting sequence nor ER retention sequence (Lys-Asp-Glu-Leu), to allow 
the protein to face to the cytosol, respectively. The consensus translation initiation Kozak se-
quence (gccaccATGG) was placed between the Z10 sequence followed by a proline and Catch-
ER.  A linker composed of four amino acids Ser-Leu-Pro-Ala was inserted between CatchER 
and extended Z5 (eZ5, equivalent to TMD1 in Taylor's model) to separate the transmembrane 
region from the calcium sensor. The hot start KOD DNA polymerase kit was used for the PCR 
reaction.  The ligation was carried out using T4 DNA ligase (New England Biolabs) at 4°C for 
48 h.   
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Figure 6.1. Construct of ER-anchoring CatchER.  
(A) The Zozrato’s RyR1 topology model. The M5 and M10 are the selected anchoring sequences. (B) The 
chimera of Z10-CatchER-Z5.   
 
6.2.2 Differentiation of C2C12 myoblast 
C2C12 myoblasts were induced to differentiate by changing 2% FBS DMEM. Cells were 
observed under ZEISS microscopy and the pictures were shown in Figure 6.2. In 24 h after 
changing medium, the tubule-like cells were observed and most of them aligned in some order. 
In 48 h, many cells were merged and the multiple nucleuses can be seen in one cell. In 96 h, the 
myotubules were observed. In 144 h, the myotubules were self-arranged in parallel. The differen-
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tiated C2C12 myotubules will be used in the future study for specific targeting CatchER to the 
ER/SR membrane. 
 
 
Figure 6.2. Induced differentiation of C2C12 myoblasts.  
The differentiation medium was applied when the cell confluency was around 70%, and fresh medium 
was applied every other day. The images were taken by ZEISS microscope.   
 
6.2.3 The fluorescent immunostaining  
All ER membrane targeted constructs, including CatZ5, CateZ5, CatLeZ5, and Z10Cat 
were tested by fluorescence immunostaining for the cellular distribution C2C12 myoblasts. The 
confluency of C2C12 cells were maintained at approximately 30-40% to avoid the differentiation. 
The 0.5 mm thick cover slip was used for seeding cells and 1.5 μg plasmid DNA were transfect-
ed and cells were cultured at 30 ºC for 48 h before imaging. Cells were fixed to the cover slip 
with 3.7% formaldehyde. Triton X-100 and digitonin were used for permeablizing membranes 
for different purposes. Digitonin is able to form complex with sterol like cholesterol which is one 
component of the cell membrane, but not in the ER membrane, and thus disrupt the packing of 
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the lipid bi-layer. Triton X-100 is a kind of detergent which can solubilize all membrane. The 
cover slip was blocked by PBS containing 5% BSA and the primary antibody (anti-GFP or anti-
Calnexin) was added. The secondary antibody conjugated with Alexa Fluor dyes were applied 
for imaging using the confocal microscopy ZEISS LSM 700. To note, the resolution of confocal 
imaging is around 50-100 nm, not able to distinguish whether the protein is anchored in the ER 
membrane or free in the ER lumen. 
CatchER with calreticulin targeting sequence and the ER retention signal peptide KDEL 
was expressed in the ER with a fine reticular network distribution and co-localized with calnexin 
as shown in Figure 6.3A. Particularly, CatchER was located in the ER lumen because the anti-
GFP antibody can only reach the cytosol protein with only digitonin treatment. In compared to 
CatchER, anti-Calnexin antibody reacted with calnexin when only cell membrane was permea-
bilized. It is in agreement with the expectation because the epitope of the anti-Calnexin antibody 
recognizes the C-terminal of calnexin, which is in the cytosolic side of the ER membrane. With 
treatment of digitonin without pre-fixation, the self-fluorescence of Z10Cat expressed C2C12 
myoblasts showed the reticular architecture (Figure 6.3B), which was colocalized with calnexin 
as well, indicating CatchER was associated with the ER membrane and CatchER was located in 
the cytosol. The fluorescence of CatZ5, CateZ5 and CatLeZ5 was not as bright as CatchER (Ta-
ble 6.1). Therefore, anti-GFP antibody was applied for visualizing the distribution of targeted 
CatchER. Similarly with Z10Cat, the ER reticular network was observed for these three targeted 
sequences (Figure 6.4), suggesting the membrane association and the location in the cytosolic 
side. However, the result of confocal imaging can not rule out the possibility that there is Z10Cat 
remaining in the ER lumen.  
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Figure 6.3. The confocal images of targeted CatchER in non-differentiated C2C12 myoblasts.  
(A) ER-lumen targeting with calreticulin targeting sequence and ER retention peptide, (B) Z10Cat. (Left) 
Green: fluorescence from CatchER self-fluorescence; Red: Alexa Fluor 555 anti-GFP antibody; (Right) 
Green: fluorescence from CatchER self-fluorescence; Red: Alexa Fluor 555 anti-calnexin antibody. Be-
fore fixed with formaldehyde, digitonin at the final concentration of 25 μM was added to PBS and incuba-
tion for 3 min to permeabilize plasma membrane. After fixing, incubation with 0.2% Triton X-100 in for 
5 min PBS was carried out to disrupt all cell membranes. 
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Figure 6.4. The confocal images of targeted CatchER in non-differentiated C2C12 myoblasts.  
Both anti-GFP and anti-Calnexin antibodies were used together. The secondary antibody conjugated with 
Alexa Fluor488 was used for GFP and Alexa Fluor597 for calnexin. Before fixed with formaldehyde, dig-
itonin at the final concentration of 25 μM was added to PBS and incubation for 3 min to permeabilize 
plasma membrane. After fixing, incubation with 0.2% Triton X-100 in for 5 min PBS was carried out to 
disrupt all cell membranes. 
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6.2.4 Cell imaging 
Cell imaging studies were carried out to evaluate the CatchER fused with FKBP and the 
ER anchoring sequences. The 1.5-2.0 μg plasmid DNA encoding the targeted CatchER was 
transfected to non-differentiated C2C12 myoblasts at the confluency around 30% and cells were 
cultured at 30 ºC for 36-48 h. To express CatchER in the induced differentiated C2C12 cells, 
DMEM was substituted with the differentiation medium containing 2% FBS when the cell con-
fluency reached 70%. The 2 μg plasmid DNA was transfected in 72 h after changing medium. 
Cells were cultured at 30 ºC for 1 week before imaging.  
Figure 6.5A illustrates the calcium concentration change induced by RyR1 agonist 4-cmc 
(100 μM), ATP (100 μM), SERCA pump inhibitor thapsigargin (1 μM), ionomycin (10 μM) and 
digitonin (25 μg/ml), which was monitored by CatFKBP in C2C12 myoblasts. In the myoblasts, 
by applying 4-cmc, it took around 75 sec to reach the maximum decrease of 25% of the initial 
fluorescence intensity. It was followed by the full recovery for approximately 2 min. Similar re-
sult can be observed in caffeine addition. Ionomycin caused the fluorescence decrease by 20%, 
although thapsigargin triggered fluorescence change was negligible. Digitonin permebilized cell 
membrane and fluorescence immediately dropped by around 90%. Before any drug treatment, 
the fluorescence was observed for the whole cell, indicating the distribution of CatFKBP was 
mainly in cytosol. Overexpression of CatFKBP may result in the excess FKBP domain in the cy-
toplasma, so that the typical reticular network was not observed. After permeabilized by digiton-
in, only 10% fluorescence remained while the cells were still observed in the bright field image, 
suggesting the fluorescent CatchER leaked out of cells. Therefore, the possibility opens that the 
endogeneous FKBP dominantly occupied the RyR1 FKBP binding site and CatFKBP was in free 
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form in cytosol. Thus, the fluorescence decreased triggered by 4-cmc and ionomycin was caused 
by the CatFKBP remaining in ER lumen.  
After differentiation began, the distribution of C2C12 cells in the petri dish was rear-
ranged and cells grew in parallel generally and the cells appeared long and thin (Figure 6.5B). In 
addition, the DNA transfection efficiency in the differentiated C2C12 cells was low.  As a result, 
only a single cell in the observation field was record.  The fluorescence intensity was not as 
bright as CatchER expressed in C2C12 myoblasts. Two regions of interest (ROIs) were selected 
from the same cell. The whole cell was bright and there was not reticular-like pattern observed. 
However, the color contrast formed between the nucleus and cell plasma can be distinguished, 
and the nucleus region looked darker. After digitonin permeabilization, the fluorescence main-
tained in the perinuclear region, while only auto-fluorescence was seen in other regions, imply-
ing that the majority of CatFKBP was free in cytosol and a portion was able to bind RyR1. Ap-
plying caffeine caused fluorescence intensity drop by around 7%. Without extracellular calcium, 
it did not recover after 4-cmc triggered fluorescence decrease. After being permeabilized, inten-
sity decreased slightly by adding 4-cmc. All the drug treatment indicated there was CatchER ex-
pressed in ER lumen. 
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Figure 6.5. CatFKBP responding to drugs in (A) non-differentiated and (B) induced differentiated C2C12 
cells.  
The ΔF/F0 time course was averaged from N cells/ROIs, and the experimental event markers were 
labeled. The fluorescence and bright filed images at the beginning and the end of the time course were 
shown in the bottom panel.  
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Figure 6.6A shows the time course of fluorescence of CatZ5 in response to different rea-
gents including 4-cmc, caffeine, ionomycin, ATP and digitonin. By applying 100 µM 4-cmc, 
fluorescence intensity decrease by 20% and the time to peak was 90 sec. In the presence of 1.8 
mM extracellular Ca
2+
, CatZ5 intensity recovered to the beginning level in around 2 min after it 
reached the minimum value. Without the extracellular calcium, the fluorescence also can recover 
back to the initial state (data not shown). Regarding the response of ATP treatment, some cells 
appeared more sensitive than the other and there was a slight increase observed in the average 
fluorescence, but the change was not significant. These phenomenon indicate that the response of 
CatZ5 was the same as CatchER, implying the location of CatZ5 was in ER lumen. However, the 
evidence was also observed that there was a portion of CatZ5 located in cytosol. First, the 
thapsigargin caused the fluorescence increase by 5%; second, the fluorescence increased by 7% 
and 10% when ionomycin was perfused in the presence of 0 and 5 mM Ca
2+
, respectively. CatZ5 
intensity remained 60% as its initial level after cells were permeabilized by digitonin. Applying 
intracellular calibration solution containing 10 mM Ca
2+
 triggered the fluorescence increase by 
20%. The fluorescence images showed the cell  was bright other than the nucleus region before 
any treatment applied to cells, but there was not typical reticular network observed. At the end of 
the data collection, fluorescence was dimmer than that of the initial but the pattern did not 
change. 
For differentiated C2C12 cells, several nucleus can be found in the long tubule-like cell 
(Figure 6.6B). The basal fluorescence intensity was very low. A  perinuclear pattern of fluores-
cence was observed. Three ROIs were selected in the single cell for the calcium imaging. Both 
caffeine and 4-cmc caused intensity drop a bit, around 3% and 5% respectively, in the absence of 
extracellular calcium, and then recovered back. The time-to-peak for the 4-cmc induced fluores-
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cence decrease was 110 sec, longer than that in non-differentiated C2C12 myoblast. After per-
meabilized, intensity dropped by around 40%, indicating approximately half of CatZ5 was either 
free in cytosol or not anchored to the membrane. The remaining CatZ5 responded to the switch 
of low and high calcium solution. 
There was not enough evidence showing the Z5 could anchor CatchER to ER membrane. 
The RyR1 activator induced CatZ5 response indicated the CatZ5 was in ER lumen, while the 
phenomenon that the intensity increased after adding ionomycin and thapsigargin suggested 
CatZ5 was in cytosol side. The amplitude of fluorescence increase induced by thapsigargin and 
ionomycin was small because cytosolic Ca
2+
 concentration is much smaller than CatchER's Kd, 
and the luminal sensor would cancel out the increase outside ER. The free cytosolic CatZ5 con-
tributed to the fluorescence increase triggered by ionomycin and thapsigargin, but it can not rule 
out the possibility that there was CatchER anchored in the ER membrane. Thus, the data implied 
three possibilities of CatZ5 location in C2C12 myoblast, ER lumen, ER membrane and free in 
cytosol. In the differentiated cells, the amplitude of fluorescence decrease was much less (20% 
and 5%) when adding RyR1 activator, and the cell membrane permeabilization caused fluores-
cence loss was similar as non-differentiated C2C12 cells, implying that there was less CatZ5 in 
ER lumen, because more signal from the cytosolic side can contribute to cancel out the fluores-
cence decrease of luminal CatZ5.  
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Figure 6.6. The calcium imaging of CatZ5 transfected to (A) C2C12 myoblasts and (B) differentiated 
C2C12 cells. 
Caffeine, 4-cmc and digitonine were applied and the time points of reagents addition were labeled. The 
inset of panel B shows the 4-cmc induced fluorescence change in another cell other than the one treated 
with caffeine. The fluorescence and bright field images were taken in the beginning and the end of the 
imaging record. 
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To enhance membrane anchoring, the extended Z5 (eZ5) was fused to C-terminal of 
CatchER. Figure 6.7A illustrates the fluorescence change induced by 4-cmc, caffeine, digitonin 
and solution with high calcium.  Similarly with CatZ5, the perinuclear pattern of fluorescence 
was observed (Figure 6.7A, initial fluorescence snapshot), although the basal fluorescence was 
dim and the photo-bleaching can not be ignored. The treatment with 4-cmc and caffeine induced 
fluorescence change was negligible, indicating there was less CatchER domain inside the ER 
lumen than CatZ5 transfected C2C12 myoblast. After being permeabilized with digitonin, the 
fluorescence intensity did not change significantly, suggesting no free CateZ5 existing in cytosol. 
Applying high calcium can triggered increase of fluorescence by approximately 10%, which was 
reversible if the solution was replaced with the one containing no calcium.  
Figure 6.7B shows the fluorescence time course of the differentiated C2C12 cells treated 
with 4-cmc, caffeine and digitonin. The fluorescence intensity decreased by 5% was induced by 
10 mM caffeine, which was not recovered after caffeine was washed away with Ringer's buffer. 
No fluorescence change was observed by adding 4-cmc. After permeabilization, the fluorescence 
intensity dropped by 60%. Perfusing intracellular solution containing 10 mM Ca
2+
 triggered the 
slight increase of fluorescence. The images taken before and after the experiment showed the 
ER-like pattern. The image collected right after applying digitonin showed a similar pattern but 
the intensity was dimmer than the initial one. Although the autofluorescence can be seen due to 
the long exposure time (0.2 sec), the fluorescence from GFP domain was still can be distin-
guished.  
Before differentiation, eZ5 fragment can target CatchER to intracellular membranes, be-
cause the green fluorescence showed a perinuclear pattern, and the fluorescence intensity did not 
change by digitonin addition. There was not luminal CatchER because the fluorescence intensity 
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was not changed by 4-cmc and caffeine. After differentiation began, CateZ5 leaked out of the 
cells when cell membrane was leaky, suggesting the membrane anchoring was not tight.  
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Figure 6.7. The calcium imaging of CateZ5 transfected (A) C2C12 myoblasts and (B) differentiated 
C2C12 cells.  
The confluence was around 30% when imaging.  Caffeine, 4-cmc and digitonin were applied and the time 
points were labeled. The fluorescence and bright field images were taken in the beginning, when just 
permeabilized by digitonin and the end of the experiment. 
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Due to the limitation of the brightness of CateZ5, it is complicated to subtract the photo-
bleaching and autofluorescence from the total observed fluorescence. To enhance fluorescence, a 
linker composed of four amino acids Ser-Leu-Pro-Ala was inserted between CatchER and the 
eZ5 fragment (251). Under the microscope, cells appeared brighter than CateZ5, the one without 
the linker, and the fluorescence pattern was similar with CatchER, CatZ5 and CateZ5. As shown 
in Figure 6.8A, treatment of 50 μM 4-cmc had no effect on the fluorescence, while the higher 
dose of 100 μM made the intensity decreased by 7%, with the time-to-peak of 70 sec. The fluo-
rescence recovered to the resting level by itself. Applying caffeine caused the decrease of fluo-
rescence as well and the amplitude of decrease was 5%. Both RyR1 activators induced CatLeZ5 
response suggested the prescience of the luminal CatchER domain.  After permeablized, fluores-
cence remained around 50% as its initial level, indicating the approximately half of CatLeZ5 was 
free in cytosol and washed away. Adding 4-cmc induced a slight but not significant fluorescence 
increase, which was contributed by the cytosol-facing CatchER overcoming the opposite signal 
from ER lumen or background noise. When the CatchER faces cytosolic side, the average in-
crease of calcium did not fall in the sensitive region of CatchER. As a result, the fluorescence 
change was small, which was consistent with our expectation. Applying 10 mM Ca
2+
 solution 
resulted in the increase of intensity by 10%. After differentiation began, the fluorescence pattern 
was not changed (Figure 6.8B). Similarly with the non-differentiated cells, 4-cmc caused the de-
crease of fluorescence by 10%. The time-to-peak was 40 sec. The loss of fluorescence induced 
by digitonin was around 10%, less than that in non-differentiated cells. The fluorescence was in-
creased in response to high calcium solution with an amplitude of 20%.  
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Figure 6.8. The calcium imaging of CatLeZ5 transfected non-differentiated C2C12 myotubules.  
The confluence was around 30% when imaging.  Caffeine and digitonine were applied and depicted.  The 
fluorescence and bright field images were taken in the beginning and the end of the experiment. 
 
Although the brightness was enhanced by inserting the linker, the presence of free cyto-
solic and the luminal CatLeZ5 still remained problems. Another transmembrane domain of RyR1 
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Z10, the last one in Zorato’s model was fused to N-terminal of CatchER as described in 6.2.1. 
The resulting construct Z10Cat was brighter than CatLeZ5, and the brightness under microscope 
was comparable with CatchER. The perinuclear ER-like pattern was observed. From the calcium 
imaging, as shown in Figure 6.9, CatchER domain in ER lumen responded to caffeine and 4-cmc 
induced calcium release. Fluorescence decreased by adding ionomycin as well. The decrease of 
fluorescence was 5% for caffeine, and 10% and 4% for 200 and 100 μM 4-cmc respectively. Af-
ter permeabilized by digitonin, the fluorescence decreased by approximately 10%, indicating the 
loss of Z10Cat. Perfusion with solution with 10 mM Ca
2+
 resulted in the fluorescence increase by 
10%.  
Surprisingly, after permeabilized by digitonin, the fluorescence was sensitive to the 
switch of Ringer's buffer and the intracellular solution. The amplitude of fluorescence increase in 
the presence in high Na
+
 Ringer's buffer was 40-50%. The major difference between the two so-
lutions is the Na
+
/K
+
 ratio. The pH difference between them was 0.2, following Hofer’s protocol, 
which can cause 5-10% fluorescence intensity difference for purified CatchER. However, in 
physiological condition, it is less possible to involve so much sodium in cytosol, so this effect 
may not be concerned in the following discussion.  
For differentiated C2C12 cells, as shown in Figure 6.8B,  Z10Ca responded like ER lu-
minal CatchER, where 4-cmc and caffeine induced fluorescence decrease by 6% (2 min), and 10% 
(40 mM) and 4% (10 mM). There was around 30% fluorescence decrease after digitonin treat-
ment, more than that observed in non-differentiated C2C12 cells. The dynamic range of 10% was 
seen in response to 10 mM Ca
2+
.  
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Figure 6.9. The calcium imaging of Z10Cat transfected to (A) C2C12 myoblasts and (B) differentiated 
C2C12 cells.  
Caffeine, 4-cmc, ionomycin and digitonin were applied and the time points were labeled. The fluores-
cence and bright field images were taken in the beginning and the end of the experiment. The inset shows 
the time course of fluorescence in panel A was data collected from the other cell.  
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6.3 Discussion 
During the differentiation, multiple nucleus are present in a single cell, ER develops to be 
SR, the SR/plasma membrane junction forms, the expression level of RyR1 and SERCA in-
creased dramatically while IP3R expression was declined (252), RyR1 re-localizes and accumu-
lates at the terminal cisternae, and the expression of Orai1 also emerges (253). Almost all tagged 
CatchER behaved differently in non-differentiated and differentiated C2C12 cells, suggesting 
both the calcium signaling and the structural arrangement of organelles vary during muscle de-
velopment. The challenge of ER/SR targeting comes out that it is complicated to find a targeting 
sequence which is able to fix the calcium probe to ER membrane through the differentiation pro-
cess.   
Table 6.1 lists the amplitude and the time-to-peak of 4-cmc induced calcium release de-
tected by CatchER with different targeting fragments in C2C12 myoblast and differentiated cells, 
as well as the loss of CatchER fluorescence after digitonin permeabilization. The performance of 
the same protein in different states during differentiation of C2C12 varies, which can not be pre-
dicted currently. The main goal of this study is to select the sequence allowing to target CatchER 
to SR membrane to investigate the calcium dynamics in the plasma/SR membrane junction. As a 
result, evaluation of the performance in the differentiated cells would be more meaningful in this 
case. It is notable that using the current microscope setting is not able to capture such fast calci-
um transients happening in the cisternae cleft. It was not expected to see the fluorescence in-
crease by activating RyR1 with a frame rate of 1 shot/15 sec. The parameters evaluated in the 
present experimental conditions are the brightness and the capability of ER/SR membrane an-
choring.  
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Binding FKBP to RyR1 (254) is the pre requisite for CatFKBP targeting to the ER. Thus, 
it was not surprised that CatFKBP was fail to form a reticular network in C2C12 myoblasts lack-
ing the RyR1 expression and it could form the prinuclear pattern after permeabilization of plas-
ma membrane in differentiated myotubule (Figure 6.5B). The calcium imaging for CatFKBP 
demonstrated that this construct could be used in differentiated C2C12 cells after the plasma 
membrane was permeabilized. However, the endogenous FKBP occupies the RyR1 so that the 
binding of CatFKBP decreases. As a result, the cell line stably expressing CatFKBP and with 
knocked down FKBP would be favored in the future study. From the case of CatFKBP, it is no-
table that overexpression of any endogenous protein would cause interference of normal signal-
ing pathways.  
To avoid that, only transmembrane domains with no channel activity were considered in 
this study. To minimize the interaction between CatchER and the targeting domain, the peptide 
length was limited as short as possible. Hence, a single transmembrane domain was first taken 
into account. The 23 amino acid-long Z5 failed to target the fusion protein to the membrane in 
either C2C12 myoblasts or the differentiated C2C12 cells. Compared to Z5, the longer sequence 
eZ5 appeared a much better ER targeting in the C2C12 myoblast. The result is in agreement with 
the previous report indicating the eZ5 sequence alone is sufficient for ER targeting of RyR1 in 
COS cells (250). However, the eZ5 of 47 amino acids was not successful in the differentiated 
one either. Besides that, the fusion with the transmembrane domains also traded in the brightness. 
Among the current four RyR1 transmembrane fragment fused CatchER, CatLeZ5 was more 
promising because it takes the advantage of good targeting in the differentiated C2C12 cells and 
relatively good brightness.  
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The comparison of all constructs with CatchER was shown in Table 6.1. The brightness 
was normalized to Z10Cat (100%). At the same experimental condition, the intensity of CatchER 
was out of the detection range and appeared saturated so the quantitative comparison between 
ER membrane tagged-CatchER with ER-lumen tagged CatchER was not available.  
Table 6.1 Data summary of CatchER with different tags in calcium imaging 
Tagged 
Catch-
ER 
C2C12 myoblast Differentiated C2C12 cells 
4-cmc % | 
 Time-to 
peak(sec) 
koff  
(s-1) 
Digiton-
in 
 % 
Bright-
ness  
% 
4-cmc % | 
Time-to-peak 
(sec) 
koff  
(s-1) 
Digiton-
in  
% 
Bright-
ness  
% 
Catch-
ER 
30   | 60 0.022 10 Saturateda NA  | NA NA NA NA 
Cat-cyt 10   | 60 0.034 100 Saturateda NA  | NA NA NA NA 
Cat-
FKBP 
25   | 75 0.050 90 >150 b 8      | 15 0.024 50 40 
CatZ5 20   | 90 0.034 40 39 5      | 110 0.014 40 44 
CateZ5 0     | 0 NA 0 20 0      | 0 NA 60 53 
Cat-
LeZ5 
7     | 70 0.024 50 55 10    | 40 0.032 10 95 
Z10Cat 4     | 80 0.035 10 100 6      | 120 0.044 30 112 
 a The intensity reached the maximum of the detection range at the same setting as the tagged CatchER. 
 
b 
The exposure time for CatFKBP was shorter than the other tagged CatchER, 0.13 sec and 0.20 sec, respec-
tively.  
 
The plasma membrane of cells used for immunostaining was permeablized before fixa-
tion with formaldehyde. The free tagged CatchER was washed away and only the ER membrane 
targeted CatchER or luminal CatchER will be detected. The fine reticular network was observed 
for all RyR1 fragments fused CatchER by the confocal microscope. Figure 6.2 showed the com-
parison of CatchER with and without triton X-100 treatment, suggesting that the antibody was 
not able to access the ER with digitonin only. It showed conclusively that fusion with the single 
or combination of RyR1 transmembrane domains can maintain proteins in the ER membrane and 
localize them in the cytosolic side. However, the colocalization analysis for the calnexin and 
CatchER with and without these targeting sequences showed no difference, with a Person's coef-
ficient around 0.8, indicating that confocal imaging is not able to distinguish whether the protein 
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is in the lumen or in the other side. In order to do so, the Western-blot could be applied to the 
trypsin digested extracted ER fraction according to the protocol established by MacLennan’s 
group (255). 
The presence of luminal CatchER was confirmed by the calcium imaging experiments, 
based on the fact that the RyR1 activators (4-cmc and caffeine) that induced calcium release 
from ER resulted in the fluorescence decrease (Table 6.1). In the Cat-cyt transfected C2C12 cells, 
the CatchER without any tag, there was also a 10% fluorescence decrease caused by 4-cmc addi-
tion, implying that the incompletely matured protein in the ER may sense the calcium concentra-
tion change there. Therefore, we propose that detection of the calcium release from ER/SR was 
attributed to the luminal CatchER that not been transported to the final location as the most likely 
explanation. Utilization of the stable cell line may solve the problem.  
The brightness was sacrificed when any sequence was fused. CatZ5 and CateZ5 suffer 
the problem of low basal intensity, which was estimated only 10% of CatchER. With a low start-
ing intensity, the It is promising to use the linker to improve the brightness. Compared with 
CateZ10 and Z10Cat, the Kozak consensus sequence did help for expression and it will be added 
to other constructs.  
6.4 Summary and conclusions 
To measure the spatial-temporal calcium change in the cleft between the SR cisternae and 
transverse tubule in the skeletal muscle, a series of targeting sequences was designed to anchor 
the calcium indicator to SR membrane. To avoid the interference of over-expressed intrinsic SR 
membrane proteins, fragments of RyR1 membrane domains were selected to be candidates. In 
this chapter, four RyR1 transmembrane fragments plus FKBP were fused to CatchER. The cellu-
lar protein localization was observed by immuno-fluorescence staining and the result showed 
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CatchER was successfully anchored in the ER membrane in C2C12 cells. The performance of 
calcium sensing evaluated by calcium imaging suggested CatchER was present in both ER lu-
men and cytosol. This work will be continued by screening more ER transmembrane domains as 
well as the fragments of DHPR which locates in the plasma membrane of skeletal muscle and 
physically couples RyR1.  
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7 THE DYNAMIC STUDY OF THE COMPLEX OF CALMODULIN AND PEPTIDES 
7.1 Introduction 
Calmodulin (CaM) is a ubiquitous calcium binding protein that serves as a signal trans-
ducer to regulate a variety of intracellular calcium-dependent signaling. Calcium binding induced 
large global change of CaM enables it to bind a diversity of target proteins such as kinase and ion 
channels for the downstream activities (256). The activation of those target proteins by CaM 
binding is determined by the mode of CaM-target interaction, which is also affected by the calci-
um concentration change in cytoplasm (257). CaM has four calcium binding EF-hand motifs, 
two in each terminal lobe. The calcium binding affinity is not equivalent for the four binding 
sites (258, 259). In addition, association with the target peptide could change the calcium binding 
affinity (260).  
CaM adopts different conformations to interact with its target proteins of which the inter-
face usually forms a helical structure. The hydrophobic interaction is the major driving force for 
association between CaM and the peptide. According to the arrangement of two lobes of CaM, 
the CaM conformation was classified as collapsed, full extended, and dimerized, although it was 
reported some peptide binding only half of CaM (PDB ID: 1CFF) (261). Based on the positions 
of the hydrophobic residues in the peptide, the CaM binding mode was simply classified as 1-10, 
1-14, 1-16 and IQ-motif by Yap (123) (Figure 7.1). The CaM binding mode forms the structural 
basis for the functional regulation and helps to understand the unknown CaM regulation mecha-
nism.  
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Figure 7.1. The binding modes of CaM and peptide complex. 
The red color indicates the peptide. The figure was provided by Dr. Hing Wong.  
 
The classic 1-10 and 1-14 modes is featured as the antiparallel orientation of CaM and 
the peptide, where the N terminal of CaM associates with the 10th or 14th residue of the peptide 
and the CaM C-terminal is in contact with the first one of the peptide by the hydrophobic interac-
tion. The antiparallel contact was determined by the electrostatic interaction because the C-
terminal of CaM was more acidic than N-terminal (262). For example, the Ca
2+
/Calmodulin de-
pendent kinase I (CaMKI) and CaM follows the 1-14 binding mode in which the basic N-
terminal of CaMKI is associated with the acidic C-terminal of CaM.  
The IQ motif has the pattern (FILV)Qxxx(RK)Gxxx(RK)xx(FILVWY), forming α helix 
(123), which can form complex with either apo or holo CaM. The conerved glutamine associates 
with CaM with hydrogen bond and the hydrophobic residues in the N and C terminal of IQ motif 
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contact with both N and C terminus of CaM in either parallel or antiparallel orientation, respec-
tively. The conserved basic residues electrostatically interact with the acidic residues of CaM. 
The conformation of CaM was usually extended when it binds the IQ motif; however, the con-
formational change of the IQ motif could occur after CaM is occupied by calcium ions (263).  
The different orientations of the terminal lobes of CaM and the relative angle enables the 
NMR residual dipolar coupling (RDC) a good approach to understand how CaM accommodates 
the target peptide since RDC data provides the long-range structural constrains which makes the 
calculation and refinement of structure convenient based on the model structure.  
7.2 Results and discussion 
7.2.1 The binding mode of CaM and N-terminal intracellular loop of connexin 43 
Gap junction plays role in cell communication, and is important for cell growth, differen-
tiation and development (264). The function of gap junction is regulated by pH, membrane volt-
age and Ca
2+
/CaM. Gap junction is composed with 12 closely packed unit called connexin. Each 
connexin has four transmembrane domains. Six connexin units form a connexon and two con-
nexons in two adjacent cells dock together, forming a gap junction channel.  Connexin 43 (Cx43) 
is a gap junction protein, belonging to the alpha family, mainly expressing in heart and fe-
tal cochlea (265). Lurtz and co-workers reported that CaM and Ca
2+
 regulated the gap junction 
channel (266). However, there is no structural evidence showing the interaction between CaM 
and Cx43. By using the calmodulin target database (http://calcium.uhnres.utoronto.ca/ctdb/ctdb/) 
(IFVSVPTLLYLAHVFYVMRKEEKLN), four predicted CaM binding sites were obtain (Figure 
7.2), where there are two in both N and C-terminal loop and the other two are in the intracellular 
loop. 
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Figure 7.2. The cartoon of connexin 43 topology and predicted CaM binding sites. 
The four CaM binding sties are indicated with rectangular frames. The sequences of sites 2-4 were shown 
and compared with other CaM targets. The figure was provided by Dr. Yanyi Chen. 
 
To understand the binding mode of the complex between CaM and the N-terminal intra-
cellular loop of connexin 43 (Cx43np), the NMR residual dipolar coupling (RDC) approach was 
applied. The assignment of the CaM-Cx43np complex was achieved by monitoring the change in 
chemical shift during Cx43np peptide titration (Figure 7.3). The anisotropic component was ob-
tained by adding the phage and no change in the NMR spectra were observed. The assignment 
was done for 90/148 residues. The RDC fitting was carried out for 12 structures of CaM-peptide 
complex and Ca
2+
-CaM, as well as the half CaM of each complex,  by the software REDCAT 
developed by Dr. James Prestegard (267). The results are shown in Table 7.1. The good fitting 
was indicated by the small value of the Q factor. The CaM-Cx43np complex showed the best fit 
for the complex of CaM and the gating domain of the calcium activated potassium channel (SK) 
413-489 (1G4Y). The N (1-65) and C (93-148) terminal domains fitted best with CaM-
chicken smooth muscle myosin light chain kinase (1CDL) and CaM-RyR1-3614-3643 (2BCX), 
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respectively. Since the RDCs of the two domains of CaM in the CaM-Cx43np complex cannot 
be fit simultaneously to the same crystal structure, the Cx43np accommodated in CaM in a way 
different from any kind of existing binding mode.  
The binding mode of CaM-SKp413-489 (1G4Y) was extended, and the complex was 
formed by 2 CaM and 2 peptides in the crystal structure, where calcium only occupied N-domain 
of CaM. There was a helix-turn-helix motif in the N-terminal of the peptide, which was in con-
tact with C-domain of CaM, while the C-terminal of the peptide inserted in the holo-N-domain 
and the bent central helix of the other CaM (268).  
The crystal structure of CaM-smMLCK (1CDL) demonstrated that the peptide spacing 
was in the classic 1-14 binding  mode (269). The peptide Trp5 interacted with the C domain of 
CaM (Leu105, Met124, Glu127, Ala128 and Met144), and Leu18 were in contact with the N 
domain of CaM (Leu32, Met51, Val55 and Met 71). CaM binds the peptide Ryanodine receptor 
1 3614-3643 in a flexible 1-17 binding mode (270). It was reported that in 1-17 peptide spacing 
pattern the two domains of CaM were more flexible and the domain motion was more independ-
ent compared to 1-10 and 1-14 peptide anchoring mode. The hydrophobic residue Trp3620 in the 
N-terminal of the peptide was in contact with the hydrophobic cavity which was formed by 
Phe92, Leu105, Met124, Met 144 and Met145 in the C-domain of CaM. Similar to the interac-
tion between C-terminal of peptide and N-CaM in 1-14 binding mode, the C-terminal Phe3636 
was inserted into the hydrophobic pocket formed by Leu32, Met51, Val55, Ile63 and Met71 of 
CaM.  
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Figure 7.3. The 15N-HSQC of holo-CaM interacted with the peptide Cx43np.  
The peptide was commercially synthesized. The final concentrations for CaM and the peptide were 0.8 
mM and 1.6 mM, respectively. Samples were prepared in Bis-tris, pH 6.5, 100 mM KCl, 10% D2O. At 
this ratio, CaM was not saturated by the peptide since minor peaks were observed in the spectra. The ex-
periment was run using Varian 800 MHz NMR spectrometer at 37°C. (A) The spectrum assignment of the 
isotropic and anisotropic complex of CaM-Cx43np. (B) RDC fitting revealed the good fit of CaM-
Cx43np complex, N and C domains to 1G4Y, 1CDL and 2BCX, and the number of residues in fitting 
were 33, 38 and 31 over 90 assigned residues, respectively. (C) The crystal structures of 1G4Y, 1CDL 
and 2BCX. Yellow color in 1CDL and 2BCX indicates the peptide; pink color indicates the C-domain 
and blue color indicates the N-domain. 
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Table 7.1 The RDC fitting of CaM-Cx43np to different CaM-peptide complex 
PDB ID  Target protein  
Binding 
Mode  
N-domain C-domain  Whole complex 
Q RMSD Q RMSD  Q RMSD 
1CDM  peptide calmodulin-
dependent protein kinase ii  
1-10  0.18  2.28  0.15 1.69 0.18 2.11 
1CDL  peptide calmodulin-
dependent protein kinase ii 
alpha chain  
1-14 0.12  1.55  0.25  2.25  0.18 2.22 
1CFF  Ca2+ pump  C-CaM 0.16  1.73  0.24 2.10  0.26 2.55 
1G4Y  Gating domain of K+ chan-
nel  
Extended  0.15  1.85  0.18  1.79  0.15 1.72 
1IQ5  Ca2+/calmodulin dependent 
kinase kinase  
1-16  0.15  1.87  0.18  2.04  0.18 2.04 
1K93  Adenylate cyclase domain 
of anthrax edema factor  
Extended  0.18  2.08  0.17  2.06  0.21 1.81 
1NIW  Endothelial nitric-oxide syn-
thase  
1-14 0.17  2.16  0.20  2.12  0.17 2.07 
1NWD  Plant glutamate decarbox-
ylase  
Collapsed 0.12  1.51  0.32  2.22  0.24 2.64 
1SY9  Cyclic-nucleotide-gated ol-
factory channel  
1-14  0.18  2.29  0.22  2.25  0.17 2.03 
2BCX  Ryanodine receptor I  1-17  0.15  1.89  0.13  1.50  0.20 2.25 
2HQW  Glutamate NMDA receptor 
subunit zeta 1  
1-7  0.15  1.84  0.20  1.91  0.18 2.08 
2IX7  Myosin 5A  Extended  0.22  2.46 0.26  2.02  0.24 2.24 
3CLN  Calcium-bound CaM  Ca2+-CaM  0.13  1.59 0.15  1.70  0.25 2.05 
 
The common feature of 1CDL and 2BCX is that in both complexes CaM adapts a col-
lapsed conformation, where the α-helical central linker between the N and C domains is partially 
bent which enables the two domains to wrap the targeted peptide. In contrast, the conformation 
of CaM in 1G4Y was extended and dimerized, where the central helix was flexible and the N 
domain was occupied by calcium leaving the apo C domain alone. Indeed, the 1-17 binding 
mode was similar to 1-14 spacing pattern and the bending angle of the linker is the only differ-
 205 
 
ence. The Q factors of RDC fitting for the full length of 1CDL, 2BCX and 1G4Y were 0.18, 0.20 
and 0.15, respectively. The number of residues in the final RDC fitting with 1G4Y was only 33, 
and the similar amount of residues was used in fitting for the half domains. Considering the resi-
due number for fitting and the overall Q factor, it was assumed that both N and C domain of 
CaM are interacting with the Cx43np peptide via van der Waals force and CaM prefers a more 
extended conformation than the classic collapsed ones (1-10, 1-14, 1-16 and 1-17).  
7.2.2 The dynamics study by T1, T2 and NOE for the complex of CaM-Cx43np 
Molecule dynamic study for peptide bound holo-CaM was carried out using Varian 600 
MHz spectrometer. T1, T2, NOE and Tau-C data were collected for further analysis. The as-
signment was done for 76/148 residues by monitoring the cross peaks during peptide titration 
(Figure 7.1). The relaxation delay time for 10 experiments was set as 0, 0.01, 0.06, 0.13, 0.23, 
0.34, 0.48, 0.74, 1.0 and 1.5 s for the T1 relaxation, and T2 was determined by performing seven 
experiments with the delays as 0.01, 0.03, 0.05, 0.07, 0.11, 0.13 and 0.15 s. For NOE experiment, 
the proton recovery period before data acquisition was 4.0 s. The relaxation R1 and R2 were ob-
tained by monoexponential fitting, and the NOE was calculated by the intensity ratio with and 
without the saturation of proton magnetization. 
The global rotational correlation time was 6.2 ns, calculated using the average R2/R1 ra-
tio, and they were 6.0 and 5.9 ns for the N and C domains of CaM, respectively. The domain mo-
tion at both terminals was consistent. The greater R2/R1 value for residues D80 and S81 than the 
average value indicated that this region underwent the conformational exchange, which was in 
the middle of the central linker. The relatively smaller NOE ratio of D80 also suggested it was 
flexible, in good agreement with the R2/R1. Figure 7.4 only shows the S2 which had the good fit 
to the template, demonstrating the flexible regions at the C domain of CaM, consistent with the 
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NOE data. The same region was found to be flexible as well in the complex 2BCX but no con-
formational exchange expected by R2/R1.  
The C-domain K115 and L116 were relatively flexible than neighboring residues as 
shown in the heteronuclear NOE. This flexible region lied in the loop connecting the EF-hand III 
and EF-hand IV. The same flexible loop was observed in the C-domain of the complex 2BCX, 
where the adjacent residue E114 caused the electrostatic interaction with K3626 of the RyR1 
peptide.  
Taken the dynamic and RDC data into consideration, it was concluded that both N and C 
domains of CaM associated together to bind the peptide Cx43np. The contact between the pep-
tide and the two domains was similar as 1-14 binding mode. The central linker around D80 was 
flexible and the conformational exchange was expected. Such conformational exchange might 
unwind the central helix and induce the bending, which in turn could affect the interaction be-
tween the peptide and CaM.  
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Figure 7.4. The dynamics analysis of CaM-Cx43np complex by T1, T2 and NOE. 
 
7.2.3 Calmodulin interacting with ryanodine receptor fragment 1977-1998 
Ryanodine receptor (RyR) is the ER membrane protein regulating the Ca
2+
 release from 
the ER. Low intracellular Ca
2+ 
activates the RyR while high concentration inhibits its function. 
The bell-shape like channel activation by intracellular Ca
2+
 can be altered by CaM. Previously, 
Dr. Jie Jiang in Yang’s group showed that the RyR channel opening was modulated by calmodu-
lin and Ca
2+ 
(271). Studies of the interaction between CaM and RyR have been taken for decades 
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(272-275). However, the size of RyR (565 kDa for a monomer) makes the big challenge for the 
structural analysis.  
In this chapter, the RDC experiment will be applied to investigate the binding mode of 
apo-CaM-RyR1p1975-1999. Before conducting the experiment, a few HSQC spectra were col-
lected to exam the quality of the sample. Figure 7.5 showed the 
1
H-
15
N HSQC spectra of the 
complex of CaM-RyRp1977-1998. Compared to the apo-CaM spectrum in blue, the one in the 
presence of RyR1p1975-1998 in red showed the substantial chemical shift perturbation (Figure 
7.5A). It was clear that the sample of this batch contained some contamination in that the spec-
trum of apo-CaM in the presence of RyR1p1975-1999 colored in green did not overlap with this 
collected one (Figure 7.5B). Calcium was the first potential substance to contaminate the sample 
since CaM has very high the calcium binding affinity. Thus, the holo-CaM 
1
H-
15
N HSQC spectra 
was used as reference. Figure 7.5C shows the spectrum overlapping with that of the holo-CaM.  
There were four residues in the downfield of f2 (
1
H), G25, G61, G98 and G134, far apart 
from others, which avoided the problem of peak overlapping. In the apo-CaM, only the glycine 
residues in the N domain G25 and G61 showed up, while four of them could be detected in the 
holo-CaM. The absence of the two glycines in the C-domain without calcium rise from the flexi-
ble and less ordered structure of apo-C-CaM. When N-domain was bound by calcium, the chem-
ical shift change occurred in G25 and G61. In the spectrum of this specific sample, four glycines 
can be detected and the chemical shift of glycines in the N-domain was consistent with those in 
the apo-CaM.  The comparison of four signature cross peaks of glycines implied that C-domain 
of CaM was occupied by the trace amount of calcium. Considered the commercial peptide may 
contain a certain amount of calcium, 5 mM EGTA may not be sufficient to maintain a near-to-
zero calcium environment. More EGTA will be added to remove the free calcium.  
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Figure 7.5. The 1H-15N HSQC spectra comparison of apo-CaM (Blue), holo-CaM (purple), apoCaM-
pRYR1975-1999 (green) and the tested CaM-pRYR1975-1999 (Red).  
Samples were prepared in 10 mM Bis-tris, pH 6.5, 100 mM KCl, 10% D2O. All spectra were collected 
using 600 MHz Varian at 25C. (A) The superimposed spectra of the apo-CaM and the tested sample. (B) 
The superimposed spectra of the previous apo-CaM-pRyR1975-1999 complex and the tested sample. (C) 
The superimposed spectra of holo-CaM and the tested sample. (D)The zoom-in spectra were manually 
shifted in D to conveniently observe the difference. 
 
7.3 Summary and conclusions 
The interaction between calmodulin (CaM) and its target peptides (1) the N-terminal in-
tracellular loop of connexin 43 (Cx43np) and (2) the peptide 1977-1998 of RyR1 was studied by 
NMR. The residual dipolar coupling and dynamics analysis illustrated that both terminal do-
mains of CaM wrapped around Cx43np simultaneously, along with bending and unwinding the 
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central helix. The anchoring pattern is close to 1-14 and 1-17 mode but the central helix is more 
extended.  
The analysis of the complex CaM-RyR1977-1998 provided a good example that using 
the signature Glycine residues (G25, G61, G98 and G134) to judge the Ca
2+
 occupancy in N and 
C terminus. In the presence of the trace amount of Ca
2+
, the C-domain of CaM in the complex is 
first loaded with Ca
2+
. This work will be continued to find out the binding mode of apo-CaM 
with the peptide RyR1977-1998. 
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8 NMR OF DIMETHYLATED LYSINE IN CALMODULIN AND CALCSIUM-
SENSING RECEPTOR (CASR) 
8.1 Conformational change of calcium sensing receptor extracellular domain (CaSR-
ECD) induced by calcium and ligand binding 
8.1.1 Using methyl group as a probe to study the ligand-protein interaction 
The challenge to study the structure and conformation of macromolecules, especially the 
membrane protein, rises from the molecular size and the solubility. Application of NMR for the 
large molecules was limited by its size due to the broadened line width caused by the short T2 
relaxation time and slow tumbling rate. Thanks to the selective labeling approach, the high-
molecular-weight protein can successfully be investigated by NMR. The isotropic hetero-
labeling method is particular useful for obtaining structural information about large membrane 
proteins by NMR since it can simplify the spectrum. In addition, the methyl group can be used as 
a probe to investigate the protein dynamics and interactions with ligands. The resonance of me-
thyl groups is intense due to the attached three protons and the fast tumbling rate makes the peak 
narrow. The HMQC experiments can be conducted to obtain the high resolution and sensitivity 
spectra because the magnetization transfer pathway of the methyl group and the macromolecules 
can be isolated due to their different relaxation rates (276-278).  
The Lys side chain can be methylated by formaldehyde and the methyl signal is easily 
detected by using 
1
H-
13
C HMQC. This methodology was pre-tested using CaM as a model (Ap-
pendix D) since CaM has 8 Lys residues and the assignment was done by Zhang and co-workers 
(279). The selectively labeling of the methyl group was also applied to the hydrophobic residues 
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including isoleucine, leucine, valine, alanine and methionine (280, 281). Those residues are usu-
ally buried in the interior of the hydrophobic core of proteins.  
Calcium sensing receptor (CaSR) belongs to the family C G-protein coupled receptor 
(GPCR). It mainly expresses in the parathyroid gland, regulating the secretion of parathyroid 
hormone (PTH) (282). PTH is essential to maintain the calcium homeostasis in human body. Ex-
tracellular calcium concentration change can through CaSR induce intracellular calcium oscilla-
tion which encodes the signaling for the downstream cellular events (283). The L-amino acids 
have been reported to enhance the EC50 of extracellular Ca
2+
 (284). However, no direct evidence 
shows the Ca
2+
 or the L-amino acids bind CaSR extracellular domain (CaSR-ECD). In this chap-
ter, the structural analysis for the interaction between CaSR and Ca
2+
 as well as L-Phe and gluta-
thione (GSH) was carried out. There are 41 Leu, 30 Phe, 4 Met and 25 Lys distributed in CaSR-
ECD. In this dissertation, 
15
N Phe-labeled expressed mammalian CaSR-ECD was first expressed 
and the [
13
C-dimethylated-Lys]-CaSR-ECD was also used to determine the calcium and amino 
acids induced conformational change.  
The calcium-sensing receptor ECD with His-tag was expressed by HEK cells in Dr. Kel-
ley Mormene’s lab in UGA (285-289). To further overcome the inhomogeneous glycan in wild 
type CaSR-ECD, Dr. Moremen uses his developed novel Lec1 mutant HEK 293 cell line to ex-
press CaSR-ECD with only mannose on the protein surface instead of the native complex glycan. 
The experimental condition and parameters were optimized to obtain the desired yield.  
The dimethylation of lysine was done by reacting with formaldehyde under the reduced 
condition at 4°C for 16 h. The reaction condition was optimized to allow the complete dimethyl-
ation. The formaldehyde was added twice together with Dimethylaminoborane (DMAB, pur-
chased from Sigma-Aldrich) for reductive methylation. For each time, the mole ratio of formal-
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dehyde and lys was 3:1 and the ratio of DMAB to formaldehyde was 3:1. The time interval of 
two additions was 3 hours. The mono-methylated peak can be easily differentiated because the 
chemical shift is in the range of 30-35 ppm while the dimethylated lysine has peaks in the range 
of 42-48 ppm. 
1
H-
13
C HMQC was applied in 600, 800 and 900 MHz VARIAN NMR spectrome-
ters. The spectral width of C13 channel is 3000 Hz, 16 scans were applied and 64 for each scan 
increment. The decoupling power for C13 was 38 and the acquisition time was 0.2 sec. The wa-
ter signal was suppressed by PRESAT pulse sequence provided by VNMRJ.  
These expressed proteins were shown to be native as judged by their conformations and 
functional ligand binding. The mammalian expressed ECD forms a dimer with a molecular 
weight of 200 kDa in the non-reducing SDS-PAGE gel and determined by PFG-NMR (290, 291). 
Glutathione is the analog of Phe to bind CaSR-ECD and the binding affinity is stronger than Phe 
so that GSH is added to CaSR to study the ligand induced additional conformational change in 
the presence of calcium. Conformational changes can be monitored by 2D NMR using the 
15
N- 
or 
13
C-labeled ECD domain (292). Figure 8.1 shows the HSQC spectrum of the selectively la-
beled 
15
N-Phe in CaSR-ECD. The chemical shift change of these labeled Phe residues upon addi-
tion of calcium was observed, although the 30 Phe peaks are not dispersed as expected. Four re-
gions were cut for detailed analysis as indicated in Figure 8.1 A, and  the chemical shift change 
as well as the peak line width difference was dramatic as shown in Figure 8.1 B. In the region 1, 
increased calcium concentration brought the two peaks closer and closer, which moved apart 
from each other upon the final added GSH. To avoid the interference from the complicated gly-
cosylation, Lec 1 HEK  cell mutant was applied for expression of CaSR-ECD with the mannose-
type N-linked oligosaccharides. Figure 8.1C shows the better peak dispersion of the 
15
N-Phe 
CaSR expressed in Lec1 mutant in 
1
H-
15
N HSQC spectrum. 
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Further information has been obtained by specifically labeling of the side chain of lysine 
with 
13
C by reductive methylation (293), since the methyl group is excellent for probing the 
change of Lys structure and dynamics of large proteins with high sensitivity because of its high 
mobility and three protons, where seven out of 25 Lys residues are near the predicted Ca
2+
-
/ligand-binding site in ECD. Unfortunately, this approach was less successful in the case of 
CaSR-ECD. As shown in Figure 8.2, all Lys dimethyl groups merged to form one big peak, 
which was also observed in another [
13
C-dimethylated Lys]-G protein-coupled receptor rhodop-
sin  (294). The peak (
1
H: 2.4 ppm, 
13
C: 44 ppm) of N-terminal dimethylated amino group moved 
upon calcium titration while the big peak stayed no changed. However, the addition of glutathi-
one clearly induced conformational change in that there were two more peaks were detected 
(Figure 8.2 Ba) and the chemical shift change of the existing peaks was observed as well. The 
similar calcium induced conformational change can be observed by performing 
1
H-
15
N HSQC to 
the uniformly labeled, deuterated 
15
N, 
13
C-CaSR-ECD (Figure 8.3), where the peaks are well 
dispersed although the peak amount is much less as expected.  
In conclusion, calcium induced conformational change of CaSR-ECD can be confirmed 
by NMR using the selectively isotropic labeled protein. The additional conformation change up-
on the glutathione was also observed in the presence of calcium. Additional labeling will be per-
formed for other isotopes such as I, M, L and V in collaboration with Moremen’s group as re-
ported(281, 295, 296). The large movements in loop and hinge regions of proteins will be studied 
using paramagnetic probes, such as lanthanide ions or nitroxide spin-labels. This method is par-
ticularly suitable and will allow us to obtain long-distance constraints (between 20 to 35 Å) of 
the ECD of the CaSR (297) by paramagnetic relaxation enhancement (PRE) as reported (298).  
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Figure 8.1. 1H-15N HSQC spectra of calcium titration of 15N-Phe selectively labeled CaSR-ECD.  
The protein was expressed from HEK 293 cells and concentrated to be 150 μM in 10 mM Tris, pH 7.4, 20% 
D2O. The water gate was applied in 
1H-15N HSQC. (A) The overlaid HSQC spectra of 15N-Phe labeled 
CaSR-ECD in different calcium concentration. calcium titration was conducted from 0 to 10 mM, and 
200 μM glutathione was supplemented in the end to mimic the amino acid binding. (B) The chemical shift 
change upon calcium titration in different regions indicated in the panel A. (C) HSQC spectra of 15N-Phe 
labeled by HER293 mutant Lec1 expression with chemical shift changes upon addition of Ca2+. Lec1 ex-
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pression without complex glycosylation sharpens resonance. The region is the area corresponding to the 
zone 1, 2 and 3 in the panel A. 
 
 
Figure 8.2. The1H-13C HMQC spectra of [13C-dimethylated-Lys]-CaSR-ECD expressed in HEK293 cells.  
(A) The overlaid HMQC spectra of 50 μM protein in 10 mM Tris, pH 8.5, 20% D2O (Red) and the one 
supplemented with 5 mM Ca2+ (Green). (B) a-d: The different regions of the overlaid HMQC spectra of 
CaSR-ECD in presence of 5 mM Ca2+ (Green) and the one supplemented with 50 μM Glutathione (Blue). 
Additional glutathione induced chemical shift change and two new peaks in the panel B(a).  
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Figure 8.3. The 1H-15N HSQC spectrum of the bacterial expressed CaSR-ECD.  
The sample was grown in D2O and uniformly 
15N, 13C labeled. The red spectrum is the sample of 200 μM 
protein in 10 mM Tris, pH 7.4, 30% D2O. The grey spectrum is the one titrated with 1.6 mM Ca
2+. The 
dispersion of peaks were obtained and the calcium induced chemical shift change can be observed. 
 
8.1.2 Using STD-NMR to study the ligand binding to CaSR-ECD 
Because of the big size of dimerized CaSR-ECD, it was difficult to obtain the high-
quality NMR spectra of sparse labeled protein. Alternatively, saturation transfer difference NMR 
(STD-NMR) could be used to verify the interaction between the ligand and protein by monitor-
ing the signal from the ligand (L-Phe). In STD-NMR, the magnetization is transferred from the 
protein to the ligand, where the bound ligand is also saturated and shows the decreased intensity. 
The effective saturation transfer is determined by the koff and the T1 relaxation rate of the protein 
(299). It is advantageous to identify the low affinity binding with Kd in the mM range (300). In 
this chapter, the 1D proton STD-NMR was conducted to demonstrate the L-Phe binding to 
CaSR-ECD.  
The HEK 293 mutant Lec1 expressed CaSR-ECD was used in STD-NMR. The protein 
with the final concentration of 10 or 20 μM was prepared in 10 mM Tris, pH 7.4 in >95% D2O. 
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L-Phe prepared in the same buffer solution was titrated and the spectra were collected using Var-
ian 800 MHz NMR spectrometer at 25C. To avoid saturation at L-Phe, the irradiation frequency 
was set at -1 ppm. The reference frequency was at 30 ppm. The saturation duration was 3.0 sec.  
Figure 8.4 A and C showed the 1D spectra comparison between CaSR-ECD and those 
supplemented with ligands. The peaks arising from the ligand were identified. For Phe, there 
were three peaks at 7.15, 7.20 and 7.25 ppm and GSH showed peaks at 2.00, 2.35, 2.75 ppm. As 
shown in Figure 8.4B, the intensity difference was observed when 0.5 mM Phe was added and it 
was increased as adding Phe, demonstrating Phe bound to CaSR-ECD. In contrast, the intensity 
difference was not obvious until 2 mM GSH was added, which may be explain by the non-
effective saturation transfer because of the high-affinity GSH binding (EC50=2 μM). Although 
the increase [GSH] also led to the increased STD signal, it can not rule out the possibility of the 
non-specific sticking to the protein. 
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Figure 8.4. The 1D proton and STD spectra of CaSR-ECD titration with L-Phe and GSH.  
The protein with the final concentration of 10 μM was prepared in 10 mM Tris, pH 7.4 in >95% D2O. L-
Phe and GSH prepared in the same buffer solution was titrated and the spectra were collected using Vari-
an 800 MHz NMR spectrometer at 25C. (A) The 1D spectral comparison between 10 μM CaSR-ECD 
and the one supplemented with 5 mM Phe. (B) The STD spectra of Phe titration to 20 μM CaSR-ECD. (C) 
The 1D spectral comparison among 50 μM GSH, 20 μM CaSR-ECD and 20 μM CaSR-ECD supplement-
ed with 773 μM GSH. (D) The STD spectra of GSH titration to 20 μM CaSR-ECD.  
 
In the presence of Ca
2+
, the STD spectra were also observed in Phe titration and the en-
hancement of the intensity difference was similar as the set without Ca
2+
. The calcium effect was 
shown in Figure 8.5A. For the intensity difference was reduced upon Ca
2+
 addition to Phe-CaSR-
ECD complex, while it increased in GSH-CaSR-ECD. However, the direct observation of the 
spectra difference was not accurate because the sample was diluted by adding Ca
2+
 and it was 
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probably somewhat lost during the titration. Thus, the calculated STD amplification factor was 
used to quantify the difference, which was given by Equation 8.1. The dissociation constant Kd 
can be obtained by plotting STD-AF versus the ligand concentration (Euqation 8.2). 
][
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I
II
AFSTD T
ref
satref


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std
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   Equation 8.2 
The Iref and Isat were the ligand peak when irradiating protein at 30 ppm and -1 ppm, re-
spectively. [L]T was the total ligand concentration and [P] was the protein concentration. The asat 
indicated the STD-AF when the protein was saturated by the ligand. 
 
 
Figure 8.5. The STD spectra comparison between Ca2+ free and loaded CaSR-ECD. 
(A) The STD spectra of20 μM CaSR-ECD with 1mM Phe in the absence (Red) and presence (blue) of 2.5 
mM Ca2+. (B) The STD spectra of20 μM CaSR-ECD with 2mM GSH in the absence (Red) and presence 
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(blue) of 2.5 mM Ca2+. (C) The relationship between STD-AF and L-Phe concentration. The titration 
range of Phe was 0-20 mM. In the full range (a), 0-7 mM (b) and 0-2 mM (c), different Kd values were 
obtained by using Equation 8.2. (d) The Kd fitting for the full range 0-20 mM Phe in the presence of 2.5 
mM Ca2+.The red, blue and black color indicated the peak at 7.25, 7.20 and 7.15 ppm. 
 
The Phe binding to CaSR-ECD appeared to have multiple phases (Figure 8.5Ca). Using 
the initial 0-2 mM Phe for Kd fitting obtained the highest binding affinity and was lower than the 
EC50 (5 mM). By fitting from 0-7 mM Phe, the calculated Kd was comparable to EC50. When the 
Phe concentration was more than 10 mM, the STD-AF kept increasing and seemed no saturation, 
which might be due to the non-specific binding. In the presence of Ca
2+
, only one binding pro-
cess was observed. Compared Figure 8.5Ca and 8.5Cd, the peak 2 and 3 (7.20 and 7.15 ppm) in 
the presence of 2.5 mM Ca
2+
 showed a greater STD-AF and the Kd was smaller, suggesting Ca
2+
 
binding enhance the Phe binding. 
8.2 Lipid interaction induced conformational change of SecA fragments 
SecA is an essential ATPase for protein secretion in bacteria. SecA is soluble and pos-
sesses low levels of intrinsic ATPase activity in solutions free of phospholipids, and transforms 
to be an integral membrane protein when interacting with lipids to function as a protein-
conducting channel in a complex form with SecYEG (301-303). It have been found by Dr. 
Phang-Cheng Tai's group
 
that SecA, without interacting with SecYEG, forms pore ring-structure 
with a pore-size of 2-3 nm in the anionic lipids as observed by TEM and AFM (304-307). Such a 
unique feature attracts interests to explore the underlying mechanism.  
Soluble SecA has two separable domain fragments: an N-terminal 68 kDa (N68: 1-609) 
domain which possesses high ATPase activity that is down-regulated by the 34-kDa C-terminal 
domain (C34) (308-311), and shows high-affinity binding to SecYEG in the membranes (312). 
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C34 has also been shown to be involved in SecA dimerization (312, 313), and in SecB/lipid 
binding (314). The N-domain containing the long helical SD domain (1-668) can form the pore 
structure in lipids and but show no channel activity. However, these two SecA domains can as-
sociate together to function the same as the integral SecA (315). Binding to signal peptides and 
to lipids causes significant conformational changes of SecA (316-320).  
Various X-ray structures of soluble bacterial SecA fragments have been obtained but all 
of them lack the un-structured C-terminal tail (304, 321-326) (Figure 8.6). By using solution 
NMR as a complementary tool, several SecA domains structures in solution have been resolved 
including the last 22 amino acids in the C terminal, and an inter-conversion between open and 
closed conformation around PBD domain (327-332). Here, we want to use differential isotope 
labeling, site-directed mutagenesis and high resolution NMR to systematically define the con-
formational changes in a helical scaffold domain and two interacting hydrophobic helices that 
interact with lipids and are critical for the formation of pore structures to function  as protein-
conducting channel activity for ion-current and protein translocation. 
The sub-domain NMR structures of soluble C34 (610-901) have been analyzed (327, 
328). The soluble C34 can also bind to lipids (312). This domain was reconstituted with lipids to 
determine whether it induced any changes by NMR. The lipid induced conformational change 
can be visualized by examining residues that have changes either in chemical shifts or line width 
by selectively labeled the domains, e.g. 
13
CH3-Met and 
13
CH3-Lys, to avoid the peak overlapping 
issue due to the large molecule size (283, 329, 333). There are 20 Lys spread at different loca-
tions of SecA C34 and most of them are exposed to solvent. It is found that the SD domain is 
essential for the pore formation and two helices after the SD domain are involved in store the 
channel activity. The hydrophobic interaction inside C34 is shown in Figure 8.6C, where the 
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electrostatic interaction between K750 and V829, K764 and L667, V669, is observed (Figure 
8.6B).  
 
 
 
Figure 8.6. The structure analysis of SecA.  
(A) The crystal structure of SecA  (PDB ID: 2FSF). The N68 fragment is colored by cyan. The C34 frag-
ment includes the yellow and pink regions plus the unstructured C-terminal tail (67 aa) of which the X-
ray structure has not been solved. (B) The lysine involved electrostatic interaction in the C34 fragment. 
The side chain amino groups of K764 and K750 form the hydrogen bond with the main chain oxygen of 
L667, V669 and V829. (C) The beads mode of the hydrophobic interactions between helices 650-670, 
760-785 and 808-830.  
 
 
There are relatively few lysine residues that may be labeled by reductive methylation in 
the lipid environment. The presence of lipids indeed induces conformational changes of C34, 
resulting in different Lys residues for di-methylation as shown in Figure 8.7A. The acquired 
1
H-
C
13
 HSQC spectrum of specifically labeled 
13
CH3-Met N68 showed the similar peak position as 
reported data (Figure 8.7B) (329). With 
13
C-Met labeling for N609 and N619, the M612 can be 
assigned. The lipid-induced change can be determined by the chemical shift change. For the uni-
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formly labeled 
15
N-C34, 
1
H-
15
N HSQC spectra appeared similar as the reported data, in which 
most of peaks are not able to be seen due to the rigid structure and only a few residues in the 
flexible tail (around 70 aa) is NMR detectable (Figure 8.7C). The assignment was borrowed from 
the published spectrum by Gelis (329). The chemical shift perturbation upon reconstitution to 
lipids confirmed the interaction between C-tail of SecA and lipids. 
The selective labeling simplified the NMR spectrum. By this method, we can achieve the 
residue assignment fast. It is confirmed that the C-tail of SecA can interact with lipids. N68 
fragment may also associates with lipids but not as significantly as C34. To further pin down the 
key determinants for such interaction using C34 and N68 by the high resolution NMR, we can (1) 
use the PRE with NO labeling of Cys residues can be applied (334); (2) measure the transverse 
relaxation of both apo- and ligand-loaded forms to explore the dynamics of SecA and its frag-
ments.  
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Figure 8.7. NMR study of selectively labeled SecA fragment N68 and C34.  
(A) 1H-13C HMQC spectrum of 13C-lysine-methylation of C34 without (red) and with (cyan) lipids. 
(B)The color indicates the pair-wise hydrophobic interaction. C, 13C-Met HMQC spectrum of N609 be-
fore (red) and after (blue) adding PEPG lipids. (C) 1H-15H HSQC NMR spectrum of C34 before (red) and 
after (blue) adding PEPG lipids. The black box indicates the chemical shift of residues caused by lipids 
binding.  
 
8.3 Summary and conclusions 
This chapter described the methodology of studying ligand interactions with large pro-
teins by NMR. The NMR signal of methyl group instead of the whole molecule was detected to 
avoid the short T2 of the large molecule. By reductive methylation of lysine residues, (1) the 
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conformational change of the extracellular domain of CaSR induced by Ca
2+
 and GSH binding, 
and (2) the conformational change of SecA-C34 induced by lipid-protein interaction, were suc-
cessfully observed. The 
15
N-Phe labeled CaSR-ECD expressed by mammalian cells and the deu-
terated uniformly 
15
N labeled CaSR-ECD expressed by bacteria confirmed the calcium and ami-
no acid analog binding induced conformational change. The STD-NMR results provided the evi-
dence of the direct binding of Phe and CaSR-ECD, and Ca
2+
 binding enhanced the Phe binding. 
The signal of 
13
CH3-Met in SecA-N68, and uniformly 
15
N labeled SecA-C34 confirmed the con-
formational change upon lipid interaction as well.  
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9 MAJOR DISCOVERIES AND SIGNIFICANCE 
The organic calcium dyes and the protein-based calcium probes have merged to reveal 
the relationship between the intracellular calcium dynamics and the calcium-dependent physio-
logical phenomenon. However, the utilization of natural calcium binding protein such as cal-
modulin and troponin limits the application in the low calcium environment like cytoplasm due 
to the intrinsic high calcium binding affinity of calmodulin and troponin. To obtain a complete 
picture of calcium movements, it is necessary to have calcium probes that can sense calcium 
concentration change in calcium stores like the endoplasmic reticulum and mitochondria. The 
major challenges to design this kind of calcium probes are that (1) we have to start a new calci-
um binding coordination differing from the classic EF-hand motif; (2) the calcium binding needs 
to induce the appropriate conformational change which will not disturb the global folding but 
conduct the fluorescence intensity change.  
Through year of efforts, we found our way to develop the calcium probes targeted to high 
calcium environment, the GFP based green fluorescent calcium indicator CatchER and mCherry 
based red fluorescent calcium indicator, MCD1 (RapidER). By statistically analyzing the calci-
um binding coordination, the half shell geometry with concentrated negative potential was uti-
lized to attract calcium ion with lower binding affinity than the classic bipyramidal calcium 
pocket. To minimize the perturbation of the folding, the calcium binding site was designed in the 
single fluorescence protein by mutagenesis without domain insertion. We take the advantage of 
the electrostatic property to drive the local conformation and dynamic change, which causes the 
repulsion force in the calcium binding site without calcium ion and relaxation after calcium bind-
ing.  The equilibrium-dialysis assay, NMR and fluorescence spectroscopy confirmed calcium 
binds to the designed proteins. The calcium concentration change reflected by the fluorescence 
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was successfully observed and validated in vitro and in situ. The kinetic study demonstrated the 
faster calcium association and disassociation rate of CatchER and MCD1 than other protein 
based calcium sensors currently, which is an important step forward to allow detection of calci-
um dynamics in the electrical excitable cells. Compared to the green CatchER, MCD1 shows less 
pH-dependent fluorescence change in the physiological condition. In addition, the red shifted 
excitation wavelength enables a broader application for simultaneous recording using multiple 
sensors. This research expands the calcium indicator toolkit not only to detect a broader range of 
calcium concentration but also to a larger fluorescence spectrum window. 
To achieve a better fluorescence dynamic range, the underlying mechanism of calcium 
induced fluorescence increase was investigated in this dissertation. Through the analysis of 
CatchER in the ground and excited state, we found that calcium binding shifted the CatchER 
chromophore acid-base equilibrium in the ground state to generate increase of proportion of the 
anionic form and retarded the geminate recombination to accumulate more anionic form via pro-
ton transfer in the excited state by exciting the neutral chromophore. Employing the calcium 
binding site disturbs the classic hydrogen bonding network existing in w.t.-EGFP chromophore, 
leading to the geminate recombination. It is the first time to observe the phenomenon of gemi-
nate recombination in the world of fluorescent proteins. Calcium binding rescues the proton mi-
gration pathway, reduces the geminate quenching and then increases the fluorescence lifetime of 
the indirectly excited anionic chromophore. The substantial Ca
2+
 binding induced lifetime in-
crease (44%) enables the future application of CatchER in the lifetime imaging, which is more 
quantitative compared to the intensity-based imaging method. 
The heterogeneous distribution of intracellular calcium is determined by the calcium 
movement and diffusion among organelles. The resulted spatial-temporal calcium dynamics is 
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essential in signal transduction. The specific targeting especially to the space in proximity to cal-
cium channels will enable the detection of the amount and the kinetics of calcium concentration 
change in the first place and later connection of the calcium ion migration chain. In this disserta-
tion, we focused on the cleft between SR terminal cisternae and T-tubule, where calcium ions 
accumulate quickly once they release from SR upon coupling between DHPR and RyR1 due to 
an action potential. Instead of using an intact membrane protein to locate our calcium sensor 
CatchER, we selected the transmembrane fragments from RyR1 to avoid the over-expression of 
any intrinsic native protein. The confocal imaging result showed that the fusion of the selected 
fragments of RyR1 allowed to anchor CatchER in ER membrane, although the orientation was 
not completely the same. This work set the base for future screening of membrane anchoring se-
quences and will be continued. 
Residual dipolar coupling (RDC) and protein dynamics study was carried out to under-
stand the interaction between calmodulin and the connexin 43 N-terminal loop. The dynamic T1, 
T2, NOE, and S2 parameters suggested that both terminal domains move accordingly, the central 
linker around D80 is flexible and the conformational exchange is expected. Such conformational 
exchange might unwind the central helix and induce the bending, which in turn could affect the 
interaction between the peptide and CaM. The RDC fitting for the N and C domains of CaM 
suggested that N domain fits 1-14 mode as 1CDL and C domain fits 1-17 mode as 2BCX. In 
both binding mode, CaM adaptes the collapsed conformation to wrap around the peptide, and the 
central helix is bent and partial unwound. For the full length RDC fitting, the extended CaM in 
1G4Y has the best fit, which is a dimer and the central linker was flexible. Since the interactions 
of both terminal domains with the peptide fails to fit in the same complex model, a binding mode 
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other than any existing one may occur in CaM-Cx43np complex, in which both N and C domains 
contact with the target peptide but more extended than that in the classic collapsed conformation. 
The large molecular size makes the study of the interaction between a ligand and a pro-
tein challenging especially when using NMR spectroscopy. It is common to observe overlapped 
peaks or spectra with a large amount of missing peaks due to the broad line width that caused by 
the slowing tumbling rate of macromolecules, even in the deuterated proteins. The methyl group, 
of which the faster tumbling rate superimposes that of the macromolecule and the bonded three 
protons, enables the resonance intense and narrow in a 
1
H-
13
C spectrum. In this dissertation, the 
calcium sensing receptor (CaSR) and bacterial membrane protein SecA were reductively methyl-
ated by H
13
CHO and HMQC was applied to detect the interaction between proteins and lig-
ands/lipids. Efforts were also taken to obtain the HSQC and HMQC spectra of [
15
N-Phe]-CaSR-
ECD and [
13
C-Met]-SecA. Using those selectively labeled proteins, the calcium and glutathione 
induced conformational change in CaSR-ECD was observed, as well as the lipids interaction in-
duced conformational change in SecA. The advantage of applying 1D proton STD-NMR to illus-
trate the low-affinity ligand-protein binding was shown in the study of Phe-CaSR interaction. 
Thus, the protocol of utilizing the selective labeling approach was built in our lab for other pro-
jects involving macromolecule-ligand interactions. 
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APPENDICES  
Appendix A Scripts for NMR data processing 
Resi_sorting-1.py 
import sys, string 
a=open('<filename>', "r") 
b=open('presort.txt', 'w') 
lines=a.readlines() 
for i in range(0, len(lines)): 
    if i>=3:     
        b.write(lines[i]) 
a.close() 
b.close() 
Resi-sorting-2.py 
import sys, string, re 
a1=open('presort.txt', "r") 
new=open('sorted_aligned.txt', 'w') 
lines1=a1.readlines() 
splitter=re.compile(r'[\D]') 
t=[] 
resinum_list=[] 
resinum_sort=[] 
for i in range(0, len(lines1)): 
    t.append(lines1[i].split())    
for j in range(0, len(lines1)): 
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    resinum_list.append(splitter.split(t[j][0])) 
    resinum_sort.append(resinum_list[j][1]) 
    t[j][0]=t[j][0].replace(t[j][0],resinum_sort[j]) 
for n in range(len(t)): 
    t[n][0]=int(float(t[n][0])) 
t.sort() 
for x in range(0,len(t)): 
    t[x].insert(3,'\n') 
t1=t 
t2=[] 
t2.append(t1[0]) 
for x in range(0, len(t1)-1):             
    if t1[x+1][0]!=t1[x][0]+1: 
        diff = t1[x+1][0] - t1[x][0] 
        for index in range(1, diff+1): 
            t2.append([t1[x][0]+index, '0', '999', '\n']) 
    else: 
        t2.append(t1[x+1]) 
for y in range(0,len(t2)): 
   t2[y][0]=str(t2[y][0]) 
for z in range(0,len(t2)): 
    t2[z]='\t'.join(t2[z]) 
t2=''.join(t2) 
#print t2 
new.write(t2)         
new.close() 
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a1.close() 
 
To convert  nmrpipe output to sparky readable file *.ucsf for TauC data processing 
(tosparky.com) 
#!/bin/csh 
pipe2ucsf test1.ft2 1.ucsf 
pipe2ucsf test2.ft2 2.ucsf  
pipe2ucsf test3.ft2 3.ucsf  
pipe2ucsf test4.ft2 4.ucsf  
pipe2ucsf test5.ft2 5.ucsf 
pipe2ucsf test6.ft2 6.ucsf 
pipe2ucsf test7.ft2 7.ucsf 
pipe2ucsf test8.ft2 8.ucsf  
 
To generate the Modelfree input mfdata (mfdata-gen.py) 
import string 
afile=open('input.txt','r') 
mfdata=open('mfdata.txt','w') 
lines=afile.readlines() 
alist=[] 
blist=[] 
for i in range (1, len(lines)): 
 alist.append(lines[i].split()) 
blist=alist 
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newlist=['spin\t','sample_','n','\n','R1\t','599.863\t','R1','\t','0.030\t','1\n','R2\t','599.863\t','R2','\t','0.300\t','1\
n','NOE\t','599.863\t','NOE','\t','0.040\t','1\n','\n'] 
for n in range (0, len(alist)): 
 pos1=newlist.index('spin\t')+2  
 newlist.pop(pos1)   #remove the value at the given index  
 newlist.insert(pos1,blist[n][0]) 
 pos2=newlist.index('R1\t')+2 
 newlist.pop(pos2) 
 newlist.insert(pos2,blist[n][1]) 
 pos3=newlist.index('R2\t')+2 
 newlist.pop(pos3) 
 newlist.insert(pos3,blist[n][2]) 
 pos4=newlist.index('NOE\t')+2 
 newlist.pop(pos4) 
 newlist.insert(pos4,blist[n][3]) 
 table=''.join(newlist) 
 print table 
 mfdata.write(table) 
afile.close() 
mfdata.close() 
  
 
 
To evaluate the accuracy of the output of Modelfree (sim_acc_val.py) 
import string, math 
afile=open('simu_acc.txt','r') 
lines=afile.readlines() 
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alist=[] 
a=[] 
acc=[] 
for n in range(0, len(lines)): 
 alist.append(lines[n].split()) 
a=alist 
extra=[] 
for x in range(0,len(alist)): 
 if len(alist[x])!=6: 
  extra.append(alist[x]) 
for x in range(0,len(extra)): 
 a.remove(extra[x]) 
a.remove(a[0]) 
for i in range(0, len(a)): 
 for j in range(0,len(a[0])): 
         a[i][j]=float(a[i][j]) 
for i in range(0,len(a)/3): 
 Esum=((a[i][1]-a[i][4])/a[i][2])**2+((a[i+len(a)/3][1]-
a[i+len(a)/3][4])/a[i+len(a)/3][2])**2+((a[i+len(a)/3*2][1]-a[i+len(a)/3*2][4])/a[i+len(a)/3*2][2])**2 
 Csum=(0.1*a[i][4]/a[i][2])**2+(0.1*a[i+len(a)/3][4]/a[i+len(a)/3][2])**2+(0.1*a[i+len(a)/3*2]
[4]/a[i+len(a)/3*2][2])**2 
 perc=Esum/Csum  
 if perc>0.5: 
  print a[i][0] 
 acc.append(str(perc)) 
seq=[] 
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for i in range(0,len(a)/3): 
 seq.append(str(a[i][0])) 
out=open('sim-acc-out.txt','w') 
for i in range (0, len(seq)): 
 out.write(''.join([seq[i],'\t',acc[i],'\n'])) 
afile.close() 
out.close() 
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Appendix B Protocols for NMR data processing 
NMR Diffusion Experiment and Data Processing Using 600 MHz Spectrometer Computer 
Put sample in the Shigemi NMR tube. The material above and below protein sample 
should be the same to obtain good diffusion data.  
Experiment set-up: 
Type explib to find the experiment with pulse sequence “diffusion-led” (under Hing’s 
profile, it should be exp29) 
Type jexp29 to go to the diffusion experiment and then type dg to show the parameters. 
Adjust pw by typing pw=x.xx 
Array gradient level by typing array 
>Parameter:  gzlvl1 
>Steps: 40 
>Initial value: 100 
>Increment: 400 (the strongest gradient level will be 15700) 
Check parameters and run by typing ga. ( Usually nt=320; ss=32 in 600 MHz. This pulse 
sequence is not sensitive as 1D proton, so more scans are required than normal 1D. ) 
It is better to check whether the water signal is overflow by a test run (set, gzlvl1=15700, 
ss=4, nt=32, and run). The stronger the gradient level, the less intensity of protein peaks but 
higher water intensity will be generated. The gradient steps and level is dependent on the decay 
of the molecule. If it decays fast, both the gradient steps and max level can be reduced. 
Processing: 
Directly from the varian: 
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1.  After diffusion experiment is complete, (exp29) type wft (1) to phase the data for the 
first spectrum. 
2.  Type vs? to find out what the scale is and set it higher. 
3.  Choose a peak in the spectrum that is not the solvent peak, and put the cursor on the 
peak and left click.   
4.  Type nl.  Write down the peak height and frequency. 
5.  Type wft (2) and type nl again to write down peak height and frequency. 
6.  Repeat steps 4 and 5 for all 40 spectra for the same peak. 
Using Mnova: 
1. Copy the data directory (***.fid) to the local PC installed Mnova. 
2. File-Open-Open Fid file under data directory. 
     
3. Hold shift key and arrow up/down key to select first spectrum, which is the active 
spectrum.  
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4. Use the mouse middle wheel to adjust the intensity. 
5. Phase the first spectrum manually. Right click on the spectrum and select manual 
phase. Adjust phase by dragging mouse up or down while holding either right (PH1) 
or left (PH0) button of mouse in the light blue window. Hold Ctrl key for the fine 
tune. Adjust pivot point if you can not get right phase and adjust the phase again. 
    
6. Select stacked spectrum. Increase the peak intensity and look at the decay. Choose 
protein peaks which decays slower than the buffer peak. Expand the protein peak to 
be integrated by zooming in.  
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7. To integrate the selected region, go to Analysis – Integration – Manual. You may al-
so go back to the active spectrum to see a single one instead of the stacked spetra, 
which is easier to select the region to be integrated. The baseline regions beside the 
peak are also needed to be integrated. 
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8. Save the integration. Go to File- Save as and choose MestReNova integrals (*.txt) 
from the Save as type. Put the file name and click Save. 
 
9. Open data file from Excel:  
A: Data sets number; B: Fid name; C and D: integrated peak region in ppm; E: 
Normalized peak; F: Integrated value for data fitting. The rest of columns are similar 
but for baseline area integration. Subtract baseline from integrated protein peak. Use 
KGraph to get diffusion constant. 
 
10. Fitting data by KGraph by exp(-m1*m0^2); m1=x.xxx (m0 is gradient strength) 
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γ is the gyromagnetic ratio γ proton= 2.675 x 10
8
 rad s
-1
 T
-1
   
g is the gradient strength 
∆ is the delay time between two pulses and δ is the delay time in gradient channel. Both 
are constant in the experiment.  
D is the diffusion constant. 
 
RDC J-modulation data processing protocol  
1. Before starting, you need Linux system or Mac OS, perl, Sybyl, GNUplot. 
2. In the fid directory, type csh to use C-shell. 
3. Go to the data result directory xxx.fid  
4. Create a new sub-directory by mkdir Isotropic, move all files to Isotropic.  
5. Under the directory Isotropic, create a new sub-directory by mkdir Data. 
6. Copy scripts NH-jmod4edit.pl to the result data directory xxx.fid; copy make_seperate2.pl 
and fitR_all.pl to the Data directory. So the directory tree will be: 
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7. Then type NH-jmod4edit.pl Isotropic Delta. Isotropic is the name of the directory that con-
tains all the fid files. This command will process the first fid. After this step, a file called 
test1.ft2 will be generated in the Isotropic directory. 
8. Type nmrDraw to open the NMRDraw program.  
9. Select the file test1.ft2 to open. Adjust the phase of the data. Only require to adjust the first 
one and then the other ones will be automatically phased in the same way as the first one. 
10. Edit the ft2.com file to correct the phase. Under Linux: gedit ft2.com; Under Mac: xedit 
ft2.com 
11. In the fid directory, type NH-jmod4edit.pl Isotropic Delta spark. This will process all the 
fid files and generate .ucsf files for each fid. 
12. Open the Sparky program. Open the .ucsf files and assign the peaks. Open the HSQC which 
has been assigned. Check whether the RDC spectra are shifted compared to HSQC. If so, ad-
just them back according to HSQC spectrum by clicking st. Move mouse cursor to the 
HSQC and select all peaks by clicking pa, copy all assignment by clicking oc; move mouse 
cursor to one RDC spectrum and paste assignment by clicking op.  
13. Repeat step 12 for all .ussf files.  
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14. Save the peak list with data height flag on. Open the peak list window by clicking lt. Click 
Option button and check “Data height”, “Assignment” and “Frequency (ppm)”. Click Save 
and save them as *.list under the Data directory.  
15. Repeat 14 to save peak lists of all *.ucsf. 
16. After saving all the peak lists for each fid, go to the Data directory and 
type ./make_seperate2.pl, this will generate .dat files for each assigned peak. 
17. Type ./fitR_all.pl. This will generate a file called fit, in which you can find the coupling 
constants (J) for the assigned signals of the isotropic sample. The program gnuplot must be 
correctly installed first. To do this in Mac OS X 10.4: 
18. Install Aquaterm 1.0.0.dmg, which is under ~/Joy/. This step is required by OS X10.4. 
19. Install gnuplot-4.0.0.dmg. Or compile gnuplot-4.4.4. Both are under ~/Joy/. To compile 
gnuplot-4.4.4, unpack the tar file by tar xpf gnuplot-4.4.4.tar; go to the gnuplot-4.4.4 direc-
tory, and type ./configure, many message about your system will show up; type make check, 
which will compile gnuplot and do the self-checking;  type sudo make install, and type the 
password. 
20. This program can only run under bash, not fully functions under c-shell. So don’t run 
fitR_all.pl under C-shell, even not working in the terminal which was changed to C-shell 
and then changed back to bash. Otherwise many errors will occur and no results come out. 
21. You can use command more fit to see the fit file. It contains three columns, residue assign-
ment, coupling constant and the error. Note that the column is not sorted as the residue num-
ber but the alphabetical order. 
22. Repeat the above steps for the data collected with aligning medium and obtain the file fit 
containing J+D. 
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23. Calculate the RDC by subtracting the coupling constant of the isotropic sample from the 
aligned sample. RDC=(J+D)-J. 
24. Save the RDC as a single column .txt file. For residues that their RDCs cannot be deter-
mined, give a value of 999 instead. So every residue must have a RDC value. 
25. Open the REDCAT program by typing REDCAT.tcl. 
File  Prepare Input. 
Enter the name of your PDB file under PDB Input file.  
The pdb file should contain H atom coordinates. This can be done by adding H in Sybyl. 
The pdb file should contain only ATOM …. 
Enter a name for the output REDCAT file (for example: xxx.redcat). 
Fill in other info: 
Atom 1 = N 
Atom 2 = H 
Gap = 0 
Max RDC =24350 
Error = 10% of the range of RDC (for example, if RDCs are from -15 to 20, then range = 
35, error = 35  10% = 3.5) 
Click the Run button. After the .redcat file is prepared, click OK, and Done. 
File  Load 
Load the .redcat file, which is generated at step 21 and named at step 19. 
File  Import RDC Tool  Two Column ASCII 
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Select the single column .txt file and open. NOTE: the first residue in rdc.txt should be 
the same as the pdb structure. e.g. the pdb starts from the resi#3, so the first two rdc values will 
be deleted.  
Make sure that the residues with RDC values of 999 and missing coordinates are unse-
lected.  
Hit the Run button. 
You will see a table showing each of the residues in either grey meaning not used, green 
meaning rdc accepted or red meaning rdc rejected. 
Tools  Error Analysis  Perform Error Analysis 
Unselect those residues with large error (remove residues step by step, from those with 
large error), clear the window and Run again. Repeat this until there is no red residue. 
Tools  Solution  Get Solutions 
If there is no solution, continue unselecting residues with high error until there is solution. 
If there is solution, get the best solution. 
Tools  Solution  Get Best Solution. The values of Sxx, Syy, Szz and Euler angles 
will be given in the best solution. 
Tools  Calculations  Calculate  Substitute RDC 
Enter the Sxx, Syy, Szz, and the Euler angles to calculate. Select error: constant value = 0. 
Click ‘Calculate RDC’. A file called “plotcorr.dat” will be generated, which contains 
two columns, the first one is calculated RDC and the second one is measured RDC. Plot them in 
KGraph and fit the data using Y=X equation. Y=Calculated RDC and X=Measured RDC. 
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Processing and analyzing dynamic data and preparation for Modelfree. 
1. Processing T1, T2, and NOE data the same way as regular HSQC data. 
2. Assigned the peaks. 
3. Integrate peak volume by clicking it. 
4. Selected all peaks (pa) and type it. Unselect the first one “allow … motion” 
5. Integrated the selected peaks (pi), this may take a while. 
6. Open the peak list (lt), in the option, select volume, then update, then save the 
list using filename starting with the T1 or T2 (s), for example, 
0.01lista.filename.list. 
7. Repeat the above steps for all spectra.   
8. Run make_separateT.pl to generate the volume vs time table for each resi-
due.dat. 
9. Run fitall_T1(T2).pl to fit the decay of the peak volume using the equation y 
= m1*exp(-M0/m2). M0 = relaxT, m1 is the initial volume at relaxT = 0, m2 
is T1 or T2. For CD2, T1 ~700 ms, T2 ~100 ms.  
10. Copy the T1 (s), T2 (s) and both NOE on and off to Excel and calculate the 
R1, R2 and NOE ratio of on over off 
11. Make a table with four columns: Residue, R1, R2 and NOE ratio. Copy the 
table to the notepad and save it as txt format. The filename should be input.txt. 
12. Run mfdata-gen.py to generate the mfdata file. 
 
 263 
 
Protocol of TauC data processing 
1. Prepare scripts: separate_2d.c, cut.sh, fid_8.com, ft2.com, ft2_8.com, tosparky.com, getcro.pl, 
calcTauC.pl; and save them under the fid data directory (xxx.fid). 
2. To split the fid from one to 8 fids 
a. Compile the script separate_2d.c (on the unix prompt type: gcc separate_2d.c) 
b. Once you have compiled it correctly, you will see a file generated, called a.out. 
c. Edit cut.sh. If there is n values in the Delta array, you can find fid1 - fidn ni np. You 
will just execute the script cut.sh (on the unix prompt type: cut.sh). If the script works 
correctly, you will see 8 additional fids 
3.  Check fid_8.com. There are 8 convertions included. Type ./fid.com to convert the fid from 
Varian to NMRpipe format. Files named test1.fid, test2.fid….test8.fid will be generated.  
4. Type ./ft2.com to generate test1.ft2. Then use ft2.com to process the data. Open NMRDraw 
to correct the phase. Then correct the phase by editing the ft2_8.com file, and 
type ./ft2_8.com. 
5. Convert the files into Sparky format by typing csh tosparky.com. It will generate .ucsf files. 
6. Assign the spectra and calculate TauC. 
a. Open all the spectra in Sparky, as well as a spectrum already assigned. Don’t adjust 
the peak position because the peak will move from TROSY position to the normal de-
couple position in the 8 spectra increment. Assign the peaks. (You can overlay the 
1.ucsf and the assigned spectrum by (ol). Try to shift 1.ucsf and overlay peaks with 
assigned one by (st) first. Then copy the ornaments to 1.ucsf. Using center peak (pc) 
to move ornament to the center of the peaks. Then shift the spectrum back. The corre-
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sponding ornaments will shift along with the peaks. Copy the ornament of n.ucsf to 
n+1.ucsf.  
b. Once you have assigned, type pa to select all of the peaks. Type rh to open the relaxa-
tion peak fitting window. Click the ‘set up’ button to open another window, select the 
spectra and assign the time (time (ms) = 1000  Delta, the unit of Delta is sec). Click 
close once done. Then type rh again in any of the spectrum, it will calculate the decay 
time.  Save this as raw-data.list. 
c. You will use the "getcro.pl" script to convert the data to frequency, (in unix prompt 
type: ./getcro.pl raw-data.list > data.cc). The second column in data.cc will be . 
Check data.cc, and delete the rows with either zero or negative values. 
d. Now to calculated the TauC, use the "calcTauC.pl", (in the unix prompt 
type: ./calcTauC.pl data.cc > data.TauC) this will give you the TauC.  The first col-
umn should be residue number, the second column should be TauC, and the third col-
umn is error. 
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Appendix C Analysis of hydrogen bonds of MD simulation for CatchER 
Binding site: 222 224 201 203 146 (all minus 1 from the original)    
hbond net work around cro: 66 202 204 221, water 230-236, 81 71 68 6 147  
Data was saved to series hbt,         
data was sorted, intra-residue interactions are NOT included,    
Distance cutoff is 3.00 angstroms, angle cutoff is 120.00 degrees   
Hydrogen bond information dumped for occupancies > 0.1     
Dumping schematic of time series after each h-bond key follows:   
| . - o x *      @ |    
 0-5%  5-20% 20-40% 40-60% 60-80% 80-95% 95-100%  occupancy     
              
DONOR  ACCEPTORH ACCEPTOR        
  
atom#:res@atom  atom#: res@atom atom#:res@atom %occ  distance angle 
 lifetime  max occ   
Apo             
  
|  3500:221@OE2| 996 :66@HG1  995:66@OG1 | 88.5 2.752 (0.12) 13.76(-7.54)
 8.9(-7.8) 33 |**@*@x@@**x*x*****@| 
|  1013:66@O2  | 1488 :95@HH12 1486:95@NH1 | 69.5 2.804 (0.09) 34.36(-11.41) 7.3(-7.9)
 32 |-@@**x**x@**x*@.   | 
|  1013:66@O2  | 1491 :95@HH22 1489:95@NH2 | 41 2.825 (0.1) 44.84(-10.36) 1.6(-1.5)
 10 |xxoxxoo-o.----...-@| 
|  1016:66@O3  | 1415 :91@HH 1414 :91@OH  | 55.5 2.826 (0.1) 30.4(-12.66) 2.8(-2.4)
 11 |x  o--oxo*xxoxx*x*@| 
|  1006:66@OH  | 2289 :144@HH  2288:144@OH | 31.5 2.878 (0.09) 18.64(-10.15)
 1.8(-1)  4 | o--ox-- --....-.* | 
|  1006:66@OH  | 3641 :235@H1 3640 :235@O  | 15.5 2.839 (0.09) 25.75(-12.01) 1.2(-0.4)
 2 |..... ...--.-. .o. | 
|  2333:147@ND1| 1007 :66@HH 1006 :66@OH  | 41.5 2.806 (0.11) 40.69(-13.11) 2.4(-2.3)
 10 |xx..--oxooxxxx.-   | 
Holo             
  
|  3500:221@OE2 | 996 :66@HG1  995:66@OG1 | 91.5 2.725 ( 0.12) 14.54(7.20)
 11.4(7.9) 32 |@x@**@**@**x*@@**@@| 
|  1013:66@O2  | 1488 :95@HH12 1486:95@NH1 | 53 2.807 ( 0.09) 37.27(10.83) 10.6(7.7)
 22 |@@*@x***@*o        | 
|  1013:66@O2  | 1490 :95@HH21 1489:95@NH2 | 35.5 2.814 ( 0.09) 27.21 (12.21) 5.9(6.2)
 23 |          .*x*@@**@| 
|  1013:66@O2  | 1491 :95@HH22 1489:95@NH2 | 28 2.804 ( 0.08) 46.25 ( 8.25) 1.8(0.9)
 5 |o-oxoox-x-.        | 
|  1016:66@O3  | 1415 :91@HH  1414:91@OH  | 43.5 2.820 ( 0.11) 31.46 (11.54) 2.3(2.4)
 12 |-o-oxo*ox.o-o.  .*@| 
|  1016:66@O3  | 1451 :93@HE21 1450:93@NE2 | 12 2.859 ( 0.08) 23.32 (13.57) 1.4(0.8)
 4 | -.  . . ...  ox   | 
|  1006:66@OH  | 2289 :144@HH  2288:144@OH | 27 2.877 ( 0.09) 20.57 (12.58)
 1.5(0.8) 4 |- ....--.o---o----@| 
|  3599:231@O  | 1007 :66@HH  1006:66@OH  | 92 2.747 ( 0.11) 18.07 ( 8.36) 14.2(17.5)
 69 |o*@@@@@@***@*@*x@@@| 
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Apo             
  
|  3500:221@OE2 | 996 :66@HG1  995:66@OG1 | 88.5 2.752 ( 0.12) 13.76 (-7.54)
 8.9(-7.8) 33 |**@*@x@@**x*x*****@|  
|  3500:221@OE2 | 3222 :204@HG  3221:204@OG | 85 2.723 ( 0.12) 16.34 (-8.2)
 8.1(-5.4) 24 |*o******@*x***@*** |  
|  3499:221@OE1 | 3632 :232@H1 3631:232@O  | 34 2.682 ( 0.11) 20.41 (-11.07) 1.7(-1) 
 5 |o-o... .o-oo---ox.@| 
|  3499:221@OE1 | 3635 :233@H1 3634:233@O  | 43 2.710 ( 0.12) 22.8(-13.09) 1.8(-1.2)
 6 |ox*o.--ox---.o-x--@|  
|  3499:221@OE1 | 3629 :231@H1 3628:231@O  | 16.5 2.712 ( 0.11) 26.54(-12.68) 2.1(-2)
 8 | -.-*.ox           |  
Holo              
|  3500:221@OE2 | 996 :66@HG1  995:66@OG1 | 91.5 2.725 ( 0.12) 14.54 ( 7.20)
 11.4 (7.9) 32 |@x@**@**@**x*@@**@@|  
|  3500:221@OE2 | 3222 :204@HG  3221:204@OG | 98.5 2.647 ( 0.10) 13.32 ( 7.69)
 49.2 (38.2) 115 |@@*@@@@@@@@@@*@@*@@|  
|  3499:221@OE1 | 3612 :235@H1 3611:235@O  | 40 2.698 ( 0.12) 23.40 (12.66) 1.8 (0.9)
 4 |xxox-oo--oo--..---@|  
|  3499:221@OE1 | 3615 :236@H1 3614:236@O  | 52 2.683 ( 0.13) 21.90 (12.08) 2.1 (1.4)
 6 |oxoox*x-ox-.xo-xo- |  
              
Apo              
|  1049:68@O   | 1089 :71@HG  1088:71@OG  | 91 2.733 ( 0.12) 16.44(-9.64) 11.4(-
13.7) 53 |**x**@*@@@*@*@@*@x@|  
|  1044:68@OE1 | 2900 :182@HE21 2899:182@NE2| 44 2.873 ( 0.08) 22.69 (-10.98) 1.8(-1.4)
 8 |-oxxxo-xo.-o-o.-o- |  
|  3628:231@O  | 1047 :68@HE22 1045:68@NE2 | 40.5 2.870 ( 0.08) 20.27 (-11.23) 2.8(-1.7)
 7 |o .     xx*xoox*xx@|  
Holo             
  
|  1049:68@O   | 1089 :71@HG  1088:71@OG  | 82 2.744 ( 0.11) 17.83 (10.27) 7.1(8.3)
 30 |o*@@x*@xx-x*****@@@|  
|  1049:68@O   | 3597 :230@H1 3596:230@O  | 13 2.829 ( 0.10) 29.53 (14.22) 2.6(1.5)
 6 |-.     -ox.  ...   |  
|  1044:68@OE1 | 2900 :182@HE21 2899:182@NE2| 40 2.871 ( 0.08) 23.46 (10.62) 2.3(2.4)
 13 |oxx*oox---*--.     |  
|  1044:68@OE1 | 1451 :93@HE21 1450:93@NE2 | 18.5 2.858 ( 0.10) 28.83 ( 9.70) 2.5(2.3)
 10 |.          .xoo x*@|  
|  1044:68@OE1 | 1415 :91@HH  1414:91@OH  | 17.5 2.808 ( 0.13) 22.07 (11.00) 2.7(2.6)
 10 |           --oo*o  |  
|  3608:234@O   | 1047 :68@HE22 1045:68@NE2 | 68.5 2.862 ( 0.08) 20.77 ( 9.88) 3.2(2.2)
 9 |xx***xx*xxxoxxox-o@|  
             
  
Apo             
  
|  3198:202@O   | 2326 :147@H  2325:147@N   | 44.5  2.888 ( 0.07) 20.5(-10.22) 2.2(-1.7)
 10 |.*xoxo-*-.-xoox-   | 
|  2679:167@O   | 2337 :147@HE2 2336:147@NE2 | 17.5 2.855 ( 0.10) 31.98(-11.25) 1.5(-1.3)
 7 |x       ---o-.o.   |  
|  2333:147@ND1 | 1007 :66@HH  1006:66@OH   | 41.5 2.806 ( 0.11) 40.69 (-13.11) 2.4(-2.3)
 10 |xx..--oxooxxxx.-   |  
Holo             
  
|  3198:202@O   | 2326 :147@H  2325:147@N   | 54.5 2.893 ( 0.06) 18.64 ( 8.00) 2.0(1.6)
 10 |ox-ooox-xoo-oxoox*@|  
|  2679:167@O   | 2337 :147@HE2 2336:147@NE2 | 18 2.858 ( 0.08) 39.08 (12.95) 2.6(3.0)
 12 |xx*.    .  ......  |  
|  2304:145@OD1 | 2337 :147@HE2 2336:147@NE2 | 48 2.819 ( 0.09) 34.15 (12.25) 2.7(1.8)
 7 |   .o*xxxxoxo--oxx@|  
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Apo             
  
|  3198:202@O   | 2326 :147@H  2325:147@N   | 44.5 2.888 ( 0.07) 20.5(-10.22) 2.2(-1.7)
 10 |.*xoxo-*-.-xoox-   | 
|  3195:202@OG1 | 3629 :231@H1 3628:231@O   | 10.5 2.857 ( 0.10) 18.08 (-9.79) 1.5(-0.8)
 4 |-        .....-..o |  
|  3172:200@O   | 3196 :202@HG1 3195:202@OG1 | 19 2.880 ( 0.09) 21.45 (-9.84) 1.3(-0.5)
 3 |..-.....o.  . --o-@|  
|  3172:200@O   | 3196 :202@HG1 3195:202@OG1 | 19 2.880 ( 0.09) 21.45 (-9.84) 1.3(-0.5)
 3 |..-.....o.  . --o-@|  
Holo             
  
|  3198:202@O   | 2326 :147@H  2325:147@N   | 54.5 2.893 ( 0.06) 18.64 ( 8.00) 2.0(1.6)
 10 |ox-ooox-xoo-oxoox*@|  
|  3195:202@OG1 | 3609 :234@H1 3608:234@O   | 31 2.830 ( 0.11) 16.23 (11.26) 2.8(2.2)
 8 |xo xx.-o*x-      -@|  
|  3172:200@O   | 3196 :202@HG1 3195:202@OG1 | 20.5 2.888 ( 0.08) 20.48 ( 7.77) 1.3(0.8)
 5 |----.xo.-.....  .  |  
|  3172:200@O   | 3196 :202@HG1 3195:202@OG1 | 20.5 2.888 ( 0.08) 20.48 ( 7.77) 1.3(0.8)
 5 |----.xo.-.....  .  |  
|  3198:202@O   | 3600 :231@H1 3599:231@O   | 43 2.754 ( 0.11) 17.63 (10.36) 1.8(1.1)
 6 |-o---oxxo-ooo--x-o |  
             
  
Apo             
  
|  3500:221@OE2 | 3222 :204@HG  3221:204@OG | 85 2.723 ( 0.12) 16.34 ( -8.2)
 8.1(-5.4) 24 |*o******@*x***@*** |  
Holo             
|  3500:221@OE2 | 3222 :204@HG  3221:204@OG | 98.5 2.647 ( 0.10) 13.32 ( 7.69)
 49.2( 38.2) 115 |@@*@@@@@@@@@@*@@*@@|  
              
Apo              
|  3514:222@OE1 | 1110 :72@HH12 1108:72@NH1 | 39 2.788 ( 0.10) 23.4(-10.58) 3.7(-4.5)
 22 |  .x.-x*@o.ox - -x@|  
|  3514:222@OE1 | 1113 :72@HH22 1111:72@NH2 | 27.5 2.824 ( 0.09) 31.1(-9.92) 2.6(-2.1)
 8 |    .--x*..oo.o .x |  
|  3515:222@OE2 | 1113 :72@HH22 1111:72@NH2 | 20 2.824 ( 0.10) 28.58(-12.22) 2(-1.5)
 6 |   ..    .o-.xooo  |  
|  3515:222@OE2 | 1110 :72@HH12 1108:72@NH1 | 32.5 2.803 ( 0.09) 23.17 (-10.24) 3.6(-4.2)
 17 |   -o .  ox--@-@x  |  
|  3546:224@OE2 | 1106 :72@HE  1105:72@NE  | 38 2.820 ( 0.10) 27.49 (-9.28) 3.8(-4.7)
 21 | .x-  *    @**o-*o |  
|  3546:224@OE2 | 1112 :72@HH21 1111:72@NH2 | 37.5 2.808 ( 0.10) 31.96 (-9.36) 3.4(-2.6)
 10 |  *--.x   .xo*--*x@|  
|  3545:224@OE1 | 1112 :72@HH21 1111:72@NH2 | 29.5 2.808 ( 0.09) 27.9(-9.23) 2.5(-1.5)
 7 |   oo- xxo*   -x - |  
|  3545:224@OE1 | 1106 :72@HE  1105:72@NE  | 29.5 2.830 ( 0.09) 28.36(-9.38) 3.7(-3.5)
 13 |   o.. ****   -o . |  
|  2321:146@OE1 | 2677 :167@HH22 2675:167@NH2| 21 2.801 ( 0.09) 25.37 (-11.58) 3.5(-3.3)
 12 |        x*xox.-    |  
|  2324:146@O   | 2674 :167@HH12 2672:167@NH1| 15.5 2.838 ( 0.09) 33.3 (-12.34) 1.5(-0.9)
 4 |.       ----oo-    |  
|  2322:146@OE2 | 2677 :167@HH22 2675:167@NH2| 15.5 2.800 ( 0.11) 22.26 (-10.56) 2.4(-2.1)
 9 |        -.oo-x-    |  
Holo              
|  3514:222@OE1 | 1110 :72@HH12 1108:72@NH1 | 19 2.792 ( 0.10) 25.33 ( 7.92) 2.9(3.9)
 16 |         -o@o---   |  
|  3514:222@OE1 | 1113 :72@HH22 1111:72@NH2 | 16 2.817 ( 0.09) 29.79 ( 8.79) 2.3(1.9)
 7 |         .ooo-o-   |  
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|  3546:224@OE2 | 1112 :72@HH21 1111:72@NH2 | 37.5 2.795 ( 0.09) 25.73 (10.01) 3.3(3.2)
 13 |xo-xxx**.x-.-      |  
|  3545:224@OE1 | 1112 :72@HH21 1111:72@NH2 | 29 2.806 ( 0.08) 27.11 (11.72) 1.5(0.9)
 5 |-oo..-  o-oo.-o-.  |  
|  3546:224@OE2 | 1106 :72@HE  1105:72@NE  | 16.5 2.817 ( 0.09) 29.19 ( 7.92) 1.6(1.0)
 5 |o- o.oo....        |  
|  3545:224@OE1 | 1113 :72@HH22 1111:72@NH2 | 10.5 2.778 ( 0.07) 23.30 (10.38) 2.6(3.2)
 11 |            -..-.@ |  
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Appendix D Validation of Lys methylation using CaM 
The Figure Appendix D.1 showed the dispersed peaks of dimethylated Lys. The calcium 
induced conformational change can be illustrated by the chemical shift change of the methyl 
groups. Two more peaks were observed in holo-CaM at pH 7.4, indicating the chemical envi-
ronment and dynamics of Lys was different between apo and holo-CaM. Increasing pH from 7.4 
to 10.0 resulted in the rearrangement of the peaks and there was one more peak was observed at 
pH 10.0.  
 
Figure Appendix D.1. 1H-13C HMQC of dimethylated [13CH3-Lys]-CaM. (A) The dimethylated Lys me-
thyl signals of apo (green, 1 mM EGTA) and holo (red, 10 mM Ca2+) CaM in 10 mM HEPES, pH 7.4, 
100 mM KCl at 25°C. The CaM concentration was 100 μM. The ratio of H13CHO: Lys was 5:1. And the 
ratio of H13CHO:DMAB was 1:3. The reductive methylation was carried out at 4°C for overnight. (B) 
The 1H-13C HMQC spectrum of [13CH3-Lys]-CaM in the presence of Ca
2+ at pH 10.0. The assignment 
was made according to the literature published by Zhang and Vogel in 1993. 
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Appendix E Production of lentivirus 
This protocol was provided by Dr. Guofu Fang from Emory University and modified by 
You Zhuo.  
Maintain HEK 293FT in DMEM/10% FBS/1% penicillin-streptomycin medium in 10cm 
tissue culture dish. Culture the cell in a 37 ºC incubator with a 5% CO2, and split 1:4 to 1:6, three 
times per week. 
Day 1: 293FT cell seeding 
1. Passage HEK 293FT cells grown in DMEM supplemented with 10% FBS, 1% penicil-
lin -streptomycin (pH 7.35). 
2. Seed 1x10
7
 HEK 293FT cells in 15 cm dish  and add 20 ml of DMEM supplemented 
with 10% FBS,1% penicillin-streptomycin . Swirl the cells thoroughly to obtain even distribution 
across the surface of the dish. Incubate the cells for 24 h at 37 ºC with 5%CO2 
Day 2: Transfection 
1. Observe the dishes. The cells should be approximately 70% confluent. 
2. Transfection. Mix three DNA in a sterile 1.5ml tube (For 10 x150mm Dishes): 
      250 µg lentivirus transfer vector with insertion  
      187.5 µg  pCMV∆R8.92 
      125 µg  pVSVG 
A.  Add half of the DNA mixture to a sterile 50 ml conical tube, bring volume up to 6.25 
ml with sterile distilled water.  Repeat with second aliquot 
B.  Add 6.25 ml of 0.5M CaCl2  to each tube prepared in stepA, vortex for ~20-30 sec.   
C.  Add 12.5 ml of 2X HeBS (pH7.05) to a sterile 50 ml conical tube. 
D.  Use an automatic pipet aid and Pasteur pipette to bubble air through  the HeBS tube 
prepared in step C, add DNA/CaCl2 solution in a dropwise fashion.  After adding the 
DNA/CaCl2  solution, vortex for ~20-30 sec to form precipitates. 
E.  Leave the precipitates at RT for 20 min.  Re-vortex for 20-30 sec. 
F.  Add 5 ml of the solution to each plate in a drop wise manner. Gently rock the plate 
back and forth during the addition. 
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G.  Incubation under 3% CO2 was recommended. However, incubation under                                               
5% CO2 does not cause any problem as transfection efficiency is not substantially influenced by 
medium pH when HEPES buffer is used for transfection.  3% may increase neuronal trophism. 
3. Alternatively, the lipofentamin-2000 (Invitrogen) can be used for the transfection. 
Day 3: change the media 
 Remove media, add 18 ml of  pre-warmed to 37 ºC  fresh DMEM + 10% FBS/1% peni-
cillin-streptomycin, and further incubate under 5% CO2, 37 ºC . 
Day 5 and Day 6: Harvest and concentrate the viral particles 
 A.  Transfer the culture media containing the virus from each plate  to four sterile 50 ml 
conical tubes. Close the tubes, and spray them with 70% ethanol before taking them out of the 
hood. 
B.  Centrifuge at 1000 RPM for 5 min at 4º C, to pellet detached cells. 
C.  Filter the supernatant containing the virus through a 0.45 µm sterile filter unit. 
D.  Transfer the filtered medium into six 40ml Beckman ultracentrifuge tubes, place the 
tubes in a SW28 rotor. 
E.  Ultracentrifuge at 22,000 RPM (SW28) for 2 hrs at 4 º C (or 28,000 RPM for Ti45). 
F.  Open the ultracentrifuge buckets in the hood. Use forceps to take the tubes carefully 
out of the buckets. Invert the tubes to transfer the supernatants to a flask containing bleach, wait 
1 hour, and discard. Re-suspend the each virus pellet with 500µl to1 ml PBS by pipetting down 
and up a few times, avoid foaming. 
G.  Incubate on ice for 30 min. 
H.  Put six tubes resuspended virus together to 10ml Beckman ultracentrifuge tube, add 
2ml 20% sucrose sterile solution on the bottom of centrifuge tube, ultracentrifuge at 28,000 RPM 
(SW41) for 2 hrs at 4 º C 
I.  Re-suspend the virus pellet with 70-100 µl PBS. 
J.  Aliquot 5-10 μl each tube and Store viral stock at -80 º C. 
Materials: 
HEK 293 FT cells 
DMEM/10% FBS/1% penicillin-streptomycin 
PBS 
70% ethanol in a spray bottle 
1.5ml sterile tube 
10ml culture dish 
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15 cm culture dish 
50 ml sterile PP conical tubes  
250 ml 0.45 µm pore size filter apparatus with bottle 
40 ml and 10 ml ultracentrifuge tubes (Beckman) 
Solutions for Transfection: 
50 ml 0.5 M CaCl2  
1.67 g CaCl2 ·2H2O 
50 ml H2O 
Filter sterilize with 0.45 µm pore size filter apparatus with bottle. Store at 4 º C 
100 ml 2X HeBS (HEPES-Buffered Saline) 
      1.64 g NaCl 
      1.19 g HEPES free acid 
      0.04 g Na2HPO4·7H2O 
      80 ml H2O 
      Adjust pH to 7.05 with 5N NaOH 
      Filter sterilize with 0.45 µm pore size filter apparatus with bottle. Store at 4°C. 
Infect cell with lentivirus: 
Add virus with approximately 5-10 IU to the cell medium, change medium 4 -6 hours af-
ter infection. If virus titer are not sure, for virus not concentrated, add to cells with 2x dilution,  
( for example, 2ml virus with 2ml culture medium). For concentrated virus, 1ml medium add 5ul 
virus. 
 
